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Abstract
This thesis describes work focused on the chemical synthesis and herbicidal activity of
the natural product phyllostictine A, a molecule of unique structure and unknown mode
of action.
Chapter 1 serves to introduce the natural product and describe the known activity
of the natural product. Furthermore, it discusses literature methods for the construction
of α-methylene-β-lactams, a key component of phyllostictine A.
Chapter 2 describes work towards the construction of the macrocyclic rings found in
phyllostictine A. As a result α-methylene-β-lactams have been shown, for the first time,
to participate in RCM reactions. Formation of 11- and 12-membered trisubstituted
membered rings was possible, however, the nature of the nitrogen substituent has a large
impact. For example, 12-membered rings 124, 130 were formed in 37% yield when
a para-methoxyphenyl group was utilised, while simple ethyl substitution could only
achieve yields of 20%. Boc protected lactam 169 produced only linear dimer 170. The
synthesis of tetrasubstituted alkenes via RCM was attempted with lactam 145, however,
resulted in an unexpected rearrangement product. Not only was the RCM sensitive to the
nitrogen substituent but also the size of ring being formed. For example, 11-membered
rings produced significant amounts of the 22-membered dimers 89 and 87. Throughout
the RCM reactions performed in this thesis held a preference for the Z-alkene. The
trend was confirmed both by NMR shift analysis and X-ray crystallography.
Chapter 3 describes work towards the synthesis of 4,4-disubstituted α-methylene-
β-lactam subunit of phyllostictine A. Three methods: epoxide rearrangement,
carbonylation of methyleneaziridines and carbonylation of 2-bromo-allyl-propenes
were explored.
Chapter 4 describes the herbicidal activity of phyllostictine A against the single
celled algae C. reinhardtii. ED50 data was obtained for phyllostictine A against C.
reinhardtii for the first time. Furthermore, it was shown to be comparable to the
commercial herbicide glyphosate. Six novel α-methylene-β-lactams synthesised in
Chapter 2 were tested for herbicidal activity against C. reinhardtii which has enabled us
to develop preliminary structure-activity relationships.
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Chapter 1 - Introduction
This thesis is focused on the synthesis and herbicidal activity of compounds related to
the natural product phyllostictine A, isolated from the pathogenic fungus Phyllosticta
cirsii. Phyllostictine A is an exciting, structurally unique, new herbicide isolated in
2008 by Evidente and co-workers with an unknown mode of action.1
The world’s population is estimated to reach 8-11 billion by 2050, a 100% in-
crease on 1998 levels.2 Therefore, securing food for the growing population will
continue to be an important issue. The primary problem facing growers, is that, they
start from a position of food shortage3 and the higher yields traditionally gained from
successful hybrid farming are not increasing fast enough to ensure enough food in the
years ahead.4 The birth of industrial agriculture in the 19th century created its own set
of problems including; soil erosion, nutrient deficiencies, soil disease and an increase in
pests.
Of the problems faced by growers, weeds have the biggest impact on crop yields.
Not only do herbicides increase the obtainable yield, they also reduce the overall
losses.5 Many methods of crop protection have been used throughout history. Hand
weeding is the most effective, however, this is very labour intensive and gradually
its use has declined. By the 1970’s only 5% of weeds were controlled by hand, with
methods such as chemical crop protection taking over (Table 1.1). There are now over
300 registered active compounds used in crop protection spanning 25 modes of action.
However, due to misuse of these compounds weeds are now resistant to 148 herbicides
and 84% of the known modes of action, and reports of herbicide resistance increase
year on year. Further compounding the problem, no new herbicidal modes of action
have been discovered in the last 20 years.6
In the search for new effective herbicides with new modes of action, natural products
are an attractive area of study since they are are often structurally novel, selective,
require lower dosing and degrade to become environmentally benign.7
2
Chapter 1 - Introduction
Table 1.1
% Control of weeds by year in USA
Year Human Energy Animal Energy Mechanical Energy Chemical Energy
1920 40 60 − −
1947 20 10 70 −
1975 5 trace 40 55
1990 <1 trace 24 75
1.1 Natural Products in Crop Protection
A Lithica poem from c. 400 B.C. announces “All the pest that out of earth arise, the
earth itself the antidote supplies.”8 Early reports such as this highlight the long history
natural products have had in crop protection. For example, Pliny the elder (23−79 A.D.)
describes in a document on agricultural practices the use of oils for controlling pests.8
After the agricultural revolution, powdered Chrysanthemum heads were used to control
insects. The active natural product was later found to be pyrethrum, which has been com-
mercialised today as the insecticide Raid (Figure 1.1). The sheer diversity of structures
that natural products provide has allowed several of them to be commercialised either di-
rectly or as derivatives with improved activity, stability and physicochemical properties.
For example, the fungus derived strobilurin A had the acrylate portion of its structure
optimised to the commercial fungicide Amistar by Syngenta (Figure 1.1).9 Furthermore,
the oil of the Myrtaceae shrub leptospermone has been optimised and commercialised
into the broad spectrum herbicide Callisto by Syngenta (Figure 1.1).10
1.2 Pathogenic fungas Phyllosticta
Phyllosticta is a genus of phytopathogens that cause leaf spot symptoms and fruit
diseases to an range of hosts, including some economically important crops like
citrus,11 banana, apple and grapes.12 The Phyllosticta species cause necrotic lesions
generally, circular, small and 1-2 mm in diameter. After infection, the leaf becomes
dry in the centre of the lesion, ultimately, the infected portion falls out and creates a hole.
3
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Figure 1.1
Whilst these effects are caused by herbicidal metabolites, other biologically ac-
tive metabolites have been isolated from various Phyllosticta species. For example,
taxol (entry 8, Table 1.2) a potent anti-cancer drug, and brefeldin (entry 1, Table 1.2) a
well studied antibiotic.
Table 1.2
Entry Compound Properties Taxa Ref.
1 Brefeldin Bioactive metabolite P. medicaginis 13
2 Phyllosinol Bioactive metabolite Phyllosticta. sp., P. maydis 14
3 Phyllostictine Mycoherbicide, anti-cancer P. cirsii 1,15
4 Phyllostin Anti-microbial P. cirsii 16
5 Phyllostoxin Mycoherbicide P. cirsii 16
6 PM-toxin Mycoherbicide P. maydis 17
7 Tauranine Anti-cancer activity P. spinarum 18
8 Taxol Anti-cancer activity P. tabernaemontanae 19
9 Phyllospinarone Inhibition of cell proliferation P. spinarum 18
4
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1.2.1 Phyllosticta cirsii
The genus of Phyllosticta has not been thoroughly studied, however, Phyllosticta cirsii
has yielded a variety of useful compounds, resulting from initial investigations into the
use of P. cirsii as a biocontrol for Canada thistle.20 It was this initial discovery as a po-
tential biocontrol, that lead to the eventual isolation of the active metabolites phyllostin,
phyllostoxin and the phyllostictines (Figure 1.2).
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1.3 Phyllostictines
The phyllostictines are a family of four natural products isolated in 2008 by Evidente
and co-workers (Figure 1.2). They were isolated from the filtrate cultures of Cirsium
arvense (L.) infected with P. cirsii. Also known as Canada thistle, C. arvense is a potent
weed native to the Mediterranean, that has colonised most of the world, and can reduce
wheat yields by up to 45%.21
1.3.1 Isolation and Structural Identification
The organic extract of the liquid culture (7.7 L) of P. cirsii had high phytotoxicity.
Extensive purification using a combination of column chromatography and thin layer
5
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chromatography provided four metabolites, phyllostictines A-D, containing an oxaza-
tricycloalkenone ring system (Figure 1.2). Their unique structures were characterised
primarily by a combination of 1H and 13C-NMR spectroscopy.
Phyllostictine A was found to have an initial molecular formula of C17H27NO5,
consistent with five double bond equivalents. The lactam carbonyl and tetrasubstituted
alkene were identified by NMR and IR spectroscopy. The IR also identified hydroxyl
groups, with the UV spectrum offering evidence of an α,β-unsaturated lactam. The Et
group on the nitrogen of the lactam was easily identified by a triplet at 0.83 ppm which
was coupled to a methylene at 1.30 ppm.
1
2
3 N 4
O
5 6
O 7
89
MeO OH
10
11
1213
14
15
HO
Me
Et
H
N
O
O
MeO OR
HO
Me
Et
H
R = S-MTPA
R = R-MTPA
Phyllostictine A
O
Ph
MeO CF3
R =
1
2
Figure 1.3
The absolute stereochemistry at C-15 was determined by the Mosher’s
method (Figure 1.3). Reaction of phyllostictine A with R-(−)-α-methoxy-α-
trifluoromethylphenylacetyl (MTPA) and S-(+)-MTPA chlorides yielded the di-
astereomeric S-MTPA and R-MTPA esters respectively. The comparison of these esters
with phyllostictine A gave the following differences in ppm [∆δ(1−2): H-11 +0.07;
H2-10 + 0.17; H-9 + 0.24; H-9’ + 0.13]. This allowed assignment of the S-configuration
at C-15. NOESY spectroscopy was used to identify the geometry of the double bond.
H-15 enhanced H-11, OMe and Me-C(5) indicating the depicted E-configuration of
the tetrasubstituted double bond. This NOESY data was used to assign the relative
configuration at C-5, C-11 and C-12 as R, S, and S respectively, to give the final
structure seen in Figure 1.3. Although Evidente and co-workers reported phyllostictine
6
Chapter 1 - Introduction
A as a clear oil, it would clearly be desirable to derivatise it as a crystalline solid, to
unambiguously confirm the proposed structure by X-ray crystallography.
1.3.2 Biological Activity
The four phyllostictines were tested in a leaf puncture assay, with isolated leaves of
Canada thistle. All were tested at a concentration of approximately 6 mM. The leaves
were kept moist for 3 days, at which time necrosis was seen. Phyllostictine A was
found to have the greatest activity (entry 1, Table 1.3) having necrosis of >5 mm. Phyl-
lostictines B and D had necrosis between 3-5 mm (entries 2 and 4, Table 1.3). Phyllostic-
tine C showed no activity (entry 3, Table 1.3) at this concentration. From these results,
Evidente and co-workers proposed a structure-activity relationship based on conforma-
tional freedom, and activity. They suggested that the lactam, and its nitrogen substituent
is not the origin of the activity.
Table 1.3
Entry Phyllostictine Toxicitya (20 µL 6 mM)
1 A ++++
2 B +++
3 C −
4 D +++
ascale: −, non toxic, +++, necrosis 3-5 mm, ++++,
necrosis >5 mm
Additional biological screens were undertaken. Phyllostictines A and B were tested
for anti-fungal activity against Geotrichum candidum, however, even at concentrations
as high as 100 µg/disk, they were completely inactive. Anti-bacterial activity was also
investigated. Against Lactobacillus (Gram+) bacteria, phyllostictine A was active at
5 µg/disk, whilst even when tested at 100 µg/disk, it was inactive against Escherichia
coli (Gram−). Finally, phyllostictine A caused total mortality of Artemia salina (brine
shrimp) at 10−3 M whilst phyllostictine B produced negligible activity.
Since phyllostictine A was the most active member of the family it was taken
forward for further investigation. A report by Zonno disclosed optimised phyllostictine
7
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A production of 28 mg/L.22 Phyllostictine A, furasic acid (a well known fungal toxin),
and the broad spectrum herbicide glyphosate were tested against isolated protoplasts of
C. arvense and tobacco leaf. Phyllostictine A at 10−3 M was shown to be faster acting
than glyphosate at 4.2−3 M in both assays, causing 100% inhibition (relative to the
control) after 6 h.22
The activity appears to be time dependent, for example, after 1 h in the thistle
protoplast assay, phyllostictine A at 5 x 10−4 M inhibits 50% of the control but after
6 h this had increased to 100%. The other herbicides tested did not show such a
time dependency, with furasic acid and glyphosate inhibiting around 60% and 40%
respectively, for the 6 h duration. These assays revealed that phyllostictine A could
have a foliar application, and that compared to furasic acid, a potent fungal toxin, it was
significantly more effective at similar concentrations (Figure 1.4).
In 2009, Vurro reported additional herbicidal activities of phyllostictine A. Phyl-
lostictine A was shown to inhibit the germination of Orobanche ramosa seeds, by 5%
at 10 µM, and 28% at 100 µM as a percentage of the control.7
In 2011, Kiss and co-workers reported phyllostictine A also has anti-cancer activ-
ity. Although it did not discriminate between proliferating cancer and normal cells,15 it
was shown to possess in vitro anti-cancer activity against a variety of human cancer cell
lines (U373 GBM, A549 NSCLC, Hs683 and SKMEL-28). Potency at the µM level
was observed. Furthermore, using mass spectrometry, some evidence for conjugate
addition of the thiol of cystine to C-2 of phyllostictine A was presented.
1.3.3 Known β-Lactam Herbicides
The phyllostictines all contain lactams, with A-C containing a β-lactam. β-Lactams are
well known for their antibiotic activity, providing the active functionality of the peni-
cillins. However, as far as we are aware, there is only one report of β-lactams inducing
8
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Figure 1.4 – Reproduced from Plant Sci., 2008, 175, 818-825.22
herbicidal activity. Tabtoxin (3) a monobactam metabolite of Pseudomonas syringae pv.
tabaci, which causes wildfire disease in tobacco. Like the phyllostictines, it has diverse
biological activity, being highly toxic to bacteria, algae, higher plants and animals. It has
been well studied, with Baldwin reporting the stereospecific total synthesis in 198423,24
and Crop Genetics International, patenting its use as a growth regulator and herbicide.25
NH
OOH
NH2
N
H
OOHO
OH
3
Figure 1.5
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1.4 Synthesis of α-Methylene-β-Lactams
Methods for the synthesis of α-methylene-β-lactams are quite limited, and those
available are reviewed herein being pertinent to the context of this thesis. This section
focusses on the major advances in the formation of α-methylene-β-lactams over the
last 50 years or so, with isolated examples of α-methylene-β-lactam formation26–33 not
discussed in detail.
The earliest report of their synthesis was by Moriconi and Kelly in 1966 from
CSI addition to allenes.34,35 Use of only a few allenes was surveyed (Scheme 1.1).
HN
O
•
1. Chlorosulfonyl
    isocyanate
2. Hydrolysis
7 examples, 40-91%
HN
O
77%
HN
O
H
64%
E:Z 1.3:8.7
HN
O
40%
Scheme 1.1
In 1978, three new methods36–38 for the formation of α-methylene-β-lactams were
reported, inspired by detailed reports of the biological activity of α-methylene-β-
lactones.39
Of these three methods, the most widely explored, was reported by Fletcher and
Kay of ICI Plant Protection. In a one-pot process, dibromo amide 4 was converted to 5
under phase transfer conditions (Scheme 1.2).
Some variation in the nitrogen substituents was possible, although yields were lower
with N-alkyl derivatives. No examples were reported with substituents at the alkene
terminus, or at the saturated ring carbon. The authors reported that lactam 6 rapidly
forms adducts with dimethylamine and ethanethiol at room temperature.
10
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96% 18% 83%
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Scheme 1.2
In 1978, Shibuya reported a new synthesis from a preformed β-lactam 7. The
synthesis begins with enolate formation and subsequent capture with TMS-Cl to give
silane 8. Further treatment with LDA followed by addition of a ketone, gives the
3-trimethylsilylcarbinol that undergoes elimination to give lactam 9 (Scheme 1.3). This
method enables substitution of the alkene terminus. Ohno would later use this method-
ology in the first total synthesis of the α-methylene-β-lactam containing antibiotic
asparenomycin C.27
N
O
N
O
TMS
N
O
R1
R2
1. LDA, THF, -78 °C 1. LDA, THF, -78 °C, 2. R1 R2
O
2. TMS-Cl 6 examples, 43-93%
N
Me
Me
N
Me
Ph
N
Ph Ph Ph
OPh OPh OPh
93% 86% 43%
7 8 9
Scheme 1.3
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Agawa has reported an alternative method to introduce the exocyclic double bond.37,40,41
The essential feature of this method is elimination of a sulphoxide or selenoxide, to
generate the methylene group. The authors were able to improve upon the initial report
which required temperatures >200 °C at reduced pressure with sulphoxides,37 to milder
elimination conditions of refluxing CH2Cl2 using the phenylselenoxide. The precursor
lactams 10 were derived from a Staudinger reaction of a selenium containing ketene 11,
generated in situ from 2-phenylselenopropanoyl chloride (12), and subsequent reaction
with various imines. Whilst different imines would give the potential for variation at
C-4, they only reported phenyl substitution at this position (Scheme 1.4).
O
Cl
Me
PhSe O•PhSe
Me
N
O
R' Ph
H
Me
SePh
N
O
R' Ph
H
3 examples
H2O2, CH2Cl2
Pyridine
RN=CHPh
Et3N, benzene
67-92%
12 11
1013
Scheme 1.4
After several reports of antibiotics containing α-methylene-β-lactams,27,42,43 Buynak
disclosed several papers on the chemistry of α-methylene-β-lactams.44–46 His synthesis
exploited the silver catalysed rearrangement of propargylic acetates to allenyl acetates.
He was able to show through crystallography that the methylene group is conjugated
to the amide, due to the coplanarity seen in the structure (Figure 1.6). Furthermore, he
explored some of the chemistry related to lactam 14. For example, the oxidation of 15
with selenium dioxide to form aldehyde 16, hydrogenation of 14 with PtO2 forming the
cis product 17 exclusively, and finally the alkylation of the nitrogen with simple alkyl
electrophiles (Scheme 1.5).
The next major breakthrough came with Mori’s carbonylation of 2-bromopropenylamine
23. Looking for a route to rapidly access analogues of monobactams, he discovered the
12
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palladium catalysed carbonylation of 23 was an efficient route to these molecules. It
showed good tolerance for different N-substitutions, and could be extended to include
derivatives substituted at either the alkene or C-4. The disadvantage of this method
was the need to use highly toxic HMPA. Furthermore, lengthy precursor syntheses
and variable yields were observed for lactams substituted at C-4. However, it marked
the first instance of α-methylene-β-lactams being formed by transition metal catalysis
(Scheme 1.6).
Tanaka showed that allyl stannanes 25 can be converted to the corresponding bromide
26 which can be further ring closed to α-methylene-β-lactams 27. Yields were consis-
tently good and this method is applicable to chiral substrates. The main limitation of the
13
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method lies in the synthesis of the allyl stannane precursors (Scheme 1.7).47
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In 1987, Alpa reported the metal catalysed synthesis of α-methylene-β-lactams from
methyleneaziridines.48 Using a palladium catalyst and triphenylphosphine, carbon
monoxide inserts regioselectively into the N−C sp2 bond. Only five examples were re-
ported, and all involved N-alkyl methyleneaziridines (Scheme 1.8).
Tanaka49 in a variation of his previous method, disclosed new methodology for the syn-
thesis of α-methylene-β-lactams. The dianion derived from 28 was added to an alde-
hyde. After formation of mesylate 29, the diastereomers were separted by chromatog-
raphy. Exposure of 29 to TBAF produced lactam 30 as a side product. When 29 was
exposed to NaH, 31 was formed in 55-61% yield. Only the phenyl substituted nitro-
gen is reported, but the potential variation in the initial carbonyl addition should not be
14
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underplayed (Scheme 1.9).
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In 1990, Alcaide reported a novel approach to α-methylene-β-lactams based on
Staudinger lactam formation.50,51 The lactam was formed exclusively as the trans di-
astereomer. Amine 32 is converted to the α-methylene-β-lactam by quaternization of
the amine with excess methyl iodide, followed by elimination with DBU. The route al-
lows for mono-substitution at C-4 through the imine partner and a few varied examples
are illustrated (Scheme 1.10). In 1991, Matsuda52 and co-workers reported the synthe-
sis of α-silylmethylene-β-lactams by rhodium catalysed carbonylation. Most notably,
examples were produced in which C-4 was fully substituted (Scheme 1.11).
Adam and co-workers have reported the synthesis of chiral α-methylene-β-lactams.53
Racemic 33 was subjected to kinetic resolution using Chirazyme® lipase L-2 (Candida
antarctica). This precusor 34 was produced in four steps using a simple ring closure
strategy (Scheme 1.12). Alternatively, kinetic resolution of 35 with allyl acetate and
Chirazyme L-1® (Burkholderia sp.) provided resolved acetate 36 which could be hydrol-
15
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ysed and transformed using Scheme 1.12 to yield enantiomerically pure α-methylene-
β-lactam 37 (Scheme 1.13).
Ma54 reported a general method for the synthesis of α-methylene-β-lactams via PdII
catalysed carbonylation of propargylic amines. The product contains a vinyl chloride
handle, that could be useful in subsequent transformations. The reported route offers
little variation in the N-substituent (R”’ = H, Bn or Ts), however, many examples are
provided of mono-substitution at C-4 (Scheme 1.14). Chiral amines were carbonylated to
give the corresponding α-methylene-β-lactam with high levels of enantiomeric excess.
Kambe and co-workers,55,56 have reported α-methylene-β-lactam synthesis from sub-
stituted carbamoyls, either by radical 4-exo-dig cyclisation of radicals or Pd catalysed
intramolecular addition. This novel radical cyclisation provided modest yields and no
clear route to removing the β-tellurium atom (Scheme 1.15).
Most recently You, Lei and co-workers reported a mild carbonylation of allylamines
16
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using palladium(II) in combination with copper(II) as a reoxidant to form α-methylene-
β-lactams under 1 bar of CO. They reported that it tolerates many N-substituents with
yields ranging from 27-98%. The chemistry allowed introduction of C-4 substituents
with enantiocontrol (Scheme 1.16).
In conclusion, there are many useful methods for the synthesis of α-methylene-β-
lactams, however, the synthesis of 4,4-disubstituted derivatives remains challenging. In
the context of any total synthesis of phyllostictine A, methods for their formation in an
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enantiocontrolled manner will need to be developed.
18
Chapter 1 - Introduction
R'
H
N
H
R''
N
O
R' R''
N
O
PMP
41% 93% ee
N
O
PMP
82%
N
O
n-C12H25
62%
N
O
Bn
60%
PdCl2, Cu(OPiv)2
PCy3, PivOH
CO, DMF, 100 °C
23 examples, 27-98%
Scheme 1.16
19
Chapter 1 - Introduction
1.5 Synthetic Analysis of Phyllostictine A
The phyllostictines are a structurally challenging class of molecule, with interesting
biology. To date, no synthetic studies directed towards the phyllostictines have been
disclosed. Our group is interested in developing routes to these molecules, in-particular,
achieving the first total synthesis of phyllostictine A. Along the way, we hope to develop
a deeper understanding of the herbicidal mode of action of these natural products. The
synthesis of simpler analogues, will be an important tool in determining their mode
of action, as well as potentially improving their potency and suitability as commercial
herbicides.
Our planned strategy to phyllostictine A is based upon an audacious ring closing
metathesis reaction to produce the tetrasubstituted double bond by closure of diene 38.
Demostrating the feasibility of undertaking RCM reactions of α-methylene-β-lactams
forms the basis of the work described in Chapter 2. The diene necessary to complete the
final step is anticipated to come from the cross coupling of THF 39 and α-methylene-β-
lactam 40, followed by functional group interconversions. Dr. Geden in our group has
already synthesised THF 39. Efforts are now focused on its asymmetric synthesis.
The α-methylene-β-lactam contained in phyllostictine A presents a significant
synthetic challenge, due to the fact it is both chiral and 4,4-disubstituted. As we
have seen, there are relatively few methods of forming α-methylene-β-lactams. In
the first instance it will be important to establish methods for synthesising racemic
4,4-disubstituted α-methylene-β-lactams. This topic is the basis of the work presented
in Chapter 3.
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1.6 Conclusions
Growing global populations and the misuse of herbicides has lead to the situation where
some weeds are now resistant to all the current classes of herbicide action. No new
modes of action have been identified for over 20 years. Recently, phyllostictine A, a
new potent mycoherbicide, faster acting than glyphosate and more potent than furasic
acid, has been isolated which represents an exciting new avenue for research in this
area. It contains a unique structure that was identified by a combination of MS and
NMR techniques. The Mosher’s method was used to assign the absolute and relative
stereochemistry in combination with NOESY measurements.
A key challenge in any total synthesis of these natural products will involve con-
trol of the stereochemistry at the fully substituted C-5 carbon, and formation of the
tetrasubstituted double bond of the α-methylene-β-lactam. Current knowledge of
their herbicidal mode of action is very limited. Three key ideas are explored in this
thesis: (i) the development of methods for the synthesis of the 11- and 12-membered
macrocyclic rings of phyllostictine A via RCM, (ii) an exploration of approaches to the
4,4-disubstituted α-methylene-β-lactam unit, and (iii) further development of biological
assays and structure-activity relationships related to this compound class.
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2.1 Synthetic Strategy to Phyllostictine A
Chapter 1 highlighted phyllostictine A as a fascinating natural product displaying
varied biological activity via unknown mechanisms of action. Due to the difficulties
in isolating large quantities of it from natural sources, we wish to complete the
first total synthesis of this natural product. In doing so, we also had in mind that
we wished to: (i) establish a flexible synthetic route - allowing other members of
the phyllostictine family to be made; (ii) explore the biological activity of various
synthetic intermediates, to probe the mechanism of action; and (iii) use this to develop
structure-activity relationships and hence create simpler synthetic herbicides. Com-
pletion of the total synthesis would also confirm the structure and absolute configuration.
The key steps in the strategy are described in section 1.5 and employ attractive
transition metal catalysed reactions (Scheme 1.17). It is hoped that the new knowl-
edge and chemistry developed will find application beyond phyllostictine A. This
chapter details work using model systems to ascertain whether the macrocyclic
ring of phyllostictine A can be made by ring closing metathesis (RCM). To date,
α-methylene-β-lactams have not been used as substrates in RCM. These investigations
were expected to identify: (i) the most effective catalyst systems; (ii) methods for
controlling the stereochemistry about the tetrasubstituted double bond; (iii) the optimal
N-substitution pattern for the sensitive β-lactam; and (iv) what ring sizes can be made,
thus determining which phyllostictines can be made by this approach.
We selected two simple substrates 41 and 42 for initial investigation. Upon RCM, diene
41 might produce macrocycle 43, which overlays the 12-membered ring of phyllostic-
tine A. Alternatively diene 42 would yield 44, mapping the smaller 11-membered ring
(Scheme 2.1). Thus, our first objective was to establish suitable routes to dienes 41 and
42 and examine their RCM chemistry.
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From the methods of forming α-methylene-β-lactams surveyed in section 1.4, we
chose to use the method reported by Adam and co-workers to construct these lactams
(Scheme 2.2).53 This method uses the ring closure of an activated alcohol 45, to make
the α-methylene-β-lactam 46 (Scheme 2.2). The acrylic acid 47 can be readily accessed
via the Bayliss-Hillman reaction and subsequent hydrolysis of the acrylate ester.
This is an attractive route because it provides easy substitution at two key posi-
tions. Firstly, the amide substituent can be varied by changing the amine partner in the
coupling reaction to form 48. Specifically it has been shown that protecting groups such
as PMP can be removed under mild conditions53 and replaced with other useful groups
such as Boc57 and secondly, the alkyl group ultimately attached to C-4 of the lactam
ring can be readily changed by varying the aldehyde utilised in the Bayliss-Hillman
reaction.
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2.2 Introduction to Alkene Metathesis
Metathesis reactions derive their names from the Greek meta - “change” and the-
sis - “places”. They have had a huge impact on the chemical community since their
discovery. For example, ring closing metathesis (RCM), cross metathesis (CM), ring
opening metathesis (ROM), enyne metathesis, ring opening metathesis polymerisation
(ROMP), and acyclic diene metathesis (ADMET) all have found widespread application
(Scheme 2.3).
Ph2C−W(CO)5 was the first well defined catalyst reported to show metathesis activity.58
Until then only weak metathesis activity had been reported with transition metal salts
that were combined with main group alkylating agents, for example, WOCl4/EtAlCl2.
Owing to this, the technique did not become popular with synthetic chemists until 1990,
when, Schrock introduced the molybdenum catalyst SH (Figure 2.1).59 This catalyst
showed excellent activity with a variety of alkenes, and although it requires the total
exclusion of oxygen and moisture, it still remains an important catalyst for sterically
hindered substrates or those possessing basic substituents such as amines.
The development of Ru based catalysts in the late 1980s came from the observa-
tion that performing ROMP reactions in water with RuCl3(hydrate) reduced the
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initiation time from 20 h in organic solvents to 30 min.60 Over the next two decades,
several important Ru catalysts were subsequently reported. Today, three routinely used
commercially available catalysts* are: G1,62 G2,63 and HG264,65 (Figure 2.1). The
introduction of these catalysts has changed the landscape of organic synthesis. They
are extremely powerful reagents, for reasons not limited to their high activity, ability to
simultaneously make and break C−C bonds, and their high functional group tolerance.
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*Complexes of this nature are more appropriately named initiators, because they cannot be easily
recovered after the reaction is complete. However, the word catalyst is so ubiquitous in the metathesis
literature that herein, this term is used.61
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2.2.1 Mechanism
The mechanism for olefin metathesis was originally proposed by Chauvin in 197166
(later supported with studies from Grubbs)67 and involves a series of alternating [2+2]
cycloadditions and cycloreversions via a metallacyclobutane intermediate (Scheme 2.4).
The individual steps are reversible, and therefore, the product distribution is generally
under thermodynamic control. The irreversible loss of ethylene frequently provides the
driving force for the forward reaction.
Ru
R'
Ru
R'R''
Ru
Ru
R'
R''
R'
R'
R''
Scheme 2.4
2.2.2 Use in Natural Product Synthesis
The first successful use of ring closing metathesis in natural product synthesis was
reported by Hoveyda and provided the late stage intermediate 49 in the synthesis of
the anti-fungal agent Sch 38516 alglycone 50 (Scheme 2.5).68 Other notable exam-
ples include; Nicolaou’s synthesis of the epothilones, which are potent anti-cancer com-
pounds,69 and Wood’s total synthesis of ingenol70 (51), a molecule with a diverse range
of biological activities (Scheme 2.6).
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2.2.3 Metathesis Reactions of α-Methylene-β-Lactams
In 2006, Howell and co-workers reported the cross metathesis (CM) of 3-
alkylideneoxetan-2-one 55 with a variety of alkenes using both G2 and HG2 to yield
trisubstituted alkenes 56 in 55-94% yield and Z:E selectivities of >20:1 in some in-
stances (Scheme 2.7).71
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Next they examined use of the corresponding α-methylene-β-lactams. These substrates
undergo CM with a variety of partners and nitrogen substituents. Interestingly they
28
Chapter 2 - Simplified Phyllostictine A Analogues via Metathesis
showed that for the first time, tetrasubstituted alkenes could be formed via CM.57
The reaction is clearly sensitive to the nature of the N-substituent. For instance,
comparing the results of three different N-substituents: Boc, H, PMP in the reaction
with 1-pentene, they discovered that although the yields and E:Z selectivities were
broadly similar, Boc protection required just one aliquot of the catalyst to be added,
whilst the free amide required three, and the PMP protected lactam five (Scheme 2.8).
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R1 R1
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Scheme 2.8
Furthermore, Boc substituted lactam 59 was the only one effective for tetrasubstituted
double bond formation. Similar yields were observed in the formation of tetrasubstituted
lactam 60 and trisubstituted lactam 61. However, the E:Z selectivity was affected, with
poorer selectivity seen in the formation of 60 (Scheme 2.9). With the α-methylene-β-
lactam of phyllostictine A being tetrasubstituted, it is encouraging that tetrasubstituted
alkenes can be formed via metathesis processes.
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By extending this methodology to RCM, this offers a potential route to the phyl-
lostictines. Forming tetrasubstituted double bonds by RCM, although uncommon, is a
known process. Grubbs and co-workers have developed catalysts specifically for this
task,72,73 whilst novel methods involving relay ring closing metathesis have also been
reported.74 However, the use of RCM to form tetra-substituted double bonds in natural
product total synthesis is rare. Reiser reported the formation of tetra-substituted double
bonds whilst investigating the total synthesis of the guaianolide ixerin Y, using G2 and
microwave irradiation.75 However, it is Stoltz’s report of the total synthesis of elatol 62
that is the first total synthesis employing novel catalysts to form tetrasubstituted double
bonds via RCM (Scheme 2.10).76
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2.3 Ring Closing Metathesis of N-Ethyl Lactams
2.3.1 Initial Studies Towards 11-Membered Rings
The simplest model system we could conceive was 65, bearing an N-ethyl substituent
analogous to the natural product itself. The synthesis of this molecule being explored by
RCM of diene 66 (Scheme 2.11).
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The synthesis of diene 66 began from the commercially available aldehyde 67, which
was subjected to a Baylis-Hillman reaction, yielding ester 68, in 55% yield after 7 days.†
Smooth transformation to carboxylic acid 69 with lithium hydroxide and subsequent
coupling with EtNH2 in THF gave amide 70 in 95% yield. EDC gave better results than
initial attempts with DCC, whose reactions were poor yielding with products less easy
to purify. Subsequent mesylation yielded mesylate 71 in 68% yield. Finally, ring clo-
sure with KOt-Bu at −15 °C yielded α-methylene-β-lactam 66, in an acceptable 23%
yield over the 5 steps (Scheme 2.12). The structure of lactam 66 was positively identi-
fied by the distinctive C=O IR stretch at 1747 cm-1 indicative of the β-lactam ring, the
α-methylene functionality also has distinctive singlets in the 1H-NMR at 5.57 and 5.01
ppm, respectively. Before commencing any ring closing metathesis reactions, some pre-
liminary cross metathesis reactions were carried out to gain some confidence with the
technique.
†Yields of the Baylis-Hillman reactions with long chain aldehydes such as 67 could be improved to
80%, however, extended reaction times in excess of 30 days were required.
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2.3.2 Establishing E,Z Chemical Shifts of α-Methylene-β-lactams
Although Howell reported many examples of CM with α-methylene-β-lactams, we
wished to repeat some of this work to have authentic NMR data to compare our RCM
products to and also synthesise some novel cross partners which were not investigated
by Howell. Knowing that the PMP group can be removed under oxidation with CAN,
and with reports that PMB could be removed in the same way,77 we synthesised lactam
73 and lactam 74. Lactam 73 was made via the Adam’s method, beginning from para
formaldehyde in 5 steps (Scheme 2.13).
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Lactam 74, was synthesised via carbonylation of bromide 80, which in turn, was synthe-
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sised in 90% yield from 2,3-dibromopropene and p-methoxybenzylamine. The carbony-
lation conditions involved use of Pd(PPh3)4, nBu3N, CO and DMAc. The reaction gave
the desired product 74 in 30% yield (Scheme 2.14) . Wanting to improve upon this, a
brief exploration of the ligand was undertaken. Throughout the optimisation Pd(OAc)2
was used as the Pd source Table 2.1 summarises our findings.
N
H
PMB
Br
N
O PMBPd(OAc)2, L, nBu3N
CO, DMAc, 100 °C
80 74
Scheme 2.14
Table 2.1
Ligand (L) Yield
PPh3 30%
xphos® 28%
xantphos® 60%
dppp 30%
The use of the bulky monodentate ligand Xphos® produced a comparable result to
the monodentate ligand PPh3. Next we trialled a bidentate ligand Xantphos® which
is extremely bulky and produced an improvement in yield. The less bulky bidentate
ligand, would have we used the 1,3-bis(diphenylphosphino)propane (dppp), proved less
useful.
With lactams 73 and 74 in hand, several relevant cross partners were reacted sep-
arately with both 73 and 74 under the general general conditions shown in Scheme 2.15.
The most successful cross partner was 1-octene (81) (entry 1, Table 2.2) with good
yields seen with 73 and 74. Allyl acetate (82) gave lower yields with both 73 and 74
(entry 2, Table 2.2). The other oxygen containing compounds only produced trace
33
Chapter 2 - Simplified Phyllostictine A Analogues via Metathesis
amounts of material with 74 and none with 73 (entry 3 and 4, Table 2.2). Finally, the
branched alkene 83 did not react with either starting material under these conditions
(entry 5, Table 2.2).
N N
O O RR
R'R = PMP, PMB
G2, CH2Cl2, reflux
Scheme 2.15
Table 2.2
Entry Cross Partner Conditions Yield with PMB Yield with PMP
1 81 2% G2 54% E:Z 4:1 89% E:Z 1.6:1
2
OAc
82 2% G2 25% E only 10% E:Z 10:1
3
OEt
84 2% G2
12% E only 0%
4
OH
83 2% G2 trace E:Z 1:1.3 0%
5
85
2% G2 0% 0%
The cross coupling reaction of 1-octene with 74 produced both the E and Z isomer.
This allowed us to establish the relative chemical shifts for E and Z isomers of
α-methylene-β-lactams. The isomers were readily separated by simple chromatography
and we were able to correlate the chemical shifts with reported alkene shifts.57 A full
table of the E and Z shifts recorded for α-methylene-β-lactams synthesised in this thesis
can be found in Appendix II.
Using 66, a RCM reaction was carried out with Grubbs 2nd generation catalyst
(G2) at 2 mM concentration for 24 h in refluxing CH2Cl2. Disappointingly, after
work up and chromatography, no 11-membered ring products could be isolated.
Semi-preparative HPLC of the alkene containing fractions, allowed two products
to be isolated; the linear dimer 86 (32%), and the 22-membered dimer 87 (2%),
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(Scheme 2.16). In the 1H-NMR spectra of lactam 87, the distinctive singlets of the
α-methylene group and terminal double bond pattern of 66, had been replaced by a
double triplet at 5.44 ppm, resulting from the one remaining alkene environment in the
molecule. Furthermore the m/z 465 [M + Na]+ of 87 was supportive of a cyclic dimer.
With regards to the alkene stereochemistry, from the experiments carried out in section
2.3.2 and the chemical shifts reported by Howell, the double bond 87 was assigned as
the Z-isomer. X-ray structures of related dimeric α-methylene-β-lactams 88, 89 and
90 reported later in this chapter which were also Z-configured, further supporting this
assignment.
Lactam 86 was identified by the distinctive singlets at 5.54 ppm and 5.02 ppm
and lack of terminal double bond pattern, which was replaced by single triplet at 5.31
ppm. In both cases the indicative carbonyl stretch of approx 1740 cm-1 was seen in the
IR spectrum, confirming the presence of β-lactam rings. Furthermore, a molecular ion
m/z 493 [M + Na] consistent with 86 was seen by mass spectrometry.
N
O
Et
N
O
Et
N
O Et
N
N
O
OEt
Et
22
10 mol % G2, CH2Cl2
2 mM, 55 °C, 24 h
2%
32%
66
86
87
Scheme 2.16
The formation of 11-membered rings by RCM does have precedent, however, they are
rarely efficient.78 For example, in Harmata’s synthesis of buddledone A, the conforma-
tional freedom and angle strain of diene 91 lead to the formation of linear dimer 92 as
the thermodynamic product.79 Other products isolated were the styrene coupled prod-
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uct and the starting material. A solution to the problem was eventually found by taking
advantage of the geminal disubstitution effect, imparted by TMS-protected cyanohydrin
93. This substitution released the conformational strain and allowed the formation of
buddledone A 94 in 31% over seven steps (Scheme 2.17).
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Me
Me
Me
O
Me
Me Me
Me Me
Me
O
Me
Me
Me
TMSO CN
Me
O
Me
Me
1. 20 mol % HG2
    20 mol % benzoquinone
    toluene, reflux, 48 h
2. TBAF, THF, 0 °C
59%
RCM
TMSCN
1 mol % ZnI2
THF, 12 h
94 %
91 92
93 94
Scheme 2.17
Hoveyda has also made useful observations, during the synthesis of clavirolide C (95).
Whilst RCM to form clavirolide C intermediate 96 was facile with allylic silyl ether
97, it was noted that the corresponding α,β-unsaturated ketone (not depicted) lead to
significant (30-35%) formation of the 22-membered homodimer. These two examples
highlight the sensitivity of these 11-membered ring forming reactions to subtleties in
substrate design (Scheme 2.18).
O OSiEt3MeOHH
Me
O
Me
H
OSiEt3
Me
OHHG2, Cl(CH2)2Cl
83 °C, 6 h
70%
O
Me
H
O
Me Me
O
Me97 96 95
Scheme 2.18
The isolation of 86 and 87 indicates that the formation of the 11-membered ring is not
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favored with α-methylene-β-lactams. Linear dimers often occur with unsymmetrical
dienes, and there formation is via “acyclic diene metathesis” (ADMET). It is usually
thought that metathesis steps are all reversible. However, in cases where the rate of
the reverse reaction with ethylene is slower than the dimer formation due to ethylene’s
poor solubility in CH2Cl2 results in a situation where the formation of the ADMET
dimer can be thought of as irreversible.80 This essentially shuts down the simple RCM
model for macrocycle synthesis. If monomer formation is to proceed it must go via
a cyclo-depolymerisation reaction. Fogg and co-workers provide evidence for this
mechanistic pathway by observing by GC and MALDI-MS, the formation of ADMET
dimers that subsequently, and quantitatively formed the RCM product. This has given
significant support for the idea that ADMET dimers are intermediates in RCM.80
An explanation for the observed products is presented in Scheme 2.19. Formation of 86
from 66 is irreversible by loss of ethylene. The formation of 98 is maybe slow due to
steric effects of the lactam, or electronic interactions with the amide. The catalyst at this
point may become deactivated by decomposition ending the reaction with 86 as product.
However, if formed, 98 does not appear to undergo cyclo-depolymerisation to
form the desired 11-membered 65. Instead 98 proceeds with another ADMET addition
with the presumably the most reactive alkene of 66, presumed to be the terminal
alkene. The trimer 99 may now undergo cyclo-depolymerisation to form the low strain
22-membered ring 87, and 100. Simple RCM of 100 however, is not observed and it
must either decompose becoming inactive or return to the ADMET cycle (Scheme 2.19).
It should be noted that due to the poor mass balance in this reaction, small quan-
tities of the 11-membered ring may have been formed but not isolated. Rather than
attempt to improve this reaction through variation in catalyst or reaction conditions, we
decided to explore the synthesis of the larger 12-membered ring.
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Scheme 2.19
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2.3.3 Towards 12-Membered Ring Systems
Since the synthesis of the 11-membered ring was not successful with an N-Et substituent,
we decided to explore construction of ether 101 via RCM (Scheme 2.20).
N
O
O
Et
N
O
O
Et
RCM
N
O
O
MeO OH
HO
Me
Et
Phyllostictine A102 101
Scheme 2.20
The synthesis of α-methylene-β-lactam 102 employed the same methodology used in
Scheme 2.12, however, starting from the commercially available 1,8-octadiol (103). This
versatile diol would prove to be invaluable in subsequent experiments. Using literature
methods,81 103 underwent ether synthesis with NaH and 1.1 equivalents of allyl bro-
mide, purification to remove the di-allylated material yielded 104 in a 40% yield. Sub-
sequent oxidation with PCC yielded the corresponding aldehyde 105, in 22% yield over
the two steps (Scheme 2.21). This methodology enabled us to make 105 in multi-gram
quantities.
HO OH O OH
6
O O
6
NaH, allyl bromide
TBAI, THF, 70 °C
40%
PCC, CH2Cl2
57%
103 104 105
Scheme 2.21
In a further 5 steps, we were able to produce the required α-methylene-β-lactam 102,
using the same methodology described previously (Scheme 2.22). No attempts to opti-
mise the relativity low yielding cyclisation to 102 were made as adequate quantities of
materials could be obtained.
RCM was attempted with 102, under a variety of conditions. For example, using G2 (10
mol%) at 2 mM concentration; HG2 catalyst at 2 mM; G1 catalyst at 2 mM. However,
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Scheme 2.22
none were seemingly successful. Products with the correct m/z [M + Na]+ 260 corre-
sponding to the 12-membered ring were observed by ESI-MS, but when chromatography
was used to purify these compounds, no clean products could be obtained. Other prod-
ucts were also observed by ESI-MS including what we believe to be the linear dimer
m/z [M + Na]+ 525 and the styrene coupled product [M + Na]+ 364. Attempts to iso-
late these free of impurities were also unsuccessful. No further attempts were made to
optimise the use of 102, and an alternative method was sort for the formation of 101.
2.3.4 Use of the Crotyl Group
We looked for ways to improve the synthesis of 101 from diene 102. Some initial
attempts involved using Lewis acidic additives (CuCl,65 TiOi-Pr82), as we speculated
that the amide nitrogen may have been interacting with the catalyst. However, these
reactions were unsuccessful. Evidence of the linear dimer being formed in both these
reactions by ESI-MS and 1H-NMR provided some support for an ADMET mechanism.
One of the key features of the ADMET mechanism is loss of ethylene contributing
to the stagnation of the forward reactions. Propene is less volatile and has a higher
solubility than ethylene in organic solvents,83,84 therefore we imagined that use of the
crotyl group could impart some reversibility to the initial step.
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This approach is somewhat analogues to relay ring closing metathesis. This strat-
egy involves the fast formation of cyclopentene to form Ru= in otherwise hindered
or deactivated positions. For example, Porco Jr’s total synthesis of oximidine III
intermediateiate (110) utilities relay RCM in a key step.85 Finding that 111 could
not convert to 110 with either the G2 or HG2 catalysts, they installed, via CM a
readily available terminal alkene 112. When 112 was exposed to HG, facile loss of
cyclopentene generated active Ru species 113 that subsequently formed 110 in 71%
yield.
O O
OTBSO
OPMB
O O
OTBSO
OPMB
H H
O O
OTBSO
OPMB
H
O O
OTBSO
[Ru]
OPMB
H10 mol % HG2
DCE, 71%
10 mol % G2 or HG2, CH2Cl2
111
112 113
110
Scheme 2.23
Whilst this is an elegant approach, due to the readily available nature of crotyl bromide
we looked to explore if generation of propene in the initiation would facilitate the for-
mation of the 12-membered ring. In 7 steps, we were able to prepare the crotyl derived
lactam 114 using the Adam’s approach (Scheme 2.24).
When the RCM was attempted with lactam 114, for the first time the desired
12-membered ring was formed. After initial column chromatography, and further
purification by semi-preparative HPLC, two products were isolated. They had distinct
1H-NMR spectra and were identified as the 24-membered dimer 120 (29%), and the
required 12-membered ring 101 (20%) (Scheme 2.25). However, 101 was not stable,
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Scheme 2.24
and decomposed in CDCl3 while full spectroscopic data was being acquired. Initial
1H-NMR data pointed towards the Z-stereochemistry, with the alkene having a similar
chemical shift to other Z-lactams (Appendix II). The dimeric product was evidenced by
its molecular ion m/z 497 [M + Na]+.
Insufficient material was available to repeat this result, and since other strategies
being undertaken in parallel proved more fruitful, the 7-step sequence to reproduce this
chemistry was not undertaken. The structure of 101 was later confirmed by comparison
with material made via an alternative route (Scheme 2.45).
G2 CH2Cl2, 55 °C
N
O
O
EtN
O
O
Et
12
O
O
N
N
O
O
Et
Et
24
114 101 120
Scheme 2.25
Whilst the yield of the product was rather modest, these represents the first examples of
RCM reactions of α-methylene-β-lactams. Furthermore, it was encouraging to see that
the 12-membered ring was formed in the “correct” Z-geometry relative to the natural
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product.
2.4 Ring Closing Metathesis Systems containing N-Para-
methoxyphenyl Lactams
Finding that the N-Et systems gave low yields at best in the RCM chemistry, and know-
ing that the CM metathesis of α-methylene-β-lactams is sensitive to the N-substituent,
we decided to examine the use of other N-protecting groups. To this end, we were drawn
to the use of the N-para-methoxyphenyl (N-PMP) group, which can be successfully re-
moved from α-methylene-β-lactams by use of ceric ammonium nitrate (CAN) depro-
tection.53 Moreover, alkylation of the resulting N-H compounds is reported to be facile
with simple electrophiles.46 Thus we set out to explore the synthesis and RCM reactions
of lactams 121 and 122 (Scheme 2.26).
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O PMP
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O
MeO OH
HO
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Phyllostictine A
N
O
O
MeO OH
HO
Me
Et
Phyllostictine A
RCM
121 123
122 124
Scheme 2.26
2.4.1 Towards 11-Membered Rings
The requisite 11-membered ring precursor 121 was readily synthesised in 3 steps from
acylic acid 125. (Scheme 2.27).
When diene 121 was exposed to G2, at a substrate concentration of 2 mM, the re-
sults were encouraging. The crude 1H-NMR spectrum did not show any of the linear
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dimer seen in Scheme 2.16. However, the mass balance was poor, and, there were a lot
of decomposition products. After chromatography, both 123 and 89 could be isolated
(Scheme 2.28). The 11- and 22-membered rings respectively had distinct NMR spectra.
Interestingly, both were isolated as single geometric isomers, with no evidence for the
alternative isomer by NMR. Dimer 89 appeared to be produced as a mixture of diastere-
omers (as judged by 13C-NMR) however, only one of which was crystalline and helped
to confirm the structure of the dimer.
G2, CH2Cl2, 55 °C
6%
N
O PMP
2211
N
N
O
OPMP
PMP
19%
N
H
O PMP
H
H
2 mM
H
H
121
123
89
Scheme 2.28
Whilst we were reasonably confident of our assignment of Z-stereochemistry based on
NMR shifts, crystals suitable for X-ray diffraction were obtained for the 11-membered
123. The crystal structure confirmed this assignment. (Figure 2.2). Crystals seemingly
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suitable for diffraction were also obtained for the 22-membered ring 89, and it was also
shown to be Z-configured. However, due to the poor quality of the large crystals, this
structure could not be fully refined to publishable limits.
Figure 2.2
The formation of 123 was encouraging as it was the first time we had been able to
produce this ring size and properly isolate an RCM product. The preference for the
Z-isomer might be explained by considering trans-annular strain. The alternative geo-
metric isomer, E-128 appears to suffer from significant steric clashing of CH2 groups,
encouraging the less strained Z-isomer to be formed (Figure 2.3). Further evidence is
provided by molecular mechanics calculations (MMFF94 force field). Calculations of
zero point energy for the indivdual isomers places E-128 at 227.23 kJ/mol and Z-123
at 223.55 kJ/mol. Of course, this analysis assumes that the reaction is under thermody-
namic control (vide infra).
H
N
O
PMP N
O
PMP
H
steric clash no steric clash
E- Z-128 123
Figure 2.3
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2.4.2 Towards 12-Membered Rings
As PMP protection had led to improvements in the RCM to 11-membered rings, this
modification was also explored for the formation of the larger ring size. The now well
established method for making the dienes was applied to the synthesis of α-methylene-
β-lactam 122, in 38% yield over 3 steps, from 107 (Scheme 2.29).
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Scheme 2.29
α-Methylene-β-lactam 122 was treated with the G2 catalyst at 2 mM substrate
concentration for 24 h. After work up and chromatography, three products were
isolated. The 24-membered product 88, and a chromatographically inseparable 1:1.6
E:Z ratio of the 12-membered products 131 and 124 (Scheme 2.30). Trace amounts
of the linear dimer (identified by ESI-MS) was also detected. Although the dimer was
isolated as 2 diasteromers (as judged by 13C-NMR) only one was crystalline and X-ray
crystallography was used to prove its structure.
The better yields with both N-Et and N-PMP derivatives indicate that, the 12-
membered macrocycles are more readily formed than 11-membered macrocycles. It is
not clear whether it is a reduction in ring strain that results in the improved yields, or if
the ether oxygen is having a positive effect on the cyclisation.
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Crystals suitable for X-ray diffraction were obtained from both the dimeric mate-
rial, and also the major Z-isomer 124. Both were shown to possess the Z-alkene
stereochemistry (Figure 2.4).
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24
37%
H
H122 124 131 88
Scheme 2.30
Figure 2.4
Encouraged by this initial result, we tested other common metathesis catalysts. The G1
catalyst returned starting material exclusively, whilst the HG2 catalyst produced linear
dimer 132 in 65% yield (Scheme 2.31).
HG2, CH2Cl2, 55 °C
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Scheme 2.31
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Use of the a crotyl substituted diene in section 2.3.4 led to some improvements previ-
ously, hence we elected to make crotyl substituted lactam 133. The requisite lactam was
made in 3 steps from 117.
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Scheme 2.32
When lactam 136 was exposed to the G2 catalyst at 2 mM concentration, the results
were disappointing. The combined yields 124/131 were lower at 20%, 88 was produced
in larger amounts (Scheme 2.33). Although the stereoselectivity of the 12-membered
rings was slightly improved to 1:3, no further experiments were carried out with this
system, due to the unfavourable results.
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Scheme 2.33
With the most common catalysts trialed and no improvement found, a series of dilution
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Table 2.3
Entry [mmol]a % Yield E-131 : Z-124
1 2 37 1:1.6
2 1 33 1:2.3
3 0.5 44 1:3.9
4 0.25 44 1:8.4
aConcentration of CH2Cl2 related to the substrate 122 with 10 mol% G2
experiments were carried out. The aim was to suppress dimer formation. Surprisingly,
this did not occur. The yield of the dimer 88 remained more or less constant. However,
the E:Z ratio did markedly change. At 0.25 mmol concentration (entry 4, Table 2.3)
>8:1 selectivity in favor of the Z-isomer was observed. One explanation is that over
time the Z-isomer, was being preferentially transformed into the dimer, eroding the E:Z
selectivity. To test this, 124 was purified by semi-preparative HPLC. Attempts were also
made to isolate 131 by semi-preparative HPLC, however, this was not successful.
Lactams 124 and 88 were then separately exposed to the initial metathesis reaction
conditions: 2 mM, G2, refluxing CH2Cl2 for 24 h. After work-up, both were analysed
by analytical HPLC. In the case of 124, redistribution of products was seen, with both
131 and 88 observed, in a ratio of 124:131:88 1.3:1.2:1 (by HPLC), and approximately
similar ratio was seen by 1H-NMR (Appendix III).
Using 88, although 131 could not be detected, a peak corresponding to 124 was
observed after resubjection to the metathesis conditions, in a ratio of 124:88 1:5.6. None
of the linear dimer was seen in either experiment.
These results indicate that the products are in equilibrium, and that dimer 88 is
not the thermodynamic product since if it was 88 would have remained unaffected by
the reaction conditions. Other reports in the literature support this supposition. For ex-
ample, Clark reports the formation of 137, as an inseparable mixture as well as a dimeric
product 138, during the synthesis of marine polycyclic ether sub-units (Scheme 2.34).86
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In this case, the dimeric product 138 was shown to be the thermodynamic product,
by re-subjecting it to the reactions conditions and returning only starting material 138
(Scheme 2.35).
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Whilst the HPLC experiments show that the reaction is under equilibrium, the exact
mechanism for isomerisation of the monomeric products is not clear. Stereoisomers 131
and 124 could interconvert by reformation of the Ru carbene intermediates, or by simple
isomerisation of the alkene. For example, the catalyst could degrade to RuCl2(PR3)3 in
situ, catalysts which are known to isomerise alkenes.87 Further investigation would be
required to more fully understand this complex process.
To explore structure-activity relationships (vide infra) of phyllostictine A, we
wanted to determine if the α-methylene group was important for herbicidal activity.
To this end, 141 was prepared by the hydrogenation of a mixture of 131 and 124 with
PtO2 under an atmosphere of H2. After chromatography, the hydrogenated analogue
141 was isolated in an unoptimised 48% yield as a single stereoisomer (Scheme 2.37).
This material was tentatively assigned as syn- as a result of addition of hydrogen to the
least hindered face of 124. The addition of H2 to other lactams has been shown to occur
in a syn-fashion.45 For example, Buynak took 142 and removed the double bond with
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PtO2 to form 143 exclusively (Scheme 2.36).
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2.4.3 Towards Tetrasubstituted Alkenes
Having established for the first time that α-methylene-β-lactams undergo RCM to form
trisubstituted double bonds, we next wanted to ascertain if this could be extended to the
preparation of tetrasubstituted alkenes, more closely related to phyllostictine A.
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Scheme 2.38
Tetrasubstituted alkenes are difficult to form via RCM, and often require non-standard
catalysts.72 For example, Grubbs reported several catalysts derived from the HG2 cata-
lyst. These new catalysts were obtained through optimisation of the substitution pattern
on the NHC aromatic rings.
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Using this modified catalyst GN, they were able to reduce the reaction times from: 24 h
to 1 h in general. In some cases (entry 1, Table 2.4) GN improved the yield from 30%
to >95%. Although GN is highly efficient with symmetric dienes (entry 1, Table 2.4),
it was not able to catalyse the formation of the 6-membered lactone 146 (entry 3, Ta-
ble 2.4).72 Examples such as this, highlight the challenges faced when using a RCM
strategy to form phyllostictine A.
Table 2.4
Entry Substrate Conversion % Product
HG2 GN
1
E E
147
30, 24 h >95, <1 h
Me Me
E E
150
2 O
148
43, 24 h 88, 11 h
O
151
3 O
O 149
0 0
O
O
146
To explore this further, we set about the synthesis of diene 144 with a view to forming
145 (Scheme 2.38). Lactam 144 was synthesised using the versatile approach outlined
previously. 1,8-Octanediol (103) was alkylated with 3-bromo-2-methylpropene using
NaH and tetrabutylammonium iodide. Subsequent oxidation with PCC yielded the alde-
hyde 152 in 23% yield over the 2 steps.
The Bayliss-Hillman reaction of 152 with methyl acrylate 72 proceeded in 60% yield.
Hydrolysis of ester 154 produced acid 155 in 74% yield. Subsequent amide coupling
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yielded 156, however, it could not be readily purified and co-eluted with excess p-
anisidine. As a result, this amide was subjected to mesylation and ring closure without
purification. The final lactam 144 was isolated free from p-anisidine in 32% yield over
these 3 steps (Scheme 2.40).
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Scheme 2.40
Howell reported that the HG2 catalyst was effective for promoting CM to form tetra-
substituted α-methylene-β-lactams. Therefore, 144 was exposed to this catalyst using
the standard conditions of 2 mM, at reflux for 24 h. Upon work up, no reaction was seen
and the starting material was returned. α-Methylene-β-lactam 144, was then subjected
to RCM with the G2 catalyst. Upon work up, chromatography and semi-preparative
HPLC two products were isolated. The styrene coupled product 158 in 66% yield
(relative to the styrene available from the catalyst) and lactam 159 ( 10%), where a
methyl group had been added to the α-methylene-β-lactam (Scheme 2.41). Lactam 159
was finally assigned using a combination of mass spectrometry and 1H-NMR.
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Initially we were intrigued by the 1H-NMR because where we were expecting no
alkene signal, there were three each integrating to one hydrogen. Furthermore, a new
doublet integrating to three hydrogens at 2.01 ppm (J = 7 Hz) was also seen. The
distinctive α-methylene signals had been replaced with a quartet at 5.65 ppm, indicating
that substitution had taken place. It was assigned as the Z-stereoisomer on the basis
of the chemical shift. This quartet coupled strongly in the COSY spectrum with the
new doublet at 2.01 ppm. Further evidence for this molecule was given by the mass
spectrum. The observed mass of m/z 394 [M + Na]+ was fully consistant with 159.
G2, CH2Cl2, 55 °C
N
O
O
PMP
N
O
O
PMP
~10%
144 159
Scheme 2.41
Products such as this can arise from the isomerisation of the initial alkenes, promoted
by thermal catalyst decomposition products.88,89 In the case of 159, it is proposed that
a substrate induced decomposition occurs. Steynberg has used DFT to model substrate
induced catalyst decomposition in both G1 and G2 catalysts (Scheme 2.42).90 This
DFT modelling proposed that, upon coordination of the substrate with the active Ru=
species 160, β-hydride transfer of the metallacyclobutane occurs forming 161 with an
energy barrier of 24.3 kcal/mol for G2. The energy barrier for processes such as 160 to
162 is calculated to be 12 kcal/mol.91
The resulting Ru-allyl intermediate 161 now proceeds to form propene 163, via
hydride transfer to the terminal allyl carbon, with an energetic cost of -2.3 kcal/mol.90
The resulting RuII species is inactive in metathesis, being coordinatively unsaturated.
Further evidence for this decomposition pathway was given when ethene saturated C6D6
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solution was exposed to the G1 catalyst. Following the reaction by 1H-NMR, Steynberg
and co-workers found that after 16 h a mixture of propene, 1-butene, 2-butene, cyclo-
propane, and isobutene could be observed, in a 60:21:10:7:2 ratio, determined by GC
(Scheme 2.43).
PCy3
Ru
PCy3
Cl
CH2
Cl
C6D6, 40 °C
Scheme 2.43
Guided by these results, we propose the following mechanism to account for the forma-
tion of the methyl substituted product 159. In lactam 144, both alkenes are hindered and
disubstituted, therefore, coordination with Ru to either alkene is slow and disfavored.
Coordination with the α-methylene group could occur leading to β-hydride transfer, ul-
timately making the catalyst inactive (Scheme 2.44). A possible reason why this is not
seen in the trisubstituted systems is that the terminal alkene is more reactive. Additional
support for this comes from the observation that the linear dimers formed are derived
from the terminal alkene and not from the α-methylene group.
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2.4.4 N-Et lactam formation
As seen in Scheme 2.25, formation of lactam 101 was low yielding. One solution would
be to interchange the PMP for an ethyl group after the RCM. Deprotection with ceric am-
monium nitrate in MeCN/H2O after 1 h, produced the unprotected lactam. This was im-
mediately subjected to alkylation using KOH with Et-I as solvent. After semi-preparative
HPLC, lactam 101 was isolated in 21% yield, over the two steps and as a single isomer
(Scheme 2.45). The resulting product was identical by 1H-NMR to that formed directly
from lactam 114 (Scheme 2.24). On this occasion, full characterisation was obtained
successfully.
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It is appropriate to note that the quality of the CAN used in the deprotection was critical
to success. Using old stocks, no reaction was seen even with under very forcing con-
ditions (refluxing MeCN/H2O, 24 h). However, newly purchased CAN, gave complete
deprotection in 1 h.
2.5 N-Boc Protected 12-Membered Ring System
In Howell’s paper on the cross metathesis of α-methylene-β-lactams, the best yields
were achieved with Boc protected lactams.57 With the N-Et lactams being low yielding
and optimisation with PMP somewhat exhausted, we looked to use Boc protection to
improve the yields of the RCM reactions. Importantly, N-Boc can be removed under
mild conditions in the presence of β-lactams.92
The most convenient route to N-Boc derivative 167 was via the PMP protected
lactam 122. Subjection of 122 to CAN deprotection followed by immediate protection,
with Boc2O57 yielded the Boc protected lactam 167, in 35% yield over 2 steps
(Scheme 2.46). No further efforts were made to optimise this reaction.
1. CAN, MeCN, H2O, 0 °CN
O
O
PMP
2. Boc2O, DMAP, MeCN
N
O
O
Boc
35%
122 167
Scheme 2.46
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Disappointingly, reaction of 167 with the G2 catalyst, did not yield the 12-membered
ring, but linear dimer 168 in 83% yield (Scheme 2.47).
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O Boc
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G2,
CH2Cl2, 55 °C
167
168
Scheme 2.47
Although Howell reported that Boc protected α-methylene-β-lactams are effective in
CM, a small increase in the steric bulk of the lactam prevented reaction (Scheme 2.48).
Since 167 is somewhat analogous to the structure of 169, this may account for the
disappointing results we obtained.
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R1 R1
169
170
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172
Scheme 2.48
Linear dimers are not unusual in RCM reactions that involve highly asymmetric dienes.
For example, Blechert reported that acrylate 173 preferentially forms dimer 174, rather
than 5-membered ring 175 (Scheme 2.49).64
With no hint of the desired product being formed, no further attempts were made
to optimise these reactions and instead we changed out focus to other members of the
phyllostictine family.
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2.6 Ring Closing Metathesis Studies Towards Phyllostictine C
Phyllostictine C contains a smaller 10-membered carbocyclic ring. In parallel with the
other studies, we sought to examine if this smaller ring size could be made by the same
RCM strategy. We were especially interested to ascertain if the smaller ring might result
in the formation of the E-stereochemistry, since up to this point we had seen selectivity
for the Z-stereoisomer.
We selected the PMP protecting group, as this had led to the best yields in RCM
reactions so far. Thus we targeted the preparation of diene 176, with a view to making
177 (Scheme 2.50).
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Scheme 2.50
The required diene 176, was synthesised from the commercial available aldehyde 178,
according to the scheme laid out in Scheme 2.51. After successful reaction with methyl
acrylate in a Bayliss-Hillman reaction, 179 was isolated in 39% yield. Subsequent
hydrolysis with lithium hydroxide to 180 allowed amide coupling with p-anisidine,
mediated by DCC to be achieved, forming amide 181 in 43% yield. Mesylate 182 was
successfully formed in 61% yield. Finally, ring closure with KOt-Bu yielded 176 in a
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modest 40% yield.
O
OMe
O
OMe
OH
O
OH
OH
O
N
H
OH
PMP
O
N
H
OMs
LiOH⋅H2O
THF/H2O
DCC
p-anisidine
CH2Cl2, 43%
KOtBu, THF
39% 99%
61%40%
PMP
H
O
7
7 7
7
7
N
O PMP
DABCO
MeOH
MsCl, Et3N
CH2Cl2
178 72 179 183
181182176
Scheme 2.51
Diene 176 was exposed to the G2 catalyst at 2 mM in refluxing CH2Cl2. After 4 hours,
no change was seen by TLC, and the reaction was worked up. After chromatography,
the 20-membered dimer 90, was isolated in 37% along with a trace of starting material
(Scheme 2.52). Lactam 90 was identified by its distinctive m/z [M + Na]+ 570, with none
of the desired product m/z [M + Na]+ 308 being seen. Linear dimer was also detected
having m/z [M + Na]+ 621 in the mass spectrum of some alkene containing fractions.
However, we were unable to separate it from the impurities. The stereochemistry was
assigned initially as Z on the basis of the alkene proton in the 1H-NMR δ = 5.70-5.57.
It was consistent with those of the 22- and 24- membered rings which have δ = 5.52
and 5.86-5.80 respectively. The stereochemistry was later confirmed by X-ray crystal-
lography (Figure 2.6). Generally, 10-membered rings have the largest ring strain of the
medium ring cycloalkanes93 and therefore, it is perhaps not surprising that this reaction
failed to yield 177.
Undeterred, we reasoned that it might be possible to form the 10-membered ring from
the more flexible lactam precursor 181. Therefore, 181 was exposed to the same RCM
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Figure 2.6
conditions as 176. None of the desired compound was obtained after chromatogra-
phy. The only isolated product was the linear dimer m/z [M + Na]+ 657 in trace
amounts, which contained the distinctive α-methylene singlets but no terminal double
bond (Scheme 2.53). There is scope to potentially isolate the 10-membered ring by sub-
jecting 184 to a more reactive catalyst, for example, the SH catalyst,94 although these
ideas were not pursued at this juncture.
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Scheme 2.53
Such behaviour has been seen with other Bayliss-Hillman derived substrates.95 Kim re-
ported that, exposure of 186 to G2 in toluene, produced 187 rather than lactone 188.
The only other compound isolated was 189 resulting from initiation of the catalyst
(Scheme 2.54).
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Moreover, Song has shown that simple Bayliss-Hillman substrates 190, will not form
the desired 8- or 9-membered rings but instead the dimers 191 as the thermodynamic
products (Scheme 2.55).96,97
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2.7 Conclusions
α-Methylene-β-lactams have been shown to undergo RCM for the first time and
the resulting methodology used to produce a simple analogue of phyllostictine A.
Mechanistic studies have thus far been rather inconclusive. There is some evidence
that the macrocyclic products maybe formed via an ADMET mediated mechanism,
however, the reversibility of the reaction was demonstrated through re-subjection of
products to the reaction conditions.
In general, reactions involving N-Et substituted β-lactams were poor yielding, for
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reasons that are unclear. The desired 11-membered ring 65 could not be isolated,
only the 22-membered dimer 192. With the larger 12-membered precursor 102, it was
possible to produce 12-membered ring 101 in poor yields by the use of the crotyl group
in the starting diene (Scheme 2.24). Side products were the 24-membered cyclic dimer
193 and the linear dimer 194. Interestingly, selectivity for the Z-stereochemistry was
observed.
A great improvement was made in the RCM of α-methylene-β-lactams by chang-
ing to the PMP protecting group. It is clear that 12-membered rings were more easily
produced than 11-membered rings, as the reactions produced less dimeric products.
Under optimised conditions of: G2 catalyst, 0.25 mM substrate concentration, it was
possible to produce 124 from 122 in 38% yield as a >8:1 Z:E isomers (Scheme 2.30).
HPLC studies have shown that, dimer 88 is not the thermodynamic product and
that 12-membered 124 is an equilibrium with it, under the ring closing metathesis
conditions.98
Tetrasubstituted analogues such as 145 could not be produced using this method-
ology, however, non standard catalysts such as GH may yet prove fruitful in the
future. An unusual methyl addition product 159 was seen when this was attempted
(Scheme 2.41).
Although the Boc protected α-methylene-β-lactam 167 was active in RCM, it did
not improve upon the results obtained with PMP protected lactam 122. Clearly, the
amide substituent is a very important factor in the outcome of these reactions.
Finally, we attempted to produce phyllostictine C analogues using this methodol-
ogy. However, no trace of 177 was seen and the dimeric product 90 was obtained. More
reactive catalysts may allows access to such 10-membered rings, although this is yet to
be tested.
63
Chapter 3
Towards the α-methylene-β-lactam
core of phyllostictine A
64
Chapter 3 - Towards the α-methylene-β-lactam core of phyllostictine A
3.1 New Routes to Form 4,4-Disubstituted α-Methylene-β-Lactams
In Chapter 2, the feasibility of using RCM to make the 12-membered ring of phyllostic-
tine A was demonstrated. The synthesis of the RCM precursors being achieved via a
lengthy but reliable route.53
Phyllostictine A contains not only a tetrasubstituted double bond but also a fully
substituted chiral carbon at C-5 (Figure 1.4). From the survey of methods to form
α-methylene-β-lactams carried out in Chapter 1, it is clear that no asymmetric methods
for the synthesis of 4,4-disubstituted α-methylene-β-lactams currently exist. In light of
this, we imagined that we would need to develop new methodology in this regard to
complete the total synthesis.
Of the methods surveyed, three stood out in terms of their potential to form asymmetric
α-methylene-β-lactams (Scheme 3.1). Firstly, the Staudinger synthesis of β-lactams
could provide access to simple chiral analogues, however, for this to be effective, the
methylene functionality would need to be installed after lactam formation. We proposed
that this could potentially be achieved via epoxide rearrangement.
Secondly, by ring expansion of a methyleneaziridine. The advantage of this method
would be that methyleneaziridines can be alkylated asymmetrically99 allowing for
effective formation of substituted α-methylene-β-lactams. Finally, carbonylative ring
closure was appealing because it was imagined that both simple and complex substrates
could be accessed readily under mild conditions, via the Overman rearrangement, for
which asymmetric variants exist.100
Clearly, many questions remain regarding the use of these methods. For example,
no general methods exist for rearranging epoxides to form α-methylene-β-lactams.
Methyleneaziridines substituted at C-3 have not been shown to undergo carbonylation,
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and the carbonylation of 2-bromoallyl amines does not currently extend to making
4,4-disubstituted α-methylene-β-lactams.
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This chapter details studies directed towards 4,4-disubstituted α-methylene-β-lactams
by exploration of these different routes. It was imagined these studies might identify the
most efficient routes to 4,4-disubstituted α-methylene-β-lactams relevant to the synthe-
sis of the natural product.
3.2 Epoxide Rearrangement
The only report of α-methylene-β-lactams being formed directly from the rearrangement
of epoxides, is as an undesired side product during the synthesis of (-)-SCH 57939, a po-
tential cholesterol absorption inhibitor. Epoxide 195 was exposed to p-FC6H4ONa with
the aim of forming lactam 196. However, the rearrangement product 197 was isolated in
20% yield alongside 196.101
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Related methods based on cyclic carbonate rearrangements via loss of CO2, have also
been reported. For example, Meegan and co-workers used triphosgene to form cyclic
carbonate 198, which was subsequently eliminated with DBU to form α-methylene-β-
lactam 199 in 72% (Scheme 3.3).102 These examples gave us some encouragement to
explore this strategy in the context of the total synthesis of phyllostictine A.
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67%
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To test the strategy of epoxide rearrangement to form α-methylene-β-lactams, we tar-
geted the formation of 201, by way of epoxide 202 (Scheme 3.4). This methodology has
the potential to concurrently introduce the C-15 hydroxyl group.
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To rapidly access lactams with which to test epoxide rearrangement, we used the
Staudinger synthesis to form allylic lactam 203 (Scheme 3.5). The Staudinger synthesis
uses the reactivity of an acid chloride to generate a ketene, that is then subject to
nucleophilic attack by an imine forming a zwitterionic intermediate. This intermediate
undergoes a conrotatory electrocyclic ring-closure to form the β-lactam as product.103
Using this procedure is attractive because methods for controlling the enantioselectivity
of the two stereocenters formed in the reaction are well established.104 Hence, it could
provide a route to phyllostictine A, if epoxide opening to form the corresponding
α-methylene-β-lactams could be achieved.
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Crotonyl chloride (204) and the preformed imine 205, derived from aniline and
benzaldehyde, were combined with Et3N to form lactam 203 as a single diastereomer in
46% yield after chromatography (Scheme 3.5). The data were consistent with literature
values.105 Lactam 203 was then exposed to mCPBA, providing 206 as a 1:2.5 ratio of
inseparable diastereomers, in 70% yield (Scheme 3.5). The relative stereochemistry of
the two diastereomers was not determined, and the mixture was used in subsequent
studies.
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With 206 in hand, a variety of non-nucleophilic bases were explored to try and open
epoxide 206 (Table 3.1). DBN and DBU were initially trialled since they are bulky
non-nucleophilic bases, and are often used in E1cB processes. However, reaction with
206 returned the starting material exclusively when stirred at room temperature (entries
1-2, Table 3.1). Similar results were obtained at 55 °C. KOtBu resulted in consumption
of the starting material but lactam 207 was not observed (entry 5, Table 3.1).
Strong lithium bases were also investigated. After reaction at −78 °C with LDA,
the crude 1H-NMR appeared to have a small alkene peak at δ = 5.82 as a double, dou-
blet. However, after column chromatography, 207 was not recovered (entry 6, Table 3.1).
LiNEt2 was also reacted with 206. In this case, two double doublets were seen at
5.80 ppm and 6.14 ppm potentially, derived from the two diastereomers of 207. Again,
after column chromatography, these products could not be isolated.
An acid promoted rearrangement was also attempted with CSA, in MeCN/DMSO
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(1:1). However, this returned starting material even when heated to 80 °C (entry 6,
Table 3.1). With no immediate success being achieved with this method, and the
relativity harsh conditions that would likely be needed to effect introduction of the
double bond, this strategy was abandoned.
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Scheme 3.6
Table 3.1
Entry Reagent Solvent Temp. °C Yield %
1 DBN Toluene rt 0
2 DBU Toluene rt 0
3 DBN Toluene 55 0
4 DBU Toluene 55 0
5 KOtBu HOtBu rt 0
6 LDA THF -78 trace
7 LiNEt2 THF rt trace
8 CSA MeCN/DMSO 80 0
3.3 Ring Expansion of Methyleneaziridines
The ring expansion of methyleneazirdines is a potentially powerful way to access the
α-methylene-β-lactam of phyllostictine A. This is because substituents can be readily
introduced at C-3 of the ring.106 Furthermore, stereoselectivity can be achieved in this
alkyation by use of a homochiral N-substituent. For example, Shipman and co-workers
have shown that useful levels of diastereocontrol can be realised using the use of simple
(S)-N-(1-phenylethyl) substituent (Scheme 3.7).99,107
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Combining the known alkylation and ring expansion chemistries of methyleneaziridines,
with the ring forming potential via RCM of α-methylene-β-lactams, one can conceive
a strategy to phyllostictine A. For example, model systems could be constructed from
methyleneaziridine 208 by double alkylation to give 209, before undergoing carbonyla-
tion to form 210 and finally RCM to form α-methylene-β-lactam 211 (Scheme 3.8).
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3.3.1 Use of (S)-N-(1-Phenylethyl)-2-methyleneaziridine
Whilst N-ethyl methyleneaziridine would yield the closest analogues of phyllostic-
tine A, it is very volatile, and difficult to isolate.108 As an alternative, the versatile
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methyleneaziridine 212 was used in initial studies. This methyleneaziridine 212 was
prepared and isolated after distillation in 73% yield according to literature methods
(Scheme 3.9).109
N
H Br N
Na,
 
NH3
cat. Fe(NO3)3
73%
213 212
Scheme 3.9
Initial attempts to apply the carbonylation conditions reported by Alper to 212 were
unsuccessful, returning only the starting material (Scheme 3.10).
N
Pd(OAc)2 , PPh3,
25 oC, CH2Cl2, CO N
O
212 214
Scheme 3.10
It is not only methyleneaziridines that can undergo carbonylation to form α-methylene-
β-lactams. Mori and co-workers developed carbonylation chemistry of 2-bromo-allyl-
amines (Scheme 1.6).110 However, the reported reaction uses HMPA as a solvent which
is extremely toxic. Undeterred, we decided to explore this chemistry further. In our stud-
ies, HMPA was replaced with DMAc, since it is also a high boiling polar solvent but has
lower toxicity. These new reaction conditions were applied to 213. After column chro-
matography, lactam 214 was isolated in an encouraging 10% yield (Scheme 3.11). This
known compound had data which matched that in the literature.47
NH
Br
N
OPd(PPh3)4, nBu3N
CO, DMAc, 100 °C
10%
213 214
Scheme 3.11
71
Chapter 3 - Towards the α-methylene-β-lactam core of phyllostictine A
These more forcing conditions where then applied to 212. Upon work up, the crude 1H-
NMR, showed a large amount of Bu3N, along with methylene peaks at δ = 5.73, 5.16.
An acid wash (0.1 M HCl) was used to remove the Bu3N. Unfortunately, the alkene
signals were then lost, suggesting that the compond is sensitive to acid. The reaction
was repeated without the Bu3N and after work up and chromatography, α-methylene-β-
lactam 214 was isolated in 3% yield (Scheme 3.12).
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N
OCO, Pd(PPh3)4DMAc, 100 °C
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212 214
Scheme 3.12
With a method for carbonylating methyleneaziridines at least demonstrated, we wished
to test the carbonylation potential of substituted methyleneaziridines. To achieve this,
iodide 215 was first synthesised from alcohol 216. Tosylation of alcohol 216 with tosyl
chloride and subsequent displacement with excess NaI gave the required iodide in good
yield (Scheme 3.13).
OH OTs
7
I
7
TsCl, pyridine
78%
(over 2 steps)
NaI
216 217 215
Scheme 3.13
Iodide 215 has not previously been used in the alkylation of methyleneaziridines. The
alkylation chemistry was initially conducted, using 1.3 equivalents of the methyle-
neaziridine. After forming the methyleneaziridine anion over 5 h at −78 °C, iodide 215
was added. After work up, 218 was observed in the 1H-NMR as a 40:60 mixture of
diastereomers, along with unreacted 215 (Scheme 3.14). Several attempts were made
to purify this mixture via distillation, since methyleneaziridines are not stable to chro-
matography. However, it did not prove possible to separate 218 from 215.
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Having established that electrophile 215 is useful in methyleneaziridine alkylation
chemistry, we looked to apply it to the N-Et derivative 219, as any unreacted starting
methyleneaziridine could be removed due to its increased volatility.
3.3.2 Use of N-Ethyl Methyleneaziridine
Formation of bromide 220 was achieved by reaction of 2,3-dibromopropene (221), with
EtNH2 in H2O in quantitative yield (Scheme 3.15).
N
H Br
Br
Br
EtNH2 in H2O
100%
221 220
Scheme 3.15
Cyclisation of 219 was successful with Na in liquid ammonia, but isolation proved
troublesome (Scheme 3.16). After work up and distillation, the residue contained Et2O
222, the alkyne side product 223, alongside methyleneaziridine 219, in a 30:12:58 ra-
tio (Scheme 3.16). This mixture was used to perform preliminary carbonylations and
alkylation reactions.
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Scheme 3.16
Firstly, carbonylation of methyleneaziridine 219 was attempted. Applying the conditions
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used with (S)-N-(1-phenylethyl)-2-methyleneaziridine (212), none of the desired lactam
224 was isolated (Scheme 3.17).
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Concerned that the impurities within 219 could be poisoning the catalyst, 219 was alky-
lated in the hope that the resulting product could be purified. sec-BuLi was used to gen-
erate the anion of methyleneaziridine 219, then iodide 215 was added. After work up,
methyleneaziridine 225 was observed with 73% conversion calculated by analysing the
ratio between excess 215 and 225 and correlating that with the isolated weight. 0.1 eq
of 215 remained in the reaction mixture (Scheme 3.18).
N
Et
1. sec-BuLi, TMEDA
    THF, -78 oC
I
N
Et
73% conversion
2.
219
215
225
Scheme 3.18
Carbonylation of 225 to form the corresponding lactam 226 was attempted. The condi-
tions used were based on the best conditions employed in section 2.3.2 using Xantphos®,
palladium acetate, DMAc and 100 °C. Disappointingly only starting material was recov-
ered (Scheme 3.19).
N
Et
N
O Et
Pd(OAc)2, Xantphos
nBu3N, CO
DMAc, 100 °C
225 226
Scheme 3.19
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The major problems encountered making the methyleneaziridine substrates in a high
state of purity and the very low if any conversion to product, led us to abandon this
approach.
3.4 Towards Quaternary α-Methylene-β-Lactams
The Overman rearrangement is a variant of the Claisen rearrangement, a carbon-carbon
bond forming reaction. An allyl vinyl ether forms a γ,δ-unsaturated carbonyl via a [3,3]-
sigmatropic rearrangement.111 In the Overman rearrangement, an imine provides one of
the required pi bonds, and after rearrangement, furnishes allylic amines. Crucially, β,β-
disubstituted amines can be formed. For example, Nakajima produced amide 227 in 90%
yield from imidate 228 (Scheme 3.20).112 Asymmetric Overman113 and aza-Claisen114
rearrangements have been used to form β-monosubstituted amines (Scheme 3.21).
O CCl3
NH
HN
O
CCl3
PdCl2(MeCN)2
25 °C, THF
90%
228 227
Scheme 3.20
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Ph Ph
PhPh
Co
O
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Scheme 3.21
From the methods surveyed in Chapter 1, it was clear there are currently no methods
for creating chiral 4,4-disubstituted α-methylene-β-lactams. However, we imagined that
Mori’s110 synthesis involving the carbonylation of 2-bromo-allyl amines could provide
a route to 4,4-disubstituted α-methylene-β-lactams, since the Overman rearrangement
might allow access to the requisite precursors as single enantiomers. We targeted lactam
229 as a suitable model substrate, potentially accessible via carbonylation of amine 230
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(Scheme 3.22).
Phyllostictine A
N
O
O
MeO OH
HO
Me
Et
NHMe
R
Br N
OR
Me
catalyst, CO
230 229
Scheme 3.22
Thus, we set about the synthesis of amine 230, which could be used to make racemic 229
with a variety of N-substituents by reductive amination. Alkene 231 was synthesised
in 2 steps by cuprate addition to ethyl butynoate (232) and subsequent reduced with
DIBAL (Scheme 3.23).
Formation of trichloroacetimidate 233 was straightforward from 231 throught the
use of trichloroacetonitrile and DBU. This was used without purification and immedi-
ately exposed to the rearrangement conditions. Either thermal rearrangement in toluene
with K2CO3 or a PdII catalyst can be used to promote the rearrangement, and both
methods were explored. Thermally promoted rearrangement to 233 produced significant
decomposition and low yields (5%). Yields of 233 with Pd[(Cl)2(MeCN)2] were slightly
improved (18%), although this reaction clearly needs further optimisation.
Formation of vinyl bromide 234, crucial for the carbonylation, was achieved in
the following manner. Addition of PhSeBr across the double bond gave 235. Oxidation
with ozone at −78 °C yielded selenoxide 236 which was added drop wise to refluxing
toluene for 30 min, to yield 234 in 12% yield over three steps (Scheme 3.23).115
mCPBA and peracetic acid were explored as alternative oxidants to O3, however,
neither improved the yield.
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Scheme 3.23
To overcome the very low yield for the conversion of 233 to 234, bromine installation
might be possible from the outset (Scheme 3.25). Overman rearrangements of vinyl bro-
mides are known as illustrated in Scheme 3.24.116 To make the requisite vinyl bromide,
we explored quenching of cuprate 237 with a variety of electrophilic bromine sources
(NBS, Br2, TBCHD). Unfortunately, no evidence for the formation of 238 was seen.
Br
OH
OMOM
OMOM
OMOM
Br OMOM
OMOM
OMOMH
NCl3COC
1. Cl3CCN, DBU
2. K2CO3, 165 °C
    microwave
78%
239 240
Scheme 3.24
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Scheme 3.25
The very low yields and time consuming nature of this chemistry, prevented us from
moving forward in the synthesis. Recently, work published by Li117 in early 2014 and
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highlighted in Chapter 1, provides new methodology for the synthesis of α-methylene-
β-lactams from allyl amines via a C-H activation process. Dr. Marca via the Overman
rearrangement and Dr. Geden via the aza-Claisen rearrangement are continuing to inves-
tigate this chemistry within the Shipman group, with the aim of applying it to the total
synthesis of phyllostictine A.
3.5 Conclusions
Three strategies for the synthesis of α-methylene-β-lactams have been explored. The
Staudinger method provided rapid access to allyl lactams, that allowed us to test
the epoxide rearrangement step, however, from this model study it was clear that
such β-lactams do not readily undergo epoxide rearrangement and overly harsh condi-
tions needed would be unlikely to be applicable to the total synthesis of phyllostictine A.
The strategy that used carbonylation of methyleneaziridines, might still prove
useful. However, at this time, the chemistry does not appear practical and is very
experimentally demanding (Scheme 3.12).
The Overman rearrangement may provide a useful way to build carbonylation
substrates. Unfortunately, difficulties associated with adding the requisite bromine atom
proved insurmountable in the time available, although new chemistry that negates this
need117 might ultimately allow us to overcome these difficulties.
Clearly, the synthesis of chiral 4,4-disubstituted α-methylene-β-lactams remains a
significant challenge that has yet to be solved in our laboratory.
78
Chapter 4
Herbicidal Activity
79
Chapter 4 - Herbicidal Activity
4.1 Establishment of Herbicidal Activity of Phyllostictine A
Chapter 1 described the known activity of phyllostictine A. To be able to test new
analogues and begin to understand structure-activity relationships, it was necessary to
establish an ED50 value for the natural product. We selected Chlamydomonas reinhardtii
(P. A. Dangeard) as a model organism to probe the herbicidal activity of our analogues.
This chapter details work to develop two different assays of herbicidal activity based
on the growth rates of C. reinhardtii. We aimed to: (i) establish if phyllostictine A is
active against C. reinhardtii; (ii) determine the ED50 for phyllostictine A and compare
its activity to known commerical herbicides; and (iii) evaluate a series of our synthetic
phyllostictine A analogues to develop initial structure-activity relationships.
We were generously donated a 10 mg sample of phyllostictine A by Evidente to
undertake aspects of the work. The integrity of the sample was verified by NMR
spectroscopy (Appendix I). Due to the small quantities of phyllostictine A available
to us, the assays were first optimised and developed with two commercial herbicides
(glyphosate and s-metolachlor).
4.2 Chlamydomonas reinhardtii
C. reinhardtii is a model organism that was one of the first green algae to have its
genome studied and sequenced.118 It is a photosynthetic biflagellate unicell, with a
life cycle of 7-10 h under ideal laboratory conditions.119 This short life cycle coupled
with its sensitivity to a wide range of herbicide families120 makes it a good model
for screening herbicidal activity. Furthermore, as higher plants evolved from green
algae it has the advantage of sharing many biochemical and metabolic pathways with
higher plants.121 C. reinhardtii has already been used as a model organism to explore
adaptation in the presence of a number of environmental stresses, as well as exploring
many of the basic physiological processes in plants.118
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Reboud and co-workers have already established that many commercial herbi-
cides inhibit the growth of C. reinhardtii.122 These values will allows us to compare
any novel analogues with established commercial herbicides. Furthermore, Neve and
co-workers have used C. reinhardtii for studying herbicide cycling and how it relates to
resistance.123
There are relatively few reports of C. reinhardtii being used to screen potential
herbicides,124 despite it being commented120,122,125 that it has much potential in this
regard. C. reinhardtii has been reported in screening assays that monitor residual
herbicide levels in food120 and as an initial screen of photosystem II inhibitors in water
run off, prior to further analysis.126
4.3 Herbicidal Activity of Phyllostictine A
4.3.1 Algal-Lawn
The first assay investigated was an “algal-lawn” type assay. In this assay, C. reinhardtii
in a 0.5% agar solution is applied to a Petri dish containing a 1.5% agar solution of
Bold’s Medium. Herbicides were then applied to the agar in the form of filter paper
disks. The C. reinhardtii was then allowed to grow. If the herbicide was active, rings of
inhibition were seen. The results are visual and qualitative in nature. Li and co-workers
have used this lawn style assay to semi-quantitatively identify, the relative activity of 11
herbicide families.125 C. reinhardtii was shown to be sensitive to herbicide families that
affect its susceptible modes of action. However, some herbicides, such as the cellulose
cell wall synthesis inhibitor isoxaben were inactive presumably because C. reinhardtii
has glycoprotein based cell walls.125 Other algae have also been reported as active in
algal-lawn type assays,120 although these were not explored herein.
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Taking inspiration from Evidente’s original paper describing phyllostictine A ac-
tivity in leaf puncture assays,1 and modifying the method as described in section 5.2,
three concentrations of phyllostictine A were selected (Table 4.1). s-Metolachlor was
used as a standard herbicide control (the activity against C. reinhardtii of which had
been established by the Neve group) and Bold’s media used as a control. Figure 4.1
shows clearly that at 10-3 M, phyllostictine A shows strong inhibition in the growth of
C. reinhardtii. In contrast, s-metolachlor does not show a clear zone of inhibition but
rather a general reduction in growth at 14.1 nM and 1.41 nM (s-Metolachlor is an very
potent herbicide reflected in the low concentrations required to inhibit growth). Phyl-
lostictine A shows similar visual activity to the synthetic auxins tested by Li, showing
distinct but small zones of inhibition. Mitosis inhibitors such as chloropropham showed
similar results to s-metolachlor (also a mitosis inhibitor) with larger clearing zones
(Figure 4.2).125
Figure 4.1
Table 4.1
s-metolachlor Resulta Phyllostictine A Result
14.1 nM + 10-3 M +
1.41 nM + 10-4 M -
0.141 nM - 10-5 M -
a+ = inhibition, - = no inhibition
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Figure 4.2 – Li’s results where G = chloropropham and M = 2-methyl-4-chlorophenoxyacetic
acid.125
4.3.2 Quantitative assays using C. reinhardtii
The second assay that was explored was a “liquid culture” assay. The liquid culture
assay is a quantitative assay that enables the measurement of absorbance values, which
can be correlated with an estimate of population.122 In previous studies, Lagator
established a correlation between number of cell divisions and optical density at 750 nm
(OD750).127 Once analysed with a dose-response model (section 5.2.4), ED50 values can
be calculated allowing for quantitative assessment of the potency of different herbicides.
This technique employing C. reinhardtii has already been used by the Neve group.123,128
Specifically, it was used to model the evolution of herbicide resistance. However, the
20 mL scale of the reported assay was found to be unsuitable for us as only limited
quantities of the natural product and novel analogues were available. As a result we
decided to use 96-well plates which have a total volume of 200 µL, leading to a 100-fold
reduction in scale.
Before committing to using our limited supply of phyllostictine A this miniatur-
ized micro-well plate assay was first developed using the commercial herbicide
glyphosate. Glyphosate was tested at a range of concentrations above and below the
minimum inhibitory concentration of 0.39 mM,127 to ensure a proper dose-response
was observed. The assay was repeated over several weeks to ensure its reproducibility.
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Although some variability was observed between experiments, glyphosate in this assay
was found to have a mean ED50 of 0.3 mM which is comparable to published value of
0.2 mM120 in other liquid culture assays.
Figure 4.3
Table 4.2
Experiment ED50 (mM) std. error (mM)
1 0.301 0.0355
2 0.303 0.0355
3 0.227 0.0146
4 0.267 0.0409
5 0.348 0.0657
Having optimised the assay with a commercial herbicide, we next explored the activity
of phyllostictine A. Phyllostictine A was dissolved in EtOH and a stock solution of
0.2 M was made up with Bold’s medium. The concentrations studied varied between
10-2 and 10-4 M since activity was not seen below 10-4 M during the algal-lawn studies
(Figure 4.1). The assay was repeated just twice using phyllostictine A because of the
limited amounts available.
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Table 4.3
Experiment ED50 (mM) std. error (mM)
1 0.821 0.0989
2 0.361 0.0448
The stability of the phyllostictine A compound in solution may account for the discrep-
ancy in determined ED50, although other explanations could account for the variability.
From this data, we conclude that phyllostictine A has an ED50 in the sub-mM range,
consistent with the what was seen in the algal-lawn assay. It has similar potency to
glyphosate against C. reinhardtii.
Figure 4.4
4.4 Activity of Analogues
Additionally, we have explored the activity of a small number of synthetic analogues
made in Chapter 2.
Lactam 73 was tested in three separate experiments in the 96-well plate assay,
with some variability in ED50 again observed (Table 4.4). However, it is clear that this
simple lactam has mM activity against C. reinhardtii. Lactam 73 had a mean ED50 of 4
mM whilst phyllostictine A was about an order of magnitude more potent (ED50 = 0.6
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mM).
Figure 4.5
Table 4.4
Experiment ED50 (mM) std. error (mM)
1 4.95 0.407
2 4.95 1.081
3 3.41 0.201
Due to a laboratory move and the unavailability of the incubator room, a new assay
was designed and subsequently run by Nicole Pereira. The new assay was based on
the 20 mL culture tube assay127 and miniaturised to a 5 mL volume. In other words,
larger volumes than the 96-well plate. This volume allows for ideal growth conditions
(continuous light and rotary shaking) ultimately leading to improved reproducibility.
The analogues tested using this method are show in Figure 4.6. The majority of the
compounds did not have good solubility in water or in 0.5% DMSO in H2O. As a result,
only a very narrow range of concentrations could be used.
Analogue 74 was the most active at 0.05 mM, totally inhibiting the growth of C.
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Figure 4.6
reinhardtii at this concentration. Furthermore it was more active than glyphosate at this
dose. The next most active compound was the saturated lactam 141. This is interesting
because it implies that the unsaturation is not important, and may imply that this
functional group is not important in phyllostictine A. Bicyclic lactam 124 did not show
an expected dose response being more active at lower concentrations. This finding was
reproducible. For example, at 0.01 mM, 124 inhibited the growth of C. reinhardtii to
44% of the control, however, at 0.05 mM 65% of the control was recorded. A possible
explanation is 124 has poor solubility in the Bold’s media and the constant agitation of
the incubator caused the compound to precipitate during the seven days of the assay.
This trend was not seen with related compounds 73 and 241. Lactam 141 was not more
active than 73 at any of the concentrations tested. It is therefore not clear as to whether
the unsaturation has an affect on the activity or not.
Most disappointingly, lactam 101 did not show good activity at 0.05 mM. It is
most closely related to the structure of the natural products containing both the
12-membered ether ring, and the N-Et substituted β-lactam.
Lactam 242 shows very poor activity as well as poor solubility. This was disap-
pointing to us because we believed that the addition of a hydrophilic acetate group
would improve solubility. An interesting experiment would be to hydrolyse the acetate
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Table 4.5
Concentration 0.001 mM 0.01 mM 0.025 mM 0.05 mM 0.1 mM 0.25
% Control sterr. % Control sterr. % Control sterr. % Control sterr. % Control sterr % Control sterr
N
O PMB
74
- - 60 33 - - 0 0.3 - - 2 0.3
N
O
O
PMP
141
- - 25 13 - - 2 0.3 - - - -
N
O PMP
73
82 11 29 5 - - 5 0.0 4 2 -1 0.1
Glyphosate 101 7 102 2 - - 28 15 -1 1 0 1
N
O PMP
241
- - - - 37 7 22 2 19 1
N
O PMP
AcO 242
- - 122 19 - - 42 21 - - - -
N
O
O
PMP
124
- - 45 10 52 15 66 10 - - - -
N
O
O
Et
101
91 9 83 10 - - 81 6 - - - -
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group to form the allylic alcohol, however, hydrolysing an acetate selectively in the
presence of the sensitive β-lactam would be very challenging.
Since it was demonstrated that phyllostictine A is active against C. reinhardtii,
we must conclude that other functionality in the natural product are essential for
bioactivity. Why 73 and 74 are active is consequently difficult to understand, although
their potency may arise from the aromatic nucleus.
4.5 Conclusions
For the first time phyllostictine A has been shown to have activity against C. reinhardtii.
It was shown to be active in two different assays. In the qualitative algal-lawn assay,
it produced zones of growth inhibition between 10-3 and 10-4 M. In a quantitative 96
well plate assay, a mean ED50 value 0.58 mM was determined. This level of potency
was similar to that of glyphosate (0.3 mM). Reproducability appears to be an issue on
scaling the assay down to the format.
A new culture tube assay was developed by Pereira which has proved to be more
reproducible. It was used to test 7 synthetic compounds produced in this thesis, and
these were ranked in terms of their potency at 0.05 mM. Solubility appears to be a
critical factor, with the less soluble compounds producing some odd data.
The most active compound 74 identified has little in common with phyllostictine
A, where as 101 most closely related to it had poor activity. From this initial structure
activity relationship study it appears as though the alkene contained within phyl-
lostictine A is not responsible for the observed herbicidal activity since its removal in
simple bi-cyclic analogues increases potency. This trend is not observed in mono-cyclic
analogues indicating they potentially work via different modes of action. Clearly further
analogues and alternative assays will need to be used to develop a clear picture of the
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structure-activity relationship in this compound class.
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5.1 General Information
All reactions were performed under an atmosphere of dry nitrogen in flame- or oven-
dried glassware unless otherwise stated. Anhydrous solvents were purchased from
Sigma-Aldrich or Fisher Scientific in Sure-Seal bottles for use as reaction solvents. All
other solvents were reagent grade and used as received.
Commercially available starting materials were used without further purification
unless otherwise stated. Thin layer chromatography was performed on pre-coated
aluminium-backed plates (Merck Silicagel 60 F254), visualised by UV 254 nm then
stained with potassium permanganate or ceric ammonium molybdate solution. Flash
chromatography was performed using Fluorochem LC60A 40-63 micron silica. HPLC
was performed using an Agilent 1100 series, with an Agilent Prep C-18 scaler column.
Melting points were recorded on a Gallenkamp MPD350 apparatus and are reported
as observed. Single crystal X-ray diffraction data were obtained using an Oxford
Diffraction Gemini XRD system. Infrared spectra were recorded on a Perkin Elmer
Spectrum 100 FT-IR spectrometer or a Bruker Alpha Platinum ATR spectrometer with
internal calibration.
Low resolution mass spectra were recorded on an Esquire 2000 platform with
electrospray ionisation, high resolution mass spectra were obtained using a Bruker
MicroTOF spectrometer. Nuclear magnetic resonance spectra were recorded on Bruker
DPX (300, 400, 500 or 600 MHz) or AV (400 or 700 MHz) spectrometers. Chemical
shifts are reported in parts per million relative to the standard tetramethylsilane. The
peak multiplicities were specified as singlet (s), doublet (d), triplet (t), quartet (q),
quintet (quint). Coupling constants (J) are reported in Hertz.
Biological manipulations were performed in a flow hood, using autoclaved equip-
ment.
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5.2 Materials and Methods
5.2.1 Culture Conditions
The stock populations used were maintained in disposable 25x150 mm borosilicate glass
tubes containing 20 mL of modified Bold’s Medium129 in an orbital shaker incubator.
The cultures in the incubator were maintained at 28 °C, 180 rpm and under continu-
ous light exposure provided by six florescent tubes mounted in the incubator lid (Os-
ram L30 W/21-840, cool white, light intensity measured at the tube location was 161
µmolm-2s-1).
5.2.2 Algal-lawn Assay
All manipulations were carried out in a flow hood with autoclaved Petri dishes and
pipette tips. Agar (20 mL 1.5 % in H2O) was added to a Petri-dish to form a flat even
layer, which was allowed to set with the Petri dish lid off. C. reinhardtii (1 mL from
stock population described in section 5.2.1) was added to hand hot agar (9 mL 0.5 % in
Bold’s medium) and mixed by inverting in a falcon tube. The mixture was then poured
carefully on top of the previous layer and allowed to set with the Petri dish lid off.
The back of the Petri dish were then marked up to indicate where herbicides should be
applied for example Figure 5.1. The lid was replaced and the plates stored in the dark
until needed.
Figure 5.1 – Permanent marker Layout of a Petri dish used in the algal-lawn assay.
Herbicides of the desired concentration in Bold’s medium with minimum MeOH to aid
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solvation were now applied to the “lawn” on the marked areas with 10 µL spots. Control
spots were also applied consisting of Bold’s media with the maximum MeOH % used.
The plates were run in triplicate. The plates were kept in a 28 °C room under fluorescent
lights for 7 days. The results were recorded photographically.
5.2.3 96-well Plate Assay
To ensure that approx 5000 cells of C.reinhardtii were initially added to the wells, an
estimate of the stock population was made by measuring the OD750, using a Jenway
6315 bench-top spectrophotometer with a 24-25.5 mm test tube holder fitted to allow
the 25x150 mm glass tubes to be measured. It was tested and found to have a sensitivity
to OD750 of 0.001.127
Once the OD was measured, equation (5.1), derived from studies by Lagator, was
used to estimate the population per mL.127
Cells/mL = 1119400(OD750)2 +1086300(OD750) (5.1)
The remaining volumes of herbicide (X) and Bold’s media (B) were calculated as
per equation (5.2) still allowing for a total volume of 200 µL. The plates were then
incubated for 7 days. The concentrations used are shown in Table 5.1.
X (µL) + B (µL) + (5000 cells) = 200 µL (5.2)
5.2.4 Dose Response Analysis
ED50 were derived from dose-response curves. Response was determined by record-
ing OD750 as an independent variable.130 The analysis of this optical density data was
carried out in R (R version 3.1.0:2014-04-10)131 and modelled using the drc package
version 2.3-96.132 The dose response model used to fit the optical density data was the
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Table 5.1 – Concentrations used in the 96 well plate assay
Concentration mM
Glyphosate Phyllostictine A Lactam 73
0 0 0
0.10 0.25 1.0
0.20 0.50 2.5
0.39 0.75 3.0
0.59 1.00 5.0
0.79 5.00 7.5
1.18 10.00 10.0
standard four parameter log-logistic model (Equation 5.2). The four parameters are slope
(b), lower limit (c), upper limit (d) and point of inflection which in this case is the ED50
(e). For a visual account of the dose response see Figure 5.2.
y = f (x) = c+
d − c
1+ exp(b(log(x)− log(e))) (5.2)
Generic Dose Response
Dose
R
e
s
p
o
n
s
e
0 0.01 0.1
0
20
40
60
80
100
Lower Limit (c)
Upper Limit (d)
S
lo
p
e
 (b
)
In
fl
e
c
ti
o
n
 (
e
)
Figure 5.2
95
Chapter 5 - Experimental
5.3 Chemical Synthesis
Methyl 3-hydroxy-2-methylenetridec-12-enoate (68)
HO
OMe
O
10-Undecen-al (3.00 g, 17.9 mmol) was dissolved in methyl acrylate
(1.29 mL, 14.3 mmol). MeOH (450 µL) and DABCO (280 mg, 2.5
mmol) were added and the solution stirred for 7 days. The volatiles
were removed and the crude product was purified via column chro-
matography (20% EtOAc in 40-60 °C petroleum ether) to give the title
compound as an oil (1.91 g, 52%). 1H-NMR (CDCl3, 400 MHz, δ):
6.22 (s, 1H, -CCHH), 5.85-5.75 (m, 2 x 1H, -CHCH2; -CCHH), 4.98 (d, J = 17.1 Hz,
1H, -CHCHH), 4.92 (dd, J = 10.3, 0.9 Hz, 1H, -CHCHH), 4.39 (t, J = 6.4 Hz, 1H,
-CHOH), 3.78 (s, 3H, -COOCH3), 2.86 (br s, 1H, -CHOH), 2.03 (q, J = 7.0 Hz, 2H,
-CH2CH=CH2), 1.71-1.53 (m, 2H, -CH2CHOH-), 1.50-1.22 (m, 12H, 6 x -CH2); 13C-
NMR (CDCl3, 100 MHz, δ): 167.0 (C=O), 142.7 (C), 139.1 (CH), 124.8 (CH2), 114.1
(CH2), 71.4 (CH), 51.8 (CH3), 36.3 (CH2), 33.8 (CH2), 29.5 (CH2), 29.4 (CH2), 29.2
(CH2), 29.0 (CH2), 28.9 (CH2), 25.8 (CH2); IR (cm-1): 3430 (-OH), 2926 (-OOH), 2854
(-CH2), 1719 (-CO2H), 1627 (-C=C); MS-ESI 277 [M + Na]+; HRMS ES+ [M + Na]+
calcd for C15H26NaO3, 277.1774; found, 277.1772; Rf = 0.3 (20% EtOAc in 40-60 °C
petroleum ether).
3-Hydroxy-2-methylenetridec-12-enoic acid (69)
HO
OH
O
Methyl 3-hydroxy-2-methylenetridec-12-enoate (68) (1.91 g, 7.52
mmol) was dissolved in THF (20 mL). LiOH ·H2O (1.5 g, 37.6 mmol)
in H2O (20 mL) was added and the solution stirred for 18 h. The layers
were allowed to separate and the aqueous layer acidified to pH 1 with
2N HCl, and extracted with EtOAc (3 x 20 mL). The combined or-
ganics were dried (MgSO4), filtered and the solvent removed, to give
the title compound as a clear oil, which was used without further purification (1.8 g,
99%). 1H-NMR (CDCl3, 400 MHz, δ): 6.80 (br s, 1H, -COOH), 6.30 (s, 1H, -CCH2),
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6.30 (s, 1H, -CCH2), 5.83 (s, 1H, -CCH2), 5.73 (ddt, J = 16.9 Hz, 10.3 Hz, 6.6 Hz,
1H, -CHCH2), 4.91 (ddt, J = 17.1 Hz, 5.1 Hz, 1.9 Hz, 1H, -CHCHH), 4.85 (ddt, J =
11.2 Hz, 8.2 Hz, 1.0 Hz, 1H, -CHCHH), 4.36 (t, J = 6.4 Hz, 1H, -CHOH), 1.96 (q, J
= 5.3 Hz, 2H, -CH2CH=CH2), 1.66-1.53 (m, 2H, -CH2CHOH-), 1.39-1.15 (m, 12H, 6
x -CH2); 13C-NMR (CDCl3, 100 MHz, δ): 171.2 (C=O), 141.9 (C), 139.2 (CH), 127.4
(CH2), 114.1 (CH2), 71.5 (CH), 36.1 (CH2), 33.8 (CH2), 29.5 (CH2), 29.4 (CH2), 29.39
(CH2), 29.1 (CH2), 28.9 (CH2), 25.8 (CH2); IR (cm-1): 3500 (-OH), 2924 (-OOH), 2854
(-CH2), 1693 (−CO2H), 1627 (-C=C); MS-ESI 263 [M + Na]+; HRMS ES+ [M + Na]+
calcd for C14H24NaO3, 263.1623; found, 263.1623.
3-Hydroxy-N-(4-methoxyphenyl)-2-methylenetridec-12-enamide (126)
HO
N
H
O
PMP
3-Hydroxy-2-methylenetridec-12-enoic acid (69) (900 mg, 3.75
mmol) and p-anisidine (461 mg, 3.75 mmol) were dissolved in
CH2Cl2 (20 mL) and cooled to 0 °C. DCC (772 mg, 3.75 mmol) in
CH2Cl2 (50 mL) was added slowly and the solution allowed to warm
to room temperature over 18 h. The resulting suspension was fil-
tered through Celite, washed with a small amount of CH2Cl2 and the
solvent removed. Column chromatography (30% EtOAc in 40-60 °C petroleum ether)
yielded the title compound as a white solid (688 mg, 53%). 1H-NMR (CDCl3, 300 MHz,
δ): 8.54 (br s, 1H, -CONH-), 7.50-7.43 (m, 2H, -ArH), 6.89-6.81 (m, 2H, -ArH), 5.99
(s, 1H, -CCHH), 5.78 (ddt, J = 16.8 Hz, 10.3 Hz, 6.6 Hz, 1H, -CHCH2), 5.50 (s, 1H,
-CCHH), 5.02-4.86 (m, 2H, -CHCH2), 4.43 (q, J = 6.4 Hz, 1H, -CHOH), 3.78 (s, 3H,
-ArOCH3), 2.72 (d, J = 4.7 Hz, 1H, -OH), 1.96 (q, J = 6.6 Hz, 2H, -CH2CH=CH2),
1.85-1.60 (m, 2H, -CH2CHOH-), 1.50-1.16 (m, 12H, 6 x -CH2); 13C-NMR (CDCl3, 75
MHz, δ): 164.5 (C=O), 156.2 (C), 138.6 (CH), 130.1 (C), 121.3 (2 x CH), 120.8 (CH),
113.8 (2 x CH), 113.7 (CH2), 73.7 (CH), 54.9 (CH3), 35.1 (CH2), 33.2 (CH2), 28.84
(CH2), 28.76 (CH2), 28.5 (CH2), 28.3 (CH2), 25.8 (CH2); IR (cm-1): 3283 (-OH), 2925;
2853 (-CH2), 1511 (-CONR2), 1246 (-CO-CH3), 828 (para disub -ArH); MS-ESI: 346
[M + H], 368 [M + Na]; HRMS ES+: [M + Na]+ calcd for C21H31NNaO3, 368.2196,
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found, 368.2198; Rf = 0.3 (20% EtOAc in 40-60 °C petroleum ether).
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2-(4-Methoxyphenylcarbamoyl)trideca-1,12-dien-3-yl methanesulfonate (127)
MsO
N
H
O
PMP
3-Hydroxy-N-(4-methoxyphenyl)-2-methylenetridec-12-enamide
(126) (688 mg, 1.99 mmol) was dissolved in CH2Cl2 (10 mL) and
cooled to -78 °C. Et3N (550 µL, 3.99 mmol) was added followed
by MsCl (300 µL, 3.99 mmol) dropwise. After 2 h the reaction was
quenched with H2O (10 mL) and warmed to room temperature. The
organics were separated and dried (MgSO4), filtered and the solvent
removed under reduced pressure. Column chromatography (30% EtOAc in 40-60 °C
petroleum ether) yielded the title compound as an oil (816 mg, 97%). 1H-NMR (CDCl3,
300 MHz, δ): 7.70 (br s, 1H, -CONH-), 7.49-7.41 (m, 2H, -ArH), 6.90-6.83 (m, 2H,
-ArH), 5.94 (s, 1H, -CCHH), 5.87-5.71 (m, 2H, 1 x -CHCH2 1 x -CCHH), 5.41 (t, J
= 6.6 Hz, 1H, -CHOSOOCH3), 5.03-4.88 (m, 2H, -CHCH2), 3.79 (s, 3H, -ArOCH3),
3.02 (s, 3H, -OSOOCH3), 2.05-1.97 (m, 2H, -CH2CH=CH2), 1.91 (q, J = 7.5 Hz, 2H,
-CH2CHOH-), 1.48-1.22 (m, 12H, 6 x -CH2); 13C-NMR (CDCl3, 75 MHz, δ): 164.5
(C=O), 157.0 (C), 144.2 (C), 139.3 (CH), 130.6 (C), 122.1 (2 x CH), 121.4 (CH), 114.4
(2 x CH), 114.3 (CH2), 81.5 (CH), 55.6 (CH3), 38.7 (CH3), 35.1 (CH2), 33.9 (CH2),
29.5 (CH2), 29.2 (CH2), 29.0 (CH2), 25.5 (CH2); IR (cm-1): 3358 (-NH), 2926; 2854
(-CH2), 1663 (-C=C), 1511 (-CONR2), 1351 (-S=O), 1245 (-CO-CH3), 1173 (-S=O),
827 (para disub -ArH); MS-ESI: 424 [M + H]+, 446 [M + Na]; HRMS: ES+ [M +
H]+ calcd for C22H33NNaO5S, 446.1972; found, 446.1967; Rf = 0.3 (30% EtOAc in
40-60 °C petroleum ether).
4-(Dec-9-enyl)-1-(4-methoxyphenyl)-3-methyleneazetidin-2-one (121)
N
O PMP
2-(4-Methoxyphenylcarbamoyl)trideca-1,12-dien-3-yl methanesul-
fonate (127) (230 mg, 0.54 mmol) was dissolved in THF (10 mL)
and cooled to -15 °C. KOtBu (60 mg, 0.60 mmol) was added in one
portion and stirred for 2 h at -15 °C. The reaction was quenched with
sat. NH4Cl (10 mL) the organics separated, dried (MgSO4), filtered
and the solvent removed under reduced pressure. The crude product
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was purified via column chromatography (5% EtOAc in 40-60 °C petroleum ether) to
give the title compound (111 mg, 62%). 1H-NMR (CDCl3, 400 MHz, δ): 7.39 (app d, J
= 9.0 Hz, 2H, ArH), 6.93 (app d, J = 9.0 Hz, 2H, ArH), 5.88-5.78 (m, 2 x 1H, -CCH2;
-CHCH2), 5.28 (s, 1H, -CCH2), 5.01 (dd, J = 17.1 Hz, 1.7 Hz, 1H, -CHCH2), 4.95 (d, J
= 11.1 Hz, 1H, -CHCHH), 4.58-4.53 (m, 1H, -CHCNAr), 3.83 (s, 3H, -ArOCH3), 2.10-
1.99 (m, 2H, 1H -CH2CH=CH2; -CHHCHCNAr), 1.86-1.76 (m, 1H, -CHHCHCNAr),
1.48-1.23 (m, 12H, 6 x -CH2); 13C-NMR (CDCl3, 75 MHz, δ): 164.5 (C=O), 155.6 (C),
147.9 (C), 138.6 (CH), 130.6 (C), 118.1 (CH), 117.8 (CH), 113.9 (CH), 113.8 (CH),
113.6 (CH2), 108.8 (CH), 59.9 (CH), 54.9 (CH3), 33.2 (CH2), 30.1 (CH2), 28.9 (CH2),
28.7 (CH2), 28.4 (CH2), 28.2 (CH2), 23.7 (CH2); IR (cm-1): 2925; 2853 (-CH2) 1727
(-CONR2), 1509 (-C=C), 1245 (-CO-CH3), 827 (para disub -ArH); ESI+-MS: 328 [M +
H]+, 350 [M + Na]+; HRMS: ES+ [M + H]+ calcd for C21H30NO2, 328.2271; found,
328.2277; Rf = 0.3 (5% EtOAc in 40-60 °C petroleum ether).
RCM reaction of 4-(Dec-9-enyl)-1-(4-methoxyphenyl)-3-methyleneazetidin-2-one
(121)
4-(Dec-9-enyl)-1-(4-methoxyphenyl)-3-methyleneazetidin-2-one (121) (62 mg, 0.19
mmol) was dissolved in CH2Cl2 (95 mL). Grubbs 2nd generation catalyst (15 mg,
0.018 mmol) was added in one portion and the solution heated at reflux for 24 h.
The solution was allowed to cool and the solvent removed under reduced pressure.
Column chromatography (10-20% EtOAc in 40-60 °C petroleum ether) yielded two
compounds. The 22-membered dimer (1Z,14Z)-12,25-bis(4-methoxyphenyl)-12,25-
diazatricyclo[22.2.0.011,14]hexacosa-1,14-diene-13,26-dione) (89) (11 mg, 20%) and
11-membered ring (Z)-12-(4-methoxyphenyl)-12-azabicyclo[9.2.0]tridec-1-en-13-one
(123) (3 mg, 6%).
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(Z)-12-(4-methoxyphenyl)-12-azabicyclo[9.2.0]tridec-1-en-13-one (123)
N
O PMP
H
1H-NMR (CDCl3, 600 MHz, δ): 7.42-7.39 (m, 2H, -ArH), 6.91-6.88
(m, 2H, -ArH), 5.71 (dd, J = 12.1 Hz, 4.5 Hz, 1H, -CCHCH2-), 4.52
(d, J = 5.5 Hz, 1H, -CHCNAr), 3.79 (s, 3H, -ArOCH3), 2.87-2.76 (m,
1H, -CCHCHH), 2.29-2.15 (m, 2 x 1H, -NArCHCHH-; -CCHCHH),
1.93-1.83 (m, 1H -NArCHCHH-) 1.62-1.36 (m, 12H, 6 x -CH2);
13C-NMR (CDCl3, 150 MHz, δ): 161.7 (C=O), 156.0 (C), 139.5 (C),
132.8 (C) 132.0 (CH), 117.7 (2 x CH), 114.7 (2 x CH), 59.0 (CH), 55.7 (CH3), 29.6
(CH2), 27.6 (CH2), 27.2 (CH2), 25.8 (CH2), 25.1 (CH2), 22.4 (CH2), 20.8 (CH2); ESI+-
MS: 300 [M + H]+, 322 [M + Na]+; HRMS: ES+ [M + H]+ calcd for C19H26NO2,
300.1958; found, 300.1958; IR (cm-1): 2925; 2853 (-CH2) 1731 (-CONR2), 1511
(-C=C), 1246 (-CO-CH3), 829 (para disub -ArH); mp 155-160 °C (from CH2Cl2), Rf =
0.3 (20% EtOAc in 40-60 °C petroleum ether).
(1Z,14Z)-12,25-bis(4-methoxyphenyl)-12,25-diazatricyclo[22.2.0.011,14]hexacosa-
1,14-diene-13,26-dione) (89)
N
N
O
O
PMP
PMP
1H-NMR (CDCl3, 400 MHz, δ): 7.31-7.23 (m, 4H, -ArH), 6.84-6.77
(m, 4H, -ArH), 5.52 (dt, J = 11.0 Hz, 4.5 Hz, 2H, -CCHCH2-),
4.44-4.39 (m, 2H, -CHCNAr), 3.72 (s, 6H, -ArOCH3), 2.95-2.81
(m, 2H, -CCHCHH), 2.17-2.07 (m, 2H, CCHCHH), 1.94-1.81 (m,
2H -NArCHCHH-), 1.80-1.67 (m, 2H -NArCHCHH-), 1.38-1.02 (m,
24H, 12 x -CH2); 13C-NMR (CDCl3, 100 MHz, δ): 161.6 (C=O),
161.0 (C=O), 156.0 (2 x C), 139.6 (C), 139.4 (C), 131.9 (C), 131.8
(C), 131.0 (CH), 130.7, 118.1 (2 x CH), 118.0 (2 x CH), 114.6 (4
x CH), 59.42 (CH), 59.36 (CH), 55.6 (2 x CH3), 30.3 (CH2), 30.14
(CH2), 30.08 (CH2), 29.9 (CH2), 29.8 (CH2), 29.5 (CH2), 29.4 (CH2), 29.30 (CH2),
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29.27 (CH2), 29.1 (CH2), 29.0 (CH2), 28.54 (CH2), 28.48 (CH2), 23.1 (CH2), 22.8
(CH2); ESI+-MS: 599 [M + H]+, 621 [M + Na]+; HRMS: ES+ [M + H]+ calcd
for C38H51N2O4, 599.3843; found, 599.3850; IR (cm-1): 2920; 2849 (-CH2) 1712 (-
CONR2), 1509 (-C=C), 1246 (-CO-CH3), 826 (para disub -ArH); mp 149-155 °C (from
CH2Cl2); Rf = 0.2 (20% EtOAc in 40-60 °C petroleum ether).
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8-(Allyloxy)octan-1-ol (104)
O OH
1,8 Octadiol (3.5 g, 23.3 mmol) was dissolved in
THF (25 mL) and added to NaH (60% in mineral
oil, 1.1 g, 28.0 mmol) via cannula. The slurry was
stirred for 1 h at room temperature. Allyl bromide (1.9 mL, 22.0 mmol) and TBAI (25
mg) were dissolved in THF (25 mL) and added to the NaH solution via cannula. This
was heated to reflux for 7 h. Once cool sat. NH4Cl (50 mL) was added and the aqueous
layer extracted with EtOAc (3 x 20 mL). The combined organics were dried (Na2SO4)
and the volatiles removed under reduced pressure. Column chromatography (2% MeOH
in CH2Cl2) yielded the title compound as an oil (1.77 g, 40%). Data is consistent with
that reported.81 1H-NMR (CDCl3, 400 MHz, δ): 5.91 (ddt, J = 17.1, 10.4, 5.7 Hz, 1H,
-CHCH2), 5.27 (dd, J = 17.2, 1.6 Hz, 1H, -CHCHH), 5.17 (dd, J = 10.4, 1.0 Hz, 1H,
-CHCHH), 3.96 (d, J = 5.6 Hz, 2H, -CH2CH=CH2), 3.63 (t, J = 6.6 Hz, 2H, -OCH2-),
2.42 (t, J = 6.7 Hz, 2H, OHCCH2-), 1.64-1.3 (m, 12H, 6 x CH2); Rf = 0.4 (2% MeOH
in CH2Cl2).
8-(Allylocy)octanal (105)
O
O
8-(Allyloxy)octan-1-ol (1.77 g, 9.52 mmol) was
dissolved in CH2Cl2 (30 mL) and NaOAc (376 mg,
4.57 mmol) added. PCC (2.5 g, 11.4 mmol) was
added in one portion and the solution stirred for 2 h. The mixture was diluted with Et2O
(50 mL) then filtered through a short pad of SiO2. The pad was washed exhaustively
with Et2O. The volatiles were removed under reduced pressure. Column chromatogra-
phy (10% EtOAc in 40-60 °C petroleum ether) yielded the title compound as a clear oil
(1.00 g, 57%). Data is consistent with that reported.81 1H-NMR (CDCl3, 400 MHz, δ):
9.76 (s, 1H, CHO), 5.91 (ddt, J = 17.2, 10.6, 5.5 Hz, 1H, -CHCH2), 5.27 (dd, J = 17.2,
1.8 Hz, 1H, -CHCHH), 5.17 (dd, J = 10.4, 1.8 Hz, 1H, -CHCHH), 3.96 (dt, J = 5.6, 1.4
Hz, 2H, -CH2CH=CH2), 3.42 (t, J = 6.6 Hz, 2H, -OCH2-), 2.42 (dt, J = 7.4, 1.8 Hz, 2H,
CHOCH2-), 1.72-1.3 (m, 12H, 6 x CH2); Rf = 0.3 (10% EtOAc in 40-60 °C petroleum
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ether).
Methyl 10-(allyloxy)-3-hydroxy-2-methylenedecanoate (106)
O
MeO
O
OH
8-(Allylocy)octanal (2.30 g, 12.5 mmol) was dissolved in methyl
acrylate (0.95 mL, 10.5 mmol). MeOH (300 µL) and DABCO
(294 mg, 2.6 mmol) were added and the solution stirred for 7
days. The volatiles were removed and the crude product was
purified via column chromatography (20% EtOAc in 40-60 °C
petroleum ether) to give the title compound as a clear oil (1.24 g,
44% yield). 1H-NMR (CDCl3, 250 MHz, δ): 6.21 (d, J = 1.1 Hz, 1H, -CCHH), 5.92
(ddt, J = 17.2, 10.4, 5.6 Hz, 1H, -CHCH2), 5.79 (t, J = 1.1 Hz, 1H, -CCHH), 5.26 (dq, J
= 17.2, 1.7 Hz, 1H, -CHCHH), 5.17 (dq, J = 10.3, 1.8 Hz, 1H, -CHCHH), 4.38 (t, J = 6.3
Hz, 1H, -CHOH), 3.96 (dt, J = 5.6, 1.4 Hz, 2H, -CH2CH=CH2), 3.78 (s, 3H, -COOCH3),
3.42 (t, J = 6.6 Hz, 2H, -OCH2-), 1.72-1.13 (m, 12H, 6 x CH2); 13C-NMR (CDCl3, 100
MHz, δ): 178.4 (C=O), 142.4 (C), 135.1 (CH), 125.0 (CH2), 116.7 (CH2), 71.9 (CH2),
71.8 (CH), 70.5 (CH2), 51.9 (CH3), 36.2 (CH2), 33.8 (CH2), 29.4 (CH2), 26.1 (CH2),
24.5 (CH2); IR (cm-1): 3430 (-OH), 2931 (-OOH), 2857 (-CH2), 1717 (-CO2H); MS-
ESI: 293 [M + Na]; HRMS ES+: [M + Na]+ calcd for C15H26NaO4, 293.1723, found
293.1721; Rf = 0.3 (20% EtOAc in 40-60 °C petroleum ether).
10-(Allyloxy)-3-hydroxy-2-methylenedecanoic acid (107)
O
HO
O
OH
Methyl 10-(allyloxy)-3-hydroxy-2-methylenedecanoate (106)
(1.24 g, 4.59 mmol) was dissolved in THF (20 mL). LiOH ·H2O
(940 mg, 23.0 mmol) in H2O (20 mL) was added and the solution
stirred for 18 h. The layers were allowed to separate and the
aqueous layer acidified to pH 1 with 2N HCl, and extracted with
EtOAc (3 x 20 mL). The combined organics were dried (MgSO4),
filtered and the solvent removed under reduced pressure to yield the title compound as a
clear oil which was used without further purification (900 mg, 76%). 1H-NMR (CDCl3,
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400 MHz, δ): 6.37 (s, 1H, -CCH2), 5.97-5.87 (m, 2H, -CHCH2 -CCH2), 5.27 (dq, J =
17.2 Hz, 1.5 Hz, 1H, -CHCHH), 5.17 (d, J = 10.3 Hz, 1H, -CHCHH), 4.43 (t, J = 6.0
Hz, 1H, -CHOH), 3.97 (d, J = 4.6 Hz, 2H, -CH2CH=CH2), 3.43 (t, J = 6.7 Hz, 2H,
-OCH2-), 1.71-1.24 (m, 10H, 5 x CH2); 13C-NMR (CDCl3, 100 MHz, δ): 170.6 (C=O),
141.9 (C), 135.0 (CH), 127.2 (CH2), 116.9 (CH2), 71.8 (CH2), 71.6 (CH), 70.5 (CH2),
36.2 (CH2), 29.7 (CH2), 29.4 (CH2), 29.3 (CH2), 26.1 (CH2), 25.7 (CH2); IR (cm-1):
3358 (-COOH), 2932; 2856 (-CH2), 1695 (-COOH), 1627 (-C=C), 1245 (-CO-CH3);
MS-ESI: 279 [M + Na]; HRMS ES+: [M + Na]+ calcd for C14H24NaO4, 279.1567,
found, 279.1566.
10-(Allyloxy)-3-hydroxy-N-(4-methoxyphenyl)-2-methylenedecanamide (129)
O
N
H
O
OH
PMP
10-(Allyloxy)-3-hydroxy-2-methylenedecanoic acid (107) (900
mg, 3.52 mmol) and p-anisidine (432 mg, 3.52 mmol) were dis-
solved in CH2Cl2 (50 mL) and cooled to 0 °C. DCC (724 mg, 3.52
mmol) in CH2Cl2 (80 mL) was added slowly and the solution al-
lowed to warm to room temperature over 18 h. The resulting sus-
pension was filtered through Celite, washed with a small amount
of CH2Cl2 and the solvent removed under reduced pressure. Column chromatography
(25% EtOAc, 1% Et3N in 40-60 °C petroleum ether) yielded the title compound as a
white solid (798 mg, 67% yield). 1H-NMR (CDCl3, 400 MHz, δ): 8.83 (s, 1H, NH),
7.49-7.46 (m, ArH), 6.88-6.84 (m, ArH), 6.00 (s, 1H, -CCH2), 5.71 (ddt, J = 17.2 Hz,
10.6 Hz, 5.6 Hz, 1H, -CHCH2), 5.47 (s, 1H, -CCH2), 5.26 (dq, J = 17.2 Hz, 1.7 Hz, 1H,
-CHCHH), 5.16 (dq, J = 10.4 Hz, 1.6 Hz, -CHCHH), 4.41 (t, J = 6.6 Hz, 1H, -CHOH),
3.95 (dt, J = 5.6 Hz, 1.4 Hz, 2H, -CH2CH=CH2), 3.79 (s, 3H, -ArOCH3), 3.42-3.35
(m, 3H, 1 x -OCH2-; 1 x -CHOH), 1.94-1.24 (m, 10H, 5 x CH2); 13C-NMR (CDCl3,
100 MHz, δ): 165.3 (C=O), 156.5 (C), 145.4 (C), 135.0 (CH), 130.9 (C), 121.9 (CH),
121.7 (2 x CH2), 116.8 (CH2), 114.16 (2 x CH), 74.2 (CH), 71.8 (CH2), 70.5 (CH2),
55.5 (CH3), 35.7 (CH2), 29.7 (CH2), 29.4 (CH2), 29.3 (CH2), 26.1 (CH2), 25.9 (CH2);
IR (cm-1): 3293 (-OH), 2925; 2853 (-CH2) 1511 (-CONR2), 1509 (-C=C), 1245 (-CO-
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CH3), 827 (para disub -ArH); MS-ESI: 384 [M + Na]; HRMS ES+: [M + Na]+ calcd for
C21H31NNaO4, 384.2145, found, 384.249; mp: 74-76 °C (from CHCl3); Rf = 0.3 (25%
EtOAc, 1% Et3N in 40-60 °C petroleum ether).
2-(4-Methoxyphenylcarbamoyl)-10-(allyloxy)dec-1-en-3-yl methanesulfonate (130)
O
N
H
O
OMs
PMP
10-(Allyloxy)-3-hydroxy-N-(4-methoxyphenyl)-2-
methylenedecanamide (129) (580 mg, 1.49 mmol) was
dissolved in CH2Cl2 (20 mL) and cooled to -78 °C. Et3N (410
µL, 2.99 mmol) was added, followed by MsCl (230 µL, 2.99
mmol) dropwise. After 4 h at -78 °C the reaction was quenched
with H2O (20 mL) and warmed to room temperature. The
organics were separated and dried (MgSO4), filtered and the solvent was removed.
Column chromatography (30% EtOAc in 40-60 °C petroleum ether) yielded the title
compound as a clear oil (562 mg, 79% yield). 1H-NMR (CDCl3, 400 MHz, δ): 7.77
(s, 1H, NH), 7.48-7.42 (m, 2H, ArH), 6.90-6.85 (m, 2H, ArH), 5.97-5.86 (m, 2H, 1 x
CH, 1 x CH), 5.77 (s, 1H, -CCH2), 5.42 (t, J = 6.6 Hz, 1H, -CHOMs), 5.26 (dq, J =
17.2 Hz, 1.7 Hz, 1H, -CHCHH), 5.16 (dq, J = 10.4 Hz, 1.6 Hz, 1H, -CHCHH), 3.95
(dt, J = 5.6 Hz, 1.4 Hz, 2H, -CH2CH=CH2), 3.79 (s, 3H, -ArOCH3), 3.41 (t, J = 6.6
Hz, 2H, -OCH2-), 3.02 (s, 3H, -OSOOCH3) 1.91 (q, J = 7.2 Hz, 2H, -CH2CHOMs-),
1.60-1.53 (m, 2H, -OCH2CH2-), 1.48-1.29 (m, 8H, 4 x CH2); 13C-NMR (CDCl3, 100
MHz, δ): 164.4 (C=O), 156.8 (C), 144.0 (C), 135.1 (CH), 130.5 (C), 122.0 (2 x CH),
121.0 ( CH2), 116.8 (CH2), 114.24 (2 x CH), 81.3 (CH), 71.8 (CH2), 70.4 (CH2), 55.5
(CH3), 38.6 (CH3), 35.0 (CH2), 29.7 (CH2), 29.2 (CH2), 29.0 (CH2), 26.1 (CH2), 25.3
(CH2); IR (cm-1): 3358 (-NH), 2933; 2856 (-CH2), 1666 (-C=C), 1510 (-CONR2), 1509
(-C=C), 1349 (-S=O), 1245 (-CO-CH3), 1170 (-S=O), 827 (para disub -ArH); MS-ESI:
440 [M + H]+, 462 [M + Na]+; HRMS ES+: [M + Na]+ calcd for C22H33NNaO6S
462.1921; found, 462.1937; Rf = 0.3 (30% EtOAc in 40-60 °C petroleum ether).
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4-(7-(Allyloxy)heptyl)-1-(4-methoxyphenyl)-3-methyleneazetidin-2-one (122)
N
O PMP
O
2-(4-Methoxyphenylcarbamoyl)-10-(allyloxy)dec-1-en-3-yl
methanesulfonate (130) (562 mg, 1.28 mmol) was dissolved in
THF (20 mL) and cooled to -15 °C. KOtBu (158 mg, 1.41 mmol)
was added in one portion and the solution stirred for 4 h at -15 °C.
The reaction was quenched with sat. NH4Cl (20 mL) the organics
separated, dried (MgSO4), filtered and the solvent removed under reduced pressure.
Column chromatography (30% EtOAc in 40-60 °C petroleum ether) yielded the title
compound as a clear oil. (311 mg, 71% yield). 1H-NMR (CDCl3, 400 MHz, δ):
7.40-7.33 (m, 2H, ArH), 6.92-6.87 (m, 2H, ArH), 5.91 (ddt, J = 17.2 Hz, 10.5 Hz, 5.6
Hz, 1H, -CHCH2), 5.77 (t, J = 1.6 Hz, 1H, -CCHH), 5.29-5.23 (m, 2H, 1 x -CCHH, 1
x -CHCHH), 5.16 (ddt, J = 10.4 Hz, 4.3 Hz, 1.6 Hz, 1H, -CHCHH), 4.54-4.50 (m, 1H,
-CHCNAr), 3.95 (dt, J = 5.6 Hz, 1.4 Hz, 2H, -CH2CH=CH2), 3.78 (s, 3H, -ArOCH3),
3.40 (t, J = 6.6 Hz, 2H, -OCH2-), 2.05-1.96 (m, 1H, -CHHCHCNAr), 1.83-1.73 (m,
1H, -CHHCHCNAr), 1.60-1.51 (m, 2H, -OCH2CH2-), 1.45-1.26 (m, 8H, 4 x CH2);
13C-NMR (CDCl3, 100 MHz, δ): 160.1 (C=O), 156.2 (C), 148.5 (C), 135.1 (CH), 131.1
(C), 118.4 (2 x CH), 116.7 ( CH2), 114.6 (2 x CH), 109.4 (CH2), 71.8 (CH2), 70.4
(CH2), 60.4 (CH), 55.5 (CH3), 30.8 (CH2), 29.8 (CH2), 29.5 (CH2), 29.3 (CH2), 26.1
(CH2), 24.3 (CH2); IR (cm-1): 2931; 2856 (-CH2), 1739 (-CONR2), 1510 (-C=C), 1246
(-CO-CH3), 827 (para disub -ArH); MS-ESI: 344 [M + H]+, 366 [M + Na]+; HRMS
ES+: [M + Na]+ calcd for C21H29NNaO3, 366.2040; found, 366.2036; Rf = 0.3 (30%
EtOAc in 40-60 °C petroleum ether).
Tert-butyl 2-(7-(allyloxy)heptyl)-3,4-dimethleneazetidine-1-carboxylate (167)
N
O Boc
O
4-(7-(Allyloxy)heptyl)-1-(4-methoxyphenyl)-3-methyleneazetidin-
2-one (122) (100 mg, 0.29 mmol) was dissolved in MeCN (10 mL)
and cooled to 0 °C. CAN (480 mg, 0.88 mmol) was dissolved in
H2O (10 mL) and added dropwise and the solution was stirred for 2
h at 0 °C. It was then diluted with Et2O (15 mL) and sat. NaHCO3
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(10 mL) added. The solution was separated and the aqueous layer extracted with Et2O
(3 x 10 mL), the combined organics were dried (MgSO4), filtered and the solvent
removed under reduced pressure. The oil was immediately dissolved in MeCN (10
mL), DMAP added (4 mg, 0.29 mmol) and the solution cooled to 0 °C. Boc2 (130
mg, 5.9 mmol) was added in one portion and the reaction stirred for 2 h at 0 °C. The
reaction was diluted with CH2Cl2 (10 mL) then washed with 1 M NaHSO4 (15 mL),
sat. NaHCO3 (20 mL) and brine (20 mL). The organics were dried (MgSO4), filtered
and the solvent removed under reduced pressure. Column chromatography (10% EtOAc
in 40-60 °C petroleum ether) yielded the title compound a clear oil (36 mg, 35% over 2
steps). 1H-NMR (CDCl3, 400 MHz, δ): 5.94-5.83 (m, 2H, 1 x -CHCH2, 1 x -CCHH),
5.36 (s, 1H, -CCHH), 5.23 (d, J = 17.3 Hz, 1H, -CHCHH), 5.14 (d, J = 10.3 Hz, 1H,
-CHCHH), 4.39 (s, 1H, -CHCN-), 3.93 (d, J = 5.6 Hz, 2H, -CH2O-), 3.39 (t, J = 6.6
Hz, 2H, -OCH2-), 2.01-1.89 (m, 1H, -CHHCHCN-), 1.80-1.71 (m, 1H, -CHHCHCN-),
1.60-1.53 (m, 2H, -OCH2CH2-), 1.50 (s, 9H, -C(CH3)3), 1.42-1.20 (m, 8H, 4 x CH2);
13C-NMR (CDCl3, 100 MHz, δ): 160.0 (C=O), 148.8 (C), 147.9 (C), 135.2 (CH),
116.9 (CH2), 114.5 (CH2), 83.2 (C), 71.9 (CH2), 70.6 (CH2), 60.6 (CH), 31.7 (CH2),
29.8 (CH2), 29.6 (CH2), 29.4 (CH2), 28.2 (CH3), 26.2 (CH2), 24.7 (CH2); IR (cm-1):
MS-ESI: 344 [M + Na]+; Rf = 0.3 (10% EtOAc in 40-60 °C petroleum ether).
RCM of 4-(7-(Allyloxy)heptyl)-1-(4-methoxyphenyl)-3-methyleneazetidin-2-one
(122)
4-(7-(Allyloxy)heptyl)-1-(4-methoxyphenyl)-3-methyleneazetidin-2-one (122) (50 mg,
0.14 mmol) was dissolved in CH2Cl2 (70 mL) and Grubbs 2nd generation catalyst (9 mg,
0.014 mmol) added in one portion and the solution was refluxed for 24 h. The solution
was allowed to cool to room temperature and the solvent removed under reduced pres-
sure. Column chromatography (20-30% EtOAc in 40-60 °C petroleum ether) yielded the
title compounds (dimer 14%, monomer 37% E:Z 1:1.6).
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(Z)-14-(4-Methoxyphenyl)-9-oxa-14-aza-bicyclo[10.2.0]tetradec-11-en-13-one
O
N
H
O PMP
1H-NMR (CDCl3, 400 MHz, δ): 7.31-7.28 (m, 2H, ArH), 6.83-6.81
(m, 2H, ArH), 5.88 (dd, J = 10.8 Hz, 4.1 Hz, 1H, -CHCH2O-), 4.60
(dd, J = 12.8 Hz, 10.9 Hz, 1H, CHCHHO-), 4.48 (dd, J = 6.6 Hz, 3.6
Hz, 1H, -CHCH2CH2-), 4.09 (dd, J = 12.8, 4.1 Hz, 1H, -CHCHHO-
), 3.73 (s, 3H, ArOCH3), 3.62 (ddd, J = 10.7 Hz, 4.2 Hz, 2.3 Hz, 1H,
-OCHHCH2-), 3.42 (ddt, J = 11.2, 10.8, 3.1 Hz, 1H, -OCHHCH2-), 2.03-1.92 (m, 1H,
-CHCHHCH2-), 1.92-1.88 (m, 1H, -CHCHHCH2-), 1.62-1.13 (m, 10H, 5 x CH2); 13C-
NMR (CDCl3, 125 MHz, δ): 160.0 (C=O), 156.2 (C), 142.8 (C), 131.2 (C), 126.8 (CH),
126.7 (CH), 118.3 (CH), 114.6 (CH), 68.0 (CH2), 65.0 (CH2), 59.2 (CH), 55.5 (CH3),
28.5 (CH2), 28.2 (CH2), 27.2 (CH2), 24.3 (CH2), 22.0 (CH2), 20.2 (CH2); IR (cm-1):
2918; 2852 (-CH2), 1728 (-CONR2), 1512 (-C=C), 1246 (-CO-CH3), 830 (para disub
-ArH); ESI+-MS: 316 [M + H]+, 338 [M + Na]+; HRMS: ES+ [M + H]+ calcd for
C19H26NO3, 316.1907; found, 316.1911 [M + Na]+ calcd for C19H25NNaO3, 338.1727;
found, 338.1728; Rf = 0.3 (30% EtOAc in 40-60 °C petroleum ether).
(E)-14-(4-Methoxyphenyl)-9-oxa-14-aza-bicyclo[10.2.0]tetradec-11-en-13-one
O
N
OPMP
H
1H-NMR (CDCl3, 400 MHz, δ): 7.31-7.28 (m, 2H, ArH), 6.83-6.81
(m, 2H, ArH), 6.25 (ddd, J = 6.4 Hz, 3.5 Hz, 1.5 Hz, 1H, -CHCH2O-
), 4.81 (t, J = 4.2 Hz, 1H, -CHCH2CH2-), 4.22 (dd, J = 3.5, 0.6 Hz,
0.5H, -CHCHHO-), 4.19-4.17 (m, 0.5H, -CHCHHO-), 4.00 (dd, J =
14.6, 6.4 Hz, 1H, -CHCHHO-), 3.73 (s, 3H, ArOCH3), 3.60-3.54 (m,
1H, -OCHHCH2-), 3.53-3.46 (m, 1H, -OCHHCH2-), 2.03-1.92 (m,
1H, -CHCHHCH2-), 1.92-1.88 (m, 1H, -CHCHHCH2-), 1.62-1.13 (m, 10H, 5 x CH2);
Rf = 0.3 (30% EtOAc in 40-60 °C petroleum ether).
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(1Z,14Z)-12,25-bis(4-methoxyphenyl)-12,25-diazatricyclo[22.2.0.011,14]hexacosa-
1,14-diene-13,26-dione)
O
O
N
N
O
O
PMP
PMP
H
H
1H-NMR (CDCl3, 400 MHz, δ): 7.37-7.31 (m, 4H, ArH), 6.91-
6.87 (m, 4H, ArH), 5.86-5.80 (m, 2H, 2 x -CCHCH2-), 4.57
(ddd, J = 24.1, 12.8, 6.0 Hz, 2H, 2 x -CHCHH), 4.46 (t, J
= 6.5 Hz, 2H, 2 x -NArCHCH2), 4.36 (ddd, J = 24.1, 12.8,
6.0 Hz, 2H, 2 x -CHCHH), 3.80 (s, 6H, 2 x -ArOCH3), 3.55-
3.44 (m, 4H, 2 x -CH2OCH2CH2-), 2.08-1.96 (m, 2H, 2 x -
NCHCHH-), 1.84-1.69 (m, 2H, 2 x -NCHCHH-), 1.68-1.49 (m,
4H, 2 x -CH2OCH2CH2-), 1.46-1.20 (m, 12H, 6 x -CH2); 13C-
NMR (CDCl3, 100 MHz, δ): 159.9 (C=O), 156.3 (C), 142.0
(C), 131.3 (C), 126.8 (CH), 126.7 (CH), 118.3 (CH), 114.7 (CH), 70.55 (CH2), 70.46
(CH2), 66.62 (CH2), 66.56 (CH2), 59.5 (CH), 55.7 (CH3), 31.0 (CH2), 30.9 (CH2), 30.1
(CH2), 30.0 (CH2), 29.8 (CH2), 29.4 (CH2), 26.1 (CH2), 24.3 (CH2), 24.0 (CH2); IR
(cm-1): 2931; 2856 (-CH2), 1733 (-CONR2), 1509 (-C=C), 1298 (-CO-CH3), 829 (para
disub -ArH); ESI+-MS: 631 [M + H]+, 653 [M + Na]+; HRMS: ES+ [M + H]+ calcd
for C38H51N2O6, 631.3742; found, 631.3750, [M + Na]+ calcd for C38H51N2NaO6,
653.3561; found, 653.3567; Rf = 0.2 (30% EtOAc in 40-60 °C petroleum ether).
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4,4’((But-2-ene-1,4-diylbis(oxy))bis(heptane-7,1-diyl))bis(1-(4-methoxyphenyl)-3-
methyleneazetidin-2-one (132)
N
O
PMP
O
O
N
O
PMP
4-(7-(Allyloxy)heptyl)-1-(4-methoxyphenyl)-3-
methyleneazetidin-2-one (122) (50 mg, 0.14 mmol) was
dissolved in CH2Cl2 (70 mL) and Hoveyda-Grubbs 2nd
generation catalyst (9 mg, 0.014 mmol) added in one
portion. The solution was refluxed for 24 h at which
point it was cooled to room temperature and the solvent
removed. Column chromatography (15% EtOAc, 1%
Et3N in 40-60 °C petroleum ether) yielded the title
compound as an oil (30 mg, 65% yield). 1H-NMR
(CDCl3, 400 MHz, δ): 7.37-7.33 (m, 4H, ArH), 6.92-6.87 (m, 4H, ArH), 5.80-5.77
(m, 4H, -OCH2CHCHCH2O-, -CCHH), 5.24 (s, 2H, 2 x -CCHH), 4.51 (d, J = 7.1
Hz, 2H, 2 x -NCHCCH2), 3.94 (d, J = 2.5 Hz, 4H, 2 x -CHCH2O-), 3.78 (s, 6H,
2 x -ArOCH3), 3.38 (t, J = 6.6 Hz, 4H, 2 x -CH2OCH2CH2-), 2.03-1.94 (m, 2H,
2 x -NCHCCHH-), 1.81-1.72 (m, 2H, 2 x -NCHCCHH-), 1.57-1.49 (m, 4H, 2 x
-CH2OCH2CH2-), 1.43-1.24 (m, 16H, 8 x -CH2); 13C-NMR (CDCl3, 100 MHz, δ):
160.1 (C=O), 156.2 (C), 148.5 (C), 131.1 (C), 129.5 (CH), 118.4 (CH), 114.6 (CH),
109.4 (CH2), 70.8 (CH2), 70.5 (CH2), 60.5 (CH), 55.5 (CH3), 30.7 (CH2), 29.7 (CH2),
29.5 (CH2), 29.3 (CH2), 26.1 (CH2), 24.3 (CH2); IR (cm-1): 2931; 2856 (-CH2), 1733
(-CONR2), 1509 (-C=C), 1298 (-CO-CH3), 829 (para disub -ArH); ESI+-MS: 659 [M
+ H]+; HRMS: ES+ [M + H]+ calcd for C40H55N2O6, 659.4055; found, 659.4068; Rf
= 0.3 (15% EtOAc, 1% Et3N in 40-60 °C petroleum ether).
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13-(4-Methoxyphenyl)-4-oxa-13-azabicyclo[10.2.0]tetradecan-14-one (141)
N
O
O
PMP
(E/Z)-14-(4-Methoxyphenyl)-9-oxa-14-aza-
bicyclo[10.2.0]tetradec-11-en-13-one (27 mg, 0.086 mmol)
and PtO2 (2 mg, 0.0089 mmol) were added to a flask and the
atmosphere replaced with H2. A mixture of EtOH/THF (2 mL:4
mL) was added and the suspension was stirred vigorously for 18
h at room temperature. The solvent was removed and the crude
material immediately purified via column chromatography (20% EtOAc in 40-60 °C
petroleum ether), to give the title compound as an oil (13 mg, 48%). 1H-NMR (CDCl3,
400 MHz, δ): 7.32-7.25 (m, 2H, ArH), 6.90-6.85 (m, 2H, ArH), 4.13-4.08 (m, 1H,
-NArCH-), 3.78 (s, 3H, -OCH3), 3.63-3.57 (m, 1H, -CHCH2CHHO-), 3.45-3.41
(m, 2H, -OCH2CH2CH2-), 3.40-3.32 (m, 2H, -CCHCH2CHHO-; -CCHCH2-), 2.19-
1.91 (m, 3H, -CCHCH2CH2O-; -NArCHCHH-) 1.76-1.59 (m, 3H, -NArCHCHH-;
-OCH2CH2CH2-), 1.58-0.81 (m, 8H, 4 x -CH2); 13C-NMR (CDCl3, 100 MHz, δ):
167.5 (C=O), 155.9 (C), 130.8 (C), 119.3 (2 x CH), 114.4 (2 x CH), 72.5 (CH2), 71.1
(CH2), 57.1 (CH), 55.7 (CH3), 53.0 (CH), 26.8 (CH2), 26.1 (CH2), 25.9 (CH2), 24.9
(CH2), 24.4 (CH2), 24.3 (CH2); IR (cm-1): 2932; 2853 (-CH2), 1738 (-CONR2), 1510
(-C=C), 1244 (-CO-CH3), 830 (para disub -ArH); ESI+-MS: 318 [M + H]+, 340 [M +
Na]+; HRMS: ES+ [M + H]+ calcd for C19H26NO3, 340.1883; found, 340.1883; Rf =
0.3 (20% EtOAc in 40-60 °C petroleum ether).
(Z)-4-oxa-13-azabicyclo[10.2.0]tetradec-1-en-14one
NH
O
O
(Z/E)-14-(4-Methoxyphenyl)-9-oxa-14-aza-bicyclo[10.2.0]tetradec-
11-en-13-one (5 mg, 0.06 mmol) was dissolved in MeCN (2 mL) and
cooled to 0 °C. CAN (99 mg, 0.18 mmol) in H2O (2 mL) was added
dropwise and the reaction stirred for 1 h at 0 °C, after which time it
was poured into Et2O (5 mL) and sat. NaHCO3 (5 mL). The aqueous
was extracted with Et2O (3 x 5 mL), the combined organics were dried,
and the solvent removed under reduced pressure. Semi-preparative HPLC (40% H2O
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in MeCN) yielded the title compound (1 mg, 30%), which was unstable in CDCl3.
1H-NMR (CDCl3, 300 MHz, δ): 6.12 (br s, 1H, NH), 5.87 (dd, J = 10.8 Hz, 3.0 Hz,
1H, -CHCH2O-), 4.60 (dd, J = 12.8 Hz, 10.8 Hz, 1H, CHCHHO-), 4.16-4.09 (m,
2H, -CHCH2CH2-; -CHCHHO-), 3.72-3.65 (m, 1H, -OCHHCH2-), 3.44-3.37 (m, 1H,
-OCHHCH2-), 1.72-1.12 (m, 12H, 6 x CH2); ESI+-MS: 232 [M + Na]+ 441 [2M +
Na]+; HRMS: ES+ [M + Na]+ calcd for C12H19NNaO2, 232.1308; found, 232.1313.
(Z)-13-Ethyl-4-oxa-13-azabicyclo[10.2.0]tetradec-1-en-14-one (101)
N
O
O
Et
(Z)-14-(4-Methoxyphenyl)-9-oxa-14-aza-bicyclo[10.2.0]tetradec-
11-en-13-one (19 mg, 0.06 mmol) was dissolved in MeCN (2 mL)
then cooled to 0 °C. CAN (99 mg, 0.18 mmol) in H2O (2 mL) was
added dropwise and the reaction stirred for 1 h at 0 °C, after which
time it was poured into Et2O (5 mL) and sat. NaHCO3 (5 mL). The
aqueous was extracted with Et2O (3 x 5 mL), the combined organics
were dried, and the solvent removed under reduced pressure. Column chromatography
(50% EtOAc in 40-60 °C petroleum ether) yielded the title compound, which used
immediately dissolved in Et-I (5 mL). KOH (5 mg, 0.096) was added and the solution
stirred for 18 h at room temperature. The solution was then poured into H2O (5 mL).
The layers were separated and the aqueous extracted with Et2O (2 x 5 mL). The
combined organics were dried (MgSO4), filtered and the volatiles removed under
reduced pressure. Semi-preparative HPLC (40% H2O in MeCN, flow rate 1 mL/min)
yielded the title compound as a solid (3 mg, 21% over two steps). 1H-NMR (CDCl3,
700 MHz, δ): 5.78 (dd, J = 10.8, 3.7 Hz, 1H, -CH2CHC-, 4.56 (dd, J = 12.8, 10.9 Hz,
1H, -OCHHCHC-), 4.12-4.11 (m, 2H, -OCHHCHC-; -CH2CH(C)N-), 3.69 (dt, J =
11.1 , 4.9 Hz, -OCHHCH2-), 3.54-3.49 (m, 1H, -NCHHCH3), 3.44 (dt, J = 11.1 , 4.9
Hz, -OCHHCH2-), 3.16-3.11 (m, 1H, -NCHHCH3), 1.87-1.82 (m, 1H, -CHCHHCH2-),
1.69-1.65 (m, 1H, -CHCHHCH2-), 1.53-1.49 (m, 2H, -OCH2CH2-), 1.47-1.22 (m, 10H,
5 x CH2), 1.19 (t, J = 7.2 Hz, -NCH2CH3); 13C-NMR (CDCl3, 175 MHz, δ): 163.2
(C=O), 143.7 (C), 125.2 (CH), 67.3 (CH2), 65.3 (CH2), 558.1 (CH), 34.8 (CH2), 29.7
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(CH2), 28.7 (CH2), 28.6 (CH2), 27.4 (CH2), 24.7 (CH2), 21.9 (CH2), 20.4 (CH2), 13.4
(CH3); IR (cm-1): 2928; 2856 (-CH2), 1738 (-CONR2), 1395 (-C=C), 1220 (-CO-CH2);
ESI+-MS: 260 [M + Na]+; HRMS: ES+ [M + Na]+ calcd for C14H23NNaO2, 260.1621;
found, 260.1617.
8-(But-2-en-1-yloxy)octan-1-ol (243)
O OH
1,8 Octadiol (7.1 g, 48.6 mmol) was dissolved
in THF (50 mL) and added to NaH (60% in
mineral oil, 2.2 g, 55.0 mmol) via cannula. The
slurry was stirred for 1 h at room temperature. Crotonyl bromide (5.75 mL, 56.2 mmol)
and TBAI (35 mg) were dissolved in THF (50 mL) and added to the NaH solution via
cannula. This was heated to reflux for 16 h. Once cool sat. NH4Cl (50 mL) was added
and the aqueous layer extracted with EtOAc (3 x 50 mL). The combined organics were
dried (MgSO4 and the volatiles removed under reduced pressure. Column chromatogra-
phy (20% EtOAc in 40-60 °C petroleum ether) yielded the title compound as an oil (5 g,
51%). There are two products due to the isomers of crotyl bromide used, only the major
product was well resolved and so is recorded below. The ratio is approximately 1:4.5.
1H-NMR (CDCl3, 400 MHz, δ): 5.76-5.64 (m, 1H, -CH3CHCH-), 5.63-5.53 (m, 1H, -
CH3CHCH-), 3.88 (d, J = 6.2 Hz, 2H, -OCH2CH-), 3.63 (t, J = 6.6 Hz, 1H, -CH2OCH2-
), 3.39 (t, J = 6.7 Hz, 2H, -CH2CHO-), 1.71 (d, J = 6.3 Hz, 3H, CH3CHCH-), 1.63-1.28
(m, 10H, 5 x -CH2-); 13C-NMR (CDCl3, 100 MHz, δ): 129.2 (CH), 127.8 (CH), 71.5
(CH2), 70.3 (CH2), 63.1 (CH2), 32.8 (CH2), 29.8 (CH2), 29.5 (CH2), 29.4 (CH2), 26.2
(CH2), 25.7 (CH2), 17.8 (CH3); IR (cm-1): 3353 (-OH), 2929, 2856 (CH2); MS-ESI: 223
[M + Na]+; HRMS ES+: [M + Na]+ calcd for C12H24NaO2 223.1699; found, 223.1666;
Rf = 0.3 (20% EtOAc in 40-60 °C petroleum ether).
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8-(But-2-en-1-yloxy)octanal (115)
O O
H
8-(But-2-en-1-yloxy)octan-1-ol (5 g, 25.0
mmol) was dissolved in CH2Cl2 (50 mL) and
SiO2 was added to make a slurry. PCC (6.5 g,
30.0 mmol) was added in one portion and the solution stirred for 16 h. The mixture
was diluted with Et2O (50 mL) then filtered through a short pad of SiO2. The pad
was washed exhaustively with Et2O. The volatiles were removed under reduced
pressure. Column chromatography (10% EtOAc in 40-60 °C petroleum ether) yielded
the title compound as a clear oil (1.4 g, 28%). 1H-NMR (CDCl3, 400 MHz, δ): 9.74
(apparent d, J = 1.7 Hz, 1H, -CHO), 5.76-5.64 (m, 1H, -CH3CHCH-), 5.63-5.53
(m, 1H, -CH3CHCH-), 3.88 (d, J = 6.1 Hz, 2H, -OCH2CH-), 3.38 (t, J = 6.7 Hz,
1H, -CH2OCH2-), 2.42 (t, J = 7.4 Hz, 2H, -CH2CHO-), 1.71 (d, J = 6.3 Hz, 3H,
CH3CHCH-), 1.68-1.27 (m, 10H, 5 x -CH2-); 13C-NMR (CDCl3, 100 MHz, δ): 202.9
(C=O), 129.2 (CH), 127.8 (CH), 71.5 (CH2), 70.2 (CH2), 43.9 (CH2), 29.7 (CH2), 29.2
(CH2), 29.1 (CH2), 26.0 (CH2), 22.0 (CH2), 17.7 (CH3); MS-ESI 221 [M + Na]+;
HRMS: ES+ [M + Na]+ calcd for C12H22NNaO2, 221.1512; found, 221.1517; Rf = 0.3
(10% EtOAc in 40-60 °C petroleum ether).
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Methyl 10-(but-2-en-1-yloxy)-3-hydroxy-2-methylenedecanoate (116)
O
MeO
O
OH
8-(But-2-en-1-yloxy)octanal (4 g, 20.2 mmol) was dissolved in
methyl acrylate (2 mL, 22.1 mmol), MeOH (1 mL) and DABCO
(640 mg, 5.71 mmol) were added and the solution stirred for
9 days. The volatiles were removed and the crude product was
purified via column chromatography (20% EtOAc in 40-60 °C
petroleum ether) to give the title compound as a clear oil (1.686 g,
29%). 1H-NMR (CDCl3, 400 MHz, δ): 6.22 (d, J = 1.0 Hz, 1H, CHHC-), 5.79 (t, J = 1.0
Hz, 1H, CHHC-), 5.76-5.65 (m, 1H, -CH3CHCH-), 5.64-5.53 (m, 1H, -CH3CHCH-),
4.38 (q, J = 5.6 Hz, 1H, -CH2C(C)HOH), 3.88 (dt, J = 6.1, 1.0 Hz, 2H, -OCH2CH-), 3.78
(s, 3H, -COOCH3), 3.38 (t, J = 6.7 Hz, 1H, -CH2OCH2-), 2.55 (d, J = 6.0 Hz, 1H, -OH),
1.71 (dd, J = 6.3, 1.2 Hz, 3H, CH3CHCH-), 1.68-1.25 (m, 10H, 5 x -CH2-); 13C-NMR
(CDCl3, 100 MHz, δ): 167.1 (C=O), 142.5 (C), 129.2 (CH), 127.8 (CH), 125.0 (CH2),
71.8 (CH), 71.5 (CH2), 70.3 (CH2), 51.9 (CH3), 36.2 (CH2), 29.8 (CH2), 29.4 (CH2),
26.1 (CH2), 25.8 (CH2), 17.8 (CH3); IR (cm-1): 3430 (-OH), 2929, 2855 (-CH2), 1725
(-CO2H); MS-ESI: 307 [M + Na]+; HRMS ES+: [M + Na]+ calcd for C22H33NNaO6S
462.1921; found, 462.1937; Rf = 0.3 (20% EtOAc in 40-60 °C petroleum ether).
10-(But-2-en-1-yloxy)-3-hydroxy-2-methylenedecanoic acid (117)
O
HO
O
OH
Methyl 10-(but-2-en-1-yloxy)-3-hydroxy-2-methylenedecanoate
(1.686 g, 5.94 mmol) was dissolved in THF (50 mL). LiOH ·H2O
(1.2 g, 29.3 mmol) in H2O (50 mL) was added and the solu-
tion stirred for 16 h. The layers were allowed to separate and
the aqueous layer acidified to pH 1 with 2N HCl. This was ex-
tracted with EtOAc (3 x 20 mL). The combined organics were
dried (MgSO4), filtered and the solvent removed under reduced pressure to give the title
compound as a clear oil, which was used without further purification (1.600 g, 99%).
1H-NMR (CDCl3, 400 MHz, δ): 6.38 (s, 1H, CHHC-), 5.90 (s, 1H, CHHC-), 5.76-
5.66 (m, 1H, -CH3CHCH-), 5.65-5.53 (m, 1H, -CH3CHCH-), 4.41 (t, J = 7.0 Hz, 1H,
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-CH2C(C)HOH), 3.88 (dt, J = 6.2, 1.0 Hz, 2H, -OCH2CH-), 3.40 (t, J = 6.7 Hz, 1H,
-CH2OCH2-), 1.71 (dd, J = 6.3, 1.0 Hz, 3H, CH3CHCH-), 1.68-1.25 (m, 12H, 6 x -
CH2-); 13C-NMR (CDCl3, 100 MHz, δ): 170.8 (C=O), 142.5 (C), 129.4 (CH), 127.7
(CH), 127.4 (CH2), 71.59 (CH), 71.56 (CH2), 70.3 (CH2), 36.2 (CH2), 29.7 (CH2), 29.4
(CH2), 29.3 (CH2), 26.1 (CH2), 25.7 (CH2), 17.8 (CH3); IR (cm-1): 3358 (-COOH),
2928; 2855 (-CH2), 1707 (-COOH), 1053 (-CO-CH3); MS-ESI: 293 [M + Na]+; HRMS
ES+: [M + Na]+ calcd for C15H26NaO4 293.1723; found, 293.1722.
10-(But-2-en-1-yloxy)-3-hydroxy-N-(4-methoxyphenyl)-2-methylenedecanamide
(134)
O
N
H
O
OH
PMP
10-(But-2-en-1-yloxy)-3-hydroxy-2-methylenedecanoic acid
(193 mg, 0.71 mmol) and p-anisidine (87 mg, 0.71 mmol) were
dissolved in EtOH (7 mL) and cooled to 0 °C. HOBt (88%, 20
mg, 0.11 mmol) and NMM (200 µL, 1.57 mmol) were added
followed by EDC · HCl, the solution was allowed to warm to
room temperature over 18 h. It was then diluted with EtOAc (10
mL) and washed with H2O (10 mL). The organics were separated, dried (MgSO4),
filtered and the solvent removed under reduced pressure. Column chromatography
(40% EtOAc in 40-60 °C petroleum ether) yielded the title compound (125 mg, 47%).
1H-NMR (CDCl3, 400 MHz, δ): 9.26 (s, 1H, -NH), 7.47-7.44 (m, 2H, ArH), 6.83-6.81
(m, 2H, ArH), 5.99 (s, 1H, CHHC-), 5.73-5.63 (m, 1H, -CH3CHCH-), 5.61-5.23 (m,
1H, -CH3CHCH-), 5.40 (s, 1H, CHHC-), 4.36 (t, J = 6.9 Hz, 1H, -CH2C(C)HOH),
4.29 (br s, 1H, -OH), 3.87 (d, J = 6.0 Hz, 2H, -OCH2CH-), 3.75 (s, 3H, -OCH3), 3.37
(t, J = 6.7 Hz, 1H, -CH2OCH2-), 1.69 (d, J = 6.3 Hz, 3H, CH3CHCH-), 1.66-1.21 (m,
12H, 6 x -CH2-); 13C-NMR (CDCl3, 100 MHz, δ): 165.4 (C=O), 156.4 (C), 145.1 (C),
131.0 (C), 129.3 (CH), 127.7 (CH), 121.9 (CH), 122.0 (CH2), 114.1 (CH), 73.9 (CH),
71.5 (CH2), 70.2 (CH2), 55.4 (CH3), 35.8 (CH2), 29.7 (CH2), 29.4 (CH2), 29.4 (CH2),
26.1 (CH2), 26.0 (CH2), 17.8 (CH3); IR (cm-1): 3301 (-OH), 2933; 2856 (-CH2) 1510
(-CONR2), 1244 (-CO-CH3), 830 (para disub -ArH); MS-ESI: 398 [M + Na]+; HRMS
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ES+: [M + Na]+ calcd for C22H33NNaO4 398.2302; found, 398.2323; Rf = 0.3 (40%
EtOAc in 40-60 °C petroleum ether).
4-(7-(But-2-en-1-yloxy)heptyl)-1-(4-methoxyphenyl)-3-methyleneazetidine-2-one
(133)
N
O PMP
O
10-(But-2-en-1-yloxy)-3-hydroxy-N-(4-methoxyphenyl)-2-
methylenedecanamide (852 g, 2.27 mmol) was dissolved in
CH2Cl2 (10 mL) and cooled to -78 °C. Et3N (600 µL, 4.63 mmol)
was added, followed by MsCl (350 µL, 4.54 mmol) dropwise. The
reaction was stirred for 5 h at -78 °C, after which time the reaction
was quenched with H2O (20 mL). The organics were separated, dried (MgSO4), filtered
and the solvent was removed under reduced pressure. The crude 10-(but-2-en-1-yloxy)-
2-((4-methoxyphenyl)carbamoyl)dec-1-en-3-yl methansulfonate (539 mg, 1.19 mmol)
was dissolved in THF (10 mL) and cooled to -15 °C. KOtBu (146 mg, 1.30 mmol) was
added in one portion and stirred at -15 °C for 2 h. The reaction was quenched with sat.
NH4Cl (10 mL), the organics were separated, dried (MgSO4), filtered and the solvent
removed under reduced pressure. Column chromatography (20% EtOAc in 40-60 °C
petroleum ether) yielded the title compound as a clear oil (240 mg, 30% over 2 steps).
1H-NMR (CDCl3, 400 MHz, δ): 7.37-7.34 (m, 2H, ArH), 6.90-6.88 (m, 2H, ArH),
5.77 (t, J = 1.5 Hz, 1H, CHHC-), 5.77-5.66 (m, 1H, -CH3CHCH-), 5.62-5.53 (m, 1H,
-CH3CHCH-), 5.24 (s, 1H, CHHC-), 4.52 (apparent d, J = 9.2 Hz, 1H, -CH2C(C)H-),
3.87 (d, J = 6.2 Hz, 2H, -OCH2CH-), 3.80 (s, 3H, -OCH3), 3.37 (t, J = 6.7 Hz, 1H,
-CH2OCH2-), 2.06-1.95 (m, 1H, -CHHCHN-), 1.83-1.74 (m, 1H, -CHHCHN-), 1.70
(ddd, J = 6.3, 1.1 Hz, 3H, CH3CHCH-), 1.60-1.50 (m, 2H, -OCH2CH2-), 1.47-1.24 (m,
8H, 4 x -CH2-); 13C-NMR (CDCl3, 100 MHz, δ): 160.1 (C=O), 156.2 (C), 148.5 (C),
131.1 (C), 129.2 (CH), 127.8 (CH), 118.4 (CH), 114.5 (CH), 109.4 (CH2), 71.6 (CH2),
70.2 (CH2), 60.4 (CH), 55.5 (CH3), 30.8 (CH2), 29.7 (CH2), 29.5 (CH2), 29.3 (CH2),
26.1 (CH2), 24.3 (CH2), 17.8 (CH3); IR (cm-1): 2930; 2855 (-CH2), 1735 (-CONR2),
1455 (-C=C), 1174 (-CO-CH3), 728 (para disub -ArH); MS-ESI: 380 [M + Na]+;
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HRMS ES+: [M + Na]+ calcd for C22H31NNaO3 380.2196; found, 380.2198; Rf = 0.3
(20% EtOAc in 40-60 °C petroleum ether).
8-((2-Methylallyl)oxy)octan-1-ol (153)
O OH
1,8 Octadiol (7.1 g, 48.6 mmol) was dissolved in
THF (50 mL) and added to NaH (60% in mineral
oil, 2.2 g, 55.0 mmol) via cannula. The slurry was
stirred for 1 h at room temperature. 3-Bromo-2-methylpropene (4.4 mL, 43.3 mmol)
and TBAI (50 mg) were dissolved in THF (50 mL) and added to the NaH solution via
cannula. This was heated to reflux for 16 h. Once cool sat. NH4Cl (50 mL) was added and
the aqueous layer extracted with EtOAc (3 x 50 mL). The combined organics were dried
(MgSO4 and the volatiles removed under reduced pressure. Column chromatography
(10% EtOAc in 40-60 °C petroleum ether) yielded the title compound as an oil (4.4
g, 45%). 1H-NMR (CDCl3, 400 MHz, δ): 4.95 (s, 1H, -CCH3CHH), 4.87 (s, 1H, -
CCH3CHH), 3.85 (s, 2H, -OCH2CCH3-), 3.63 (t, J = 6.6 Hz, 2H, -CH2OH), 3.37 (t, J
= 6.6 Hz, 2H, -OCH2-), 1.72 (s, 3H, CH2CCH3CH2-), 1.62-1.23 (m, 12H, 6 x -CH2-);
13C-NMR (CDCl3, 100 MHz, δ): 142.7 (C), 111.9 (CH2), 74.9 (CH2), 70.4 (CH2), 63.2
(CH2), 33.0 (CH2), 29.9 (CH2), 29.6 (CH2), 29.5 (CH2), 26.3 (CH2), 25.8 (CH2), 19.6
(CH3); Rf = 0.3 (10% EtOAc in 40-60 °C petroleum ether).
8-((2-Methylallyl)oxy)octanal (152)
O
O
8-((2-Methylallyl)oxy)octan-1-ol (153) (4.4 g, 22.0
mmol) was dissolved in CH2Cl2 (50 mL) and SiO2
was added to make a slurry. PCC (5.6 g, 26.4
mmol) was added in one portion and the solution stirred for 5 h. The mixture was di-
luted with Et2O (50 mL) then filtered through a short pad of SiO2. The pad was washed
exhaustively with Et2O. The volatiles were removed under reduced pressure. Column
chromatography (15% EtOAc in 40-60 °C petroleum ether) yields the title compound
as a clear oil (2.5 g, 51%). 1H-NMR (CDCl3, 400 MHz, δ): 9.74 (s, 1H, -CHO), 4.93
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(s, 1H, -CCH3CHH), 4.86 (s, 1H, -CCH3CHH), 3.84 (s, 2H, -OCH2CCH3-), 2.40 (td,
J = 7.4 Hz, 1.8 Hz, 2H, -OCH2-), 1.72 (s, 3H, CH2CCH3CH2-), 1.66-1.28 (m, 12H,
6 x -CH2-); 13C-NMR (CDCl3, 100 MHz, δ): 203.0 (C=O), 142.7 (C), 111.9 (CH2),
74.9 (CH2), 70.2 (CH2), 44.0 (CH2), 29.9 (CH2), 29.4 (CH2), 29.3 (CH2), 26.2 (CH2),
22.2 (CH2), 19.6 (CH3); MS-ESI: 221 [M + Na]+; HRMS ES+: [M + Na]+ calcd for
C12H22NaO2 221.1512; found, 221.1517; Rf = 0.3 (15% EtOAc in 40-60 °C petroleum
ether).
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Methyl 3-hydroxy-10-((2-methylally)oxy)-2-methylenedecanoate (154)
O
MeO
O
OH
8-((2-Methylallyl)oxy)octanal (152) (2.5 g, 12.6 mmol) was dis-
solved in methyl acrylate (1.5 mL, 18.9 mmol). and DABCO (1.4
g, 12.6 mmol) were added and the solution stirred for 7 days.
The volatiles were removed and the crude product was purified
via column chromatography (15% EtOAc in 40-60 °C petroleum
ether) to give the title compound as a clear oil (1.954 g, 60%). 1H-
NMR (CDCl3, 400 MHz, δ): 6.20 (s, 1H, -CCHH), 5.77 (s, 1H, -CCHH), 4.93 (s, 1H,
-CCH3CHH), 4.89 (s, 1H, -CCH3CHH), 4.38 (q, J = 6.4 Hz, 1H, -CHOHC-), 3.84 (s,
2H, -OCH2CCH3-), 3.76 (s, 3H, COOCH3), 3.36 (t, J = 6.6 Hz, 2H, -CH2OH), 2.57 (br
s, 1H, -OH), 1.71 (s, 3H, CH2CCH3CH2-), 1.61-1.22 (m, 12H, 6 x -CH2-); 13C-NMR
(CDCl3, 100 MHz, δ) 167.2 (C=O), 142.74 (C), 142.68 (C), 125.1 (CH2), 111.9 (CH2),
74.9 (CH2), 71.9 (CH), 70.3 (CH2), 52.0 (CH3), 36.4 (CH2), 29.9 (CH2), 29.5 (CH2),
26.3 (CH2), 25.9 (CH2), 19.6 (CH3); MS-ESI: 307 [M + Na]+;HRMS ES+: [M + Na]+
calcd for C16H28NaO4 307.1880; found, 307.1884; Rf = 0.3 (15% EtOAc in 40-60 °C
petroleum ether).
3-Hydroxy-10-((2-methylally)oxy)-2-methylenedecanoic acid (155)
O
HO
O
OH
Methyl 3-hydroxy-10-((2-methylally)oxy)-2-
methylenedecanoate (154) (1.954 g, 4.59 mmol) was dissolved
in THF (20 mL). LiOH ·H2O (1.4 mg, 34.0 mmol) in H2O (20
mL) was added and the solution stirred overnight. The layers
were allowed to separate and the aqueous layer acidified to pH 1
with 2N HCl. This was extracted with EtOAc (3 x 20 mL). The
combined organics were dried (MgSO4), filtered and the solvent removed under reduced
pressure yielded the title compound as a clear oil, which was used without further
purification (1.369 g, 74%). 1H-NMR (CDCl3, 400 MHz, δ): 7.37 (br s, 1H, -COOH),
6.36 (s, 1H, -CCHH), 5.88 (s, 1H, -CCHH), 4.93 (s, 1H, -CCH3CHH), 4.86 (s, 1H,
-CCH3CHH), 4.40 (t, J = 6.6 Hz, 1H, -CHOH-), 3.86 (s, 2H, -OCH2CCH3-), 3.38 (t, J
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= 6.6 Hz, 2H, -CHOH), 1.71 (s, 3H, CH2CCH3CH2-), 1.69-1.60 (m, 2H, -CH2CHOH-),
1.60-1.51 (m, 2H, -OCH2CH2-), 1.46-1.18 (m, 8H, 4 x -CH2-); 13C-NMR (CDCl3, 100
MHz, δ) 171.1 (C=O), 142.6 (C), 142.1 (C), 127.3 (CH2), 112.1 (CH2), 74.9 (CH2),
71.6 (CH), 70.3 (CH2), 36.3 (CH2), 29.8 (CH2), 29.52 (CH2), 29.45 (CH2), 26.3 (CH2),
25.9 (CH2), 19.6 (CH3); IR (cm-1): 3434 (-COOH), 2929; 2855 (-CH2), 1715 (-COOH),
1630 (-C=C), 1262 (-CO-CH3).
3-Hydroxy-N-(4-methoxyphenyl)-10-((2-methylally)oxy)-2-methylenedecanamide
(156)
O
N
H
O
OH
PMP
3-Hydroxy-10-((2-methylally)oxy)-2-methylenedecanoic acid
(155) (1.369 g, 5.07 mmol) and p-anisidine (623 mg, 5.07 mmol)
were dissolved in CH2Cl2 (20 mL) and cooled to 0 °C. DCC
(1.04 mg, 5.07 mmol) in CH2Cl2 (50 mL) was added slowly
and the solution allowed to warm to room temperature over 18
h. The resulting suspension was filtered through Celite, washed
with a small amount of CH2Cl2 and the solvent removed under reduced pressure.
Column chromatography (30% EtOAc in 40-60 °C petroleum ether) yielded the title
compound contaminated with p-anisidine as a white solid (1.29 g). 1H-NMR (CDCl3,
400 MHz, δ): 8.65 (br s, 1H, NH) 7.47-7.45 (m, 2H, ArH), 6.86-6.84 (m, 2H, ArH),
5.98 (s, 1H, -CCHH), 5.48 (s, 1H, -CCHH), 4.92 (s, 1H, -CCH3CHH), 4.85 (s, 1H,
-CCH3CHH), 4.42 (t, J = 7.5 Hz, 1H, -CHOHC-), 3.84 (s, 2H, -OCH2CCH3-), 3.78 (s,
3H, -ArOCH3), 3.35 (t, J = 6.5 Hz, 2H, -CH2OH), 3.02 (br s, 1H, -OH), 1.83-1.18 (m,
15H, 1 x CH3, 6 x -CH2-); 13C-NMR (CDCl3, 100 MHz, δ): 165.4 (C=O), 156.9 (C),
145.8 (C), 142.5 (C), 131.1 (C), 122.1 (CH), 121.7 (CH2), 114.3 (CH), 111.9 (CH2),
74.9 (CH2), 74.4 (CH), 70.3 (CH2), 55.7 (CH3), 35.8 (CH2), 29.9 (CH2), 29.5 (CH2),
29.4 (CH2), 26.2 (CH2), 26.1 (CH2), 19.6 (CH3); IR (cm-1): 3300 (-OH), 2928; 2855
(-CH2) 1628 (-CONR2), 1245 (-CO-CH3), 899 (para disub -ArH); MS-ESI: 376 [M +
H]+, 398 [M + Na]+; HRMS ES+: [M + Na]+ calcd for C22H33NaO4 398.2302; found,
398.2304; Rf = 0.3 (30% EtOAc in 40-60 °C petroleum ether).
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1-(4-Methoxyphenyl)-4-(7-((2-methylallyl)oxy)heptyl)-3-methyleneazetidin-2-one
(144)
N
O PMP
O
3-Hydroxy-N-(4-methoxyphenyl)-10-((2-methylally)oxy)-2-
methylenedecanamide (156) (1.2 g, 3.46 mmol) was dissolved
in CH2Cl2 (10 mL) and cooled to -78 °C. Et3N (950 µL, 6.92
mmol) was added, followed by MsCl (530 µL, 6.92 mmol)
dropwise. The reaction was allowed to warm to room temperature
over 18 h, after which time the reaction was quenched with H2O
(20 mL). The organics were separated, dried (MgSO4), filtered and the solvent was
removed under reduced pressure. The crude 2-((4-methoxyphenyl)carbamoyl)-10-((2-
methylallyl)oxy)dec-1-en-3-yl methanesulfonate was dissolved in THF (20 mL) and
cooled to 0 °C. KOtBu (474 mg, 5.08 mmol) was added in one portion and solution was
allowed to warm to room temperature over 18 h. The reaction was quenched with sat.
NH4Cl (15 mL), the organics were separated, dried (MgSO4), filtered and the solvent
removed under reduced pressure. Column chromatography (20% EtOAc in 40-60 °C
petroleum ether) yielded the title compound as a clear oil (583 mg, 32% over 2 steps).
1H-NMR (CDCl3, 400 MHz, δ): 7.37-7.32 (m, 2H, ArH), 6.91-6.86 (m, 2H, ArH),
5.76 (s, 1H, -CCHH), 5.24 (s, 1H, -CCHH), 4.93 (s, 1H, -CCH3CHH), 4.86 (s, 1H,
-CCH3CHH), 4.52 (d, J = 6.6 Hz, 1H, -CHCNAr), 3.85 (s, 2H, -OCH2CCH3-), 3.79 (s,
3H, -ArOCH3), 3.36 (t, J = 6.6 Hz, 2H, -OCH2-), 2.05-1.94 (m, 1H, -CHHCHCNAr),
1.83-1.74 (m, 1H, -CHHCHCNAr), 1.72 (s, 3H, CH2CCH3CH2-), 1.61-1.49 (m, 2H,
-OCH2CH2-), 1.45-1.26 (m, 8H, 4 x CH2); 13C-NMR (CDCl3, 100 MHz, δ): 160.3
(C=O), 156.4 (C), 148.7 (C), 142.7 (C), 131.3 (C), 118.9 (2 x CH), 114.7 (2 x CH),
111.9 (CH2), 109.5 (CH2), 74.9 (CH2), 70.3 (CH2), 60.6 (CH), 55.7 (CH3), 30.9 (CH2),
29.9 (CH2), 29.7 (CH2), 29.4 (CH2), 26.3 (CH2), 24.4 (CH2), 19.6 (CH3); IR (cm-1):
2930; 2855 (-CH2), 1736 (-CONR2), 1509 (-C=C), 1244 (-CO-CH3), 827 (para disub
-ArH); MS-ESI: 380 [M + Na]+; HRMS ES+: [M + Na]+ calcd for C22H31NNaO3
380.2196; found, 380.2193; Rf = 0.3 (20% EtOAc in 40-60 °C petroleum ether).
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RCM reactions of 1-(4-methoxyphenyl)-4-(7-((2-methylallyl)oxy)heptyl)-3-
methyleneazetidin-2-one (144)
1-(4-methoxyphenyl)-4-(7-((2-methylallyl)oxy)heptyl)-3-methyleneazetidin-2-one
(144) (50 mg, 0.14 mmol) was dissolved in CH2Cl2 (70 mL). Grubbs 2nd gener-
ation catalyst (11 mg, 0.014 mmol) was added and the reaction refluxed for 24
h. The solution was cooled and the solvent removed under reduced pressure. Col-
umn chromatography (10% EtOAc) yielded the styrene coupled product, and the
methyl substituted product. This was further purified by semi-preparative HPLC
(10% H2O in MeCN, 1 mL/min) to yield the styrene coupled product (1-(4-
methoxyphenyl)4-4(7-((2-methyl-3-phenylallyl)oxy)heptyl)-3-methyleneazetidin-2-
one) (4 mg, 66%), and the elmination product ((E)-3-ethylidene-1-(4-methoxyphenyl)-
4-(7-((2-methylallyl)oxy)heptyl)azetidin-2-one) (7 mg, 13%).
((Z)-3-ethylidene-1-(4-methoxyphenyl)-4-(7-((2-methylallyl)oxy)heptyl)azetidin-2-
one) (144)
N
O PMP
O
1H-NMR (CDCl3, 400 MHz, δ): 7.35-7.33 (m, 2H, ArH), 6.89-
6.87 (m, 2H, ArH), 5.74 (q, J = 7.1 Hz, 1H, -CCHCH3), 4.94
(s, 1H, -CCH3CHH), 4.87 (s, 1H, -CCH3CHH), 4.40 (dd, J =
7.4, 2.2 Hz, 1H, -CHCNAr), 3.85 (s, 2H, -OCH2CCH3-), 3.79
(s, 3H, -ArOCH3), 3.37 (t, J = 6.6 Hz, 2H, -OCH2-), 2.10 (d, J
= 7.1 Hz, 3H, -CCHCH3), 2.01-1.89 (m, 1H, -CHHCHCNAr),
1.78-1.66 (m, 1H, -CHHCHCNAr), 1.73 (s, 3H, CH2CCH3CH2-), 1.66-1.62 (m, 2H,
-OCH2CH2-), 1.48-1.24 (m, 8H, 4 x CH2); 13C-NMR (CDCl3, 100 MHz, δ): 161.1
(C=O), 142.6 (C), 140.3 (C), (C), 131.5 (C), 125.3 (CH), 118.1 (CH), 114.9 (CH), 111.8
(CH2), 74.8 (CH2), 70.1 (CH2), 59.5 (CH), 55.5 (CH3), 31.1 (CH2), 29.7 (CH2), 29.6
(CH2), 29.3 (CH2), 26.1 (CH2), 24.3 (CH2), 19.5 (CH3), 14.7 (CH3); IR (cm-1): 2935;
2850 (-CH2), 1722 (-CONR2), 1510 (-C=C), 1247 (-CO-CH3), 827 (para disub -ArH);
MS-ESI: 394 [M + Na]+; HRMS ES+: [M + Na]+ calcd for C23H33NNaO3 394.2358;
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found, 394.2361.
(1-(4-methoxyphenyl)4-4(7-((2-methyl-3-phenylallyl)oxy)heptyl)-3-
methyleneazetidin-2-one)
N
O PMP
O
1H-NMR (CDCl3, 400 MHz, δ): 8.01-8.04 (m, 2H, ArH),
7.43-7.33 (m, 4H, ArH), 6.93-6.91 (m, 2H, ArH), 6.44 (s,
1H, -CCH3CHPh), 4.93 (s, 1H, -CCH3CHH), 4.86 (s, 1H, -
CCH3CHH), 4.55 (d, J = 3.8 Hz, 1H, -CHCNAr), 3.84 (s, 2H,
-OCH2CCH3-), 3.81 (s, 3H, -ArOCH3), 3.35 (t, J = 6.6 Hz,
2H, -OCH2-), 2.11-1.90 (m, 1H, -CHHCHCNAr), 1.78-1.66
(m, 1H, -CHHCHCNAr), 1.71 (s, 3H, CH2CCH3CH2-), 1.54-1.39 (m, 2H, -OCH2CH2-
), 1.39-1.19 (m, 8H, 4 x CH2); 13C-NMR (CDCl3, 100 MHz, δ): 130.0 (CH), 128.7
(CH), 118.4 (CH), 114.6 (CH), 111.8 (CH2), 74.8 (CH2), 70.0 (CH2), 58.7 (CH), 55.5
(CH3), 31.1 (CH2), 29.7 (CH2), 29.6 (CH2), 29.5 (CH2), 26.1 (CH2), 24.3 (CH2), 19.5
(CH3); IR (cm-1): 2930; 2855 (-CH2), 1730 (-CONR2), 1509 (-C=C), 1269 (-CO-CH3),
827 (para disub -ArH); MS-ESI: 470 [M + Na]+; HRMS ES+: [M + Na]+ calcd for
C29H37NNaO3 470.2671; found, 470.2674.
Methyl 3-hydroxy-2-methylenedodec-11-enoate (179)
OMe
O
HO
Dec-9-enal (1.00 g, 6.49 mmol) was dissolved in methyl acrylate (0.5
mL, 5.36 mmol). DABCO (150 mg, 1.34 mmol) and MeOH (150 µL)
were added and the solution stirred for 24 h. The volatiles were re-
moved under reduced pressure. Column chromatography (10% EtOAc
in 40-60 °C petroleum ether) yielded the title compound as an oil (120
g, 8%). 1H-NMR (CDCl3, 400 MHz, δ): 6.22 (s, 1H, -CCHH), 5.86-
5.76 (m, 2 x 1H, -CHCH2; -CCHH), 4.99 (dd, J = 17.1, 1.5 Hz, 1H, -CHCHH), 4.92
(dd, J = 10.2, 1.0 Hz, 1H, -CHCHH), 4.38 (q, J = 6.6 Hz, 1H, -CHOH), 3.78 (s, 3H,
-COOCH3), 2.53 (br s, 1H, -CHOH), 2.03 (q, J = 7.0 Hz, 2H, -CH2CH=CH2), 1.69-1.61
(m, 2H, -CH2CHOH-), 1.47-1.25 (m, 10H, 5 x -CH2); 13C-NMR (CDCl3, 100 MHz, δ):
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167.1 (C=O), 142.5 (C), 139.2 (CH), 125.0 (CH2), 114.1 (CH2), 71.9 (CH), 51.9 (CH3),
36.2 (CH2), 33.8 (CH2), 29.40 (CH2), 29.38 (CH2), 29.1 (CH2), 28.9 (CH2), 25.8 (CH2);
IR (cm-1):3432 (-OH), 2925 (-OOH), 2855 (-CH2), 1717 (−CO2Me), 1639 (-C=C); MS-
ESI: 263 [M + Na]+; HRMS ES+: [M + Na]+ calcd for C14H24NaO3 263.1618; found,
263.1615; Rf = 0.3 (10% EtOAc in 40-60 °C petroleum ether).
3-Hydroxy-2-methylenedodec-11-enoic acid (183)
OH
O
HO
Methyl 3-hydroxy-2-methylenedodec-11-enoate (179) (120 mg, 0.50
mmol) was dissolved in THF (2.5 mL). LiOH · H2O (100 mg, 2.50
mmol) in H2O (2.5 mL) was added and the solution stirred for 18 h. The
layers were allowed to separate and the aqueous layer acidified to pH
1 with 2N HCl, and extracted with EtOAc (3 x 10 mL). The combined
organics were dried (MgSO4), filtered and the solvent removed to give
the title compound as a clear oil, which was used without further purification (110 mg,
97%). 1H-NMR (CDCl3, 400 MHz, δ): 6.39 (s, 1H, -CCHH), 5.92 (s, 1H, -CCHH), 5.81
(ddt, J = 17.0 Hz, 10.2 Hz, 6.7 Hz, 1H, -CHCH2), 4.91 (dq, J = 17.1 Hz, 1.8 Hz, 1H,
-CHCHH), 4.85 (dq, J = 10.2 Hz, 1.0 Hz, 1H, -CHCHH), 4.43 (dd, J = 7.4, 5.6 Hz,
1H, -CHOH), 2.03 (q, J = 6.5 Hz, 2H, -CH2CHCH2), 1.73-1.59 (m, 2H, -CH2CHOH-),
1.48-1.24 (m, 10H, 5 x -CH2); 13C-NMR (CDCl3, 100 MHz, δ): 171.2 (C=O), 141.8
(C), 139.2 (CH), 127.5 (CH2), 114.2 (CH2), 71.5 (CH), 36.2 (CH2), 33.8 (CH2), 29.4
(CH2), 29.3 (CH2), 29.1 (CH2), 28.9 (CH2), 25.8 (CH2); IR (cm-1): 3550 (-OH), 2925
(-OOH), 2854 (-CH2), 1693 (−CO2H), 1627 (-C=C); MS-ESI: 249 [M + Na]+; HRMS
ES+: [M + Na]+ calcd for C13H22NaO3 249.1461; found, 249.1459.
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3-Hydroxy-N-(4-methoxyphenyl)-2-methylenedodec-11-enamide (181)
N
H
O
HO
PMP
3-Hydroxy-2-methylenedodec-11-enoic acid (183) (110 mg, 0.49
mmol) and p-anisidine (60 mg, 0.49 mmol) were dissolved in
CH2Cl2 (3 mL) and cooled to 0 °C. DCC (100 mg, 0.49 mmol)
in CH2Cl2 (10 mL) was added slowly and the solution was allowed
to warm to room temperature over 18 h. The resulting suspension
was filtered through Celite, washed with a small amount of CH2Cl2
and the solvent removed. Column chromatography (30% EtOAc in 40-60 °C petroleum
ether) yielded the title compound as a white solid (64 mg, 40%). 1H-NMR (CDCl3, 400
MHz, δ): 8.49 (br s, 1H, -CONH-), 7.42-7.40 (m, 2H, -ArH), 6.82-6.79 (m, 2H, -ArH),
5.93 (s, 1H, -CCHH), 5.72 (ddt, J = 16.9 Hz, 10.3 Hz, 6.7 Hz, 1H, -CHCH2), 5.45 (s,
1H, -CCHH), 4.91 (dq, J = 17.1 Hz, 1.7 Hz, 1H, -CHCHH), 4.85 (dq, J = 10.2 Hz,
1.2 Hz, 1H, -CHCHH), 4.38 (q, J = 6.3 Hz, 1H, -CHOH), 3.73 (s, 3H, -ArOCH3), 2.70
(d, J = 5.2 Hz, 1H, -OH), 1.96 (q, J = 7.7 Hz, 2H, -CH2CHCH2), 1.74-1.58 (m, 2H,
-CH2CHOH-), 1.41-1.16 (m, 10H, 5 x -CH2); 13C-NMR (CDCl3, 100 MHz, δ): 164.9
(C=O), 156.8 (C), 145.5 (C), 139.2 (CH), 130.1 (C), 121.9 (CH), 121.5 (CH2), 114.2
(CH), 74.3 (CH), 55.5 (CH3), 35.7 (CH2), 33.8 (CH2), 29.4 (CH2), 29.3 (CH2), 29.0
(CH2), 28.9 (CH2), 25.8 (CH2); IR (cm-1): ; MS-ESI: 332 [M + H]+, 354 [M + Na]+;
HRMS ES+: [M + H]+ calcd for C20H30NO3 332.2220; found, 332.221; Rf = 0.3 (30%
EtOAc in 40-60 °C petroleum ether).
2-((4-Methoxyphenyl)carbamoyl)dodeca-1,11-dien-3-yl methanesulfonate (182)
N
H
O
MsO
PMP
3-Hydroxy-N-(4-methoxyphenyl)-2-methylenedodec-11-
enamide (181) (400 mg, 1.21 mmol) was dissolved in CH2Cl2 (12
mL) and cooled to 0 °C. Et3N (310 µL, 2.42 mmol) was added
followed by MsCl (200 µL, 2.42 mmol) dropwise. After 2 h the
reaction was quenched with H2O (10 mL) and warmed to room
temperature. The organics were separated and dried (MgSO4),
filtered and the solvent removed under reduced pressure. Column chromatography
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(30% EtOAc in 40-60 °C petroleum ether) yields the title compound as an oil (291 mg,
61%). 1H-NMR (CDCl3, 400 MHz, δ): 7.78 (br s, 1H, -CONH-), 7.39-7.36 (m, 2H,
-ArH), 6.80-6.78 (m, 2H, -ArH), 5.87 (s, 1H, -CCHH), 5.77-5.67 (m, 2H, 1 x -CHCH2
1 x -CCHH), 5.35 (t, J = 6.6 Hz, 1H, -CHOSOOCH3), 4.91 (dq, J = 17.1, 1.7 Hz, 1H,
-CHCH2), 4.85 (m, 1H, -CHCH2), 3.71 (s, 3H, -ArOCH3), 2.94 (s, 3H, -OSOOCH3),
1.95 (q, J = 7.4 Hz, 2H, -CH2CHCH2), 1.83 (q, J = 7.1 Hz, 2H, -CH2CHOH-),
1.42-1.17 (m, 10H, 5 x -CH2); 13C-NMR (CDCl3, 100 MHz, δ): 164.5 (C=O), 156.8
(C), 143.9 (C), 139.1 (CH), 130.5 (C), 122.0 (2 x CH), 121.0 (CH), 114.2 (2 x CH),
114.2 (CH2), 81.3 (CH), 55.5 (CH3), 38.6 (CH3), 35.1 (CH2), 33.7 (CH2), 29.2 (CH2),
29.02 (CH2), 28.98 (CH2), 28.8 (CH2), 25.4 (CH2); Rf = 0.3 (30% EtOAc in 40-60 °C
petroleum ether).
1-(4-Methoxyphenyl)-3-methylene-4-(non-8-en-1-yl)azetidin-2-one (176)
N
O PMP
2-((4-Methoxyphenyl)carbamoyl)dodeca-1,11-dien-3-yl methanesul-
fonate (182) (291 mg, 0.74 mmol) was dissolved in THF (10 mL) and
cooled to -15 °C. KOtBu (90 mg, 0.81 mmol) was added in one por-
tion and stirred for 2 h at -15 °C. The reaction was quenched with sat.
NH4Cl (10 mL) the organics separated, dried (MgSO4), filtered and
the solvent removed under reduced pressure. The crude product was
purified via column chromatography (10% EtOAc in 40-60 °C petroleum ether) to give
the title compound (154 mg, 67%). 1H-NMR (CDCl3, 400 MHz, δ): 7.37-7.35 (m, 2H,
ArH), 6.90-6.89 (m, 2H, ArH), 5.84-5.74 (m, 2 x 1H, -CCHH; -CHCH2), 5.25 (t, J = 1.2
Hz, 1H, -CCHH), 4.98 (dq, J = 17.1 Hz, 1.7 Hz, 1H, -CHCH2), 4.92 (dq, J = 10.1, 1.1
Hz, 1H, -CHCHH), 4.54-4.51 (m, 1H, -CHCNAr), 3.80 (s, 3H, -ArOCH3), 2.06-1.95
(m, 2H, 1H -CH2CHCH2; -CHHCHCNAr), 1.84-1.73 (m, 1H, -CHHCHCNAr), 1.45-
1.23 (m, 10H, 5 x -CH2); 13C-NMR (CDCl3, 75 MHz, δ): 160.1 (C=O), 156.2 (C), 148.5
(C), 139.1 (CH), 131.1 (C), 118.4 (CH), 114.5 (CH), 114.2 (CH2), 109.4 (CH2), 60.5
(CH), 55.5 (CH3), 33.7 (CH2), 30.7 (CH2), 29.5 (CH2), 29.2 (CH2), 28.9 (CH2), 28.8
(CH2), 24.3 (CH2); IR (cm-1): 2927; 2855 (-CH2), 1736 (-CONR2), 1509 (-C=C), 1244
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(-CO-CH3), 827 (para disub -ArH); MS-ESI: 336 [M + Na]+; HRMS ES+: [M + Na]+
calcd for C20H27NNaO2, 336.1934; found, 336.1940; Rf = 0.3 (10% EtOAc in 40-60 °C
petroleum ether).
(1Z,13Z)-11,23-Bis(4-methoxyphenyl)-11,23-diazatricyclo[20.2.0.010,13]tetracosa-
1,13-diene-12,24-dione (90)
N
N
O
OPMP
PMP
1-(4-Methoxyphenyl)-3-methylene-4-(non-8-en-1-yl)azetidin-2-
one (176) (50 mg, 0.16 mmol) was dissolved in CH2Cl2 (80 mL).
Grubbs 2nd generation catalyst (13 mg, 0.016 mmol) was added in
one portion and the solution heated at reflux for 4 h. The solution
was allowed to cool and the solvent removed under reduced
pressure. Column chromatography (20% EtOAc in 40-60 °C
petroleum ether) yielded the title compound, the 20-membered
dimer (17 mg, 37%). 1H-NMR (CDCl3, 400 MHz, δ): 7.30-7.23
(m, 4H, -ArH), 6.84-6.78 (m, 4H, -ArH), 5.70-5.57 (m, 2H, -CCHCH2-), 4.41-4.31 (m,
2H, -CHCNAr), 3.72 (s, 6H, -ArOCH3), 2.81-2.68 (m, 2H, -CCHCHH), 2.38-2.24 (m,
2H, -CCHCHH), 1.98-1.82 (m, 2H -NArCHCHH-), 1.82-1.78 (m, 2H -NArCHCHH-),
1.54-1.06 (m, 20H, 10 x -CH2); 13C-NMR (CDCl3, 100 MHz, δ): 160.8 (C=O), 155.9
(C), 139.8 (C), 131.5 (C) 132.4 (CH), 118.0 (CH), 114.5 (CH), 59.3 (CH), 55.5 (CH3),
30.6 (CH2), 30.4 (CH2), 29.4 (CH2), 29.2 (CH2), 28.9 (CH2), 28.1 (CH2), 27.6 (CH2),
23.6 (CH2), 23.2 (CH2); MS-ESI: 593 [M + Na]+; HRMS ES+: [M + Na]+ calcd
for C36H46N2NaO4, 593.3350; found, 593.3352; Rf = 0.3 (20% EtOAc in 40-60 °C
petroleum ether).
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3,20-Dihydro-N1,N22-bis(4-methoxyphenyl)-2,21-dimethylenedocos-11-
enediamide (184)
OHHN
O
PMP
OH
NH
O
PMP
3-Hydroxy-N-(4-methoxyphenyl)-2-methylenedodec-11-
enamide (181) (20 mg, 60.4 µmol) was dissolved in
CH2Cl2 (30 mL). Grubbs 2nd generation catalyst (5 mg,
6.04 µmol) was added in one portion and the solution
heated at reflux for 4 h. The solution was allowed to cool
and the solvent removed under reduced pressure. Column
chromatography (30-100% EtOAc in 40-60 °C petroleum
ether) yielded the title compound (<1 mg). 1H-NMR
(CDCl3, 400 MHz, δ): 8.73 (br s, 2H, -CONH-), 7.49-7.46 (m, 4H, -ArH), 6.88-6.85
(m, 4H, -ArH), 5.99 (s, 2H, -CCHH), 5.50 (s, 2H, -CCHH), 5.35 (t, J = 5.4 Hz, 2H,
-CHCH-), 4.43 (q, J = 6.8 Hz, 2H, -CHOH), 3.79 (s, 6H, -ArOCH3), 3.02 (br s, 2H,
-OH), 2.02-1.92 (m, 4H, -CH2CH=CH2-), 1.79-1.54 (m, 4H, -CH2CHOH-), 1.42-1.18
(m, 20H, 10 x -CH2); IR (cm-1): 3293 (-OH), 2925; 2853 (-CH2), 1511 (-CONR2),
1245 (-CO-CH3), 828 (para disub -ArH) ; MS-ESI: 657 [M + Na]+.
3-Hydroxy-N-ethyl-2-methylenetridec-12-enamide (70)
N
H
O
Et
OH
3-Hydroxy-2-methylenetridec-12-enoic acid (0.9 g, 3.54 mmol) and
EtNH2 (2M in THF, 1.7 mL, 3.54 mmol) were dissolved in EtOH
(35 mL). NMM (0.8 mL, 7.44 mmol) followed by HOBt (72 mg,
0.53 mmol) and EDC ·HCl (812 mg, 4.25 mmol). The reaction was
allowed to warm to room temperature over 18 h. The solution was
diluted with EtOAc (30 mL) and H2O (20 mL) added. The layers
were separated and the aqueous extracted with EtOAc (3 x 15 mL), the combined or-
ganics were dried (MgSO4), filtered and the volatiles removed under reduced pressure.
Column chromatography (30% EtOAc in 40-60 °C petroleum ether) yields the title com-
pound as a white solid (901 mg, 95%). 1H-NMR (CDCl3, 300 MHz, δ): 8.54 (br s, 1H,
-CONH-), 5.89-5.71 (m, 2H, -CCHH, -CHCH2), 5.40 (s, 1H, -CCHH), 5.01-4.90 (m,
130
Chapter 5 - Experimental
2H, -CHCH2), 4.32 (t, J = 6.7 Hz, 1H, -CHOH), 3.39-3.30 (m, 2H, CH3CH2N-), 2.03 (q,
J, J = 7.3 Hz, 2H, -CH2CHCH2), 1.73-1.54 (m, 2H, -CH2CHOH-), 1.43-1.23 (m, 12H, 6
x -CH2), 1.17 (t, J = 7.3 Hz, CH3CH2N-); 13C-NMR (CDCl3, 75 MHz, δ): 167.3 (C=O),
145.1 (C), 138.6 (CH), 118.8 (CH2), 113.5 (CH2), 73.4 (CH), 35.1 (CH2), 33.6 (CH2),
33.2 (CH2), 28.9 (CH2), 28.8 (CH2), 28.5 (CH2), 28.3 (CH2), 25.3 (CH2), 14.1 (CH3);
IR (cm-1): 3283 (-OH), 2918; 2849 (-CH2), 1612 (-CONR2), 1457 (-C=C); ESI+-MS:
306; mp: 50-53 °C; Rf = 0.3 (30% EtOAc in 40-60 °C petroleum ether).
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2-(Ethyl)trideca-1,12-dien-3-yl methanesulfonate (71)
N
H
O
Et
OMs
3-Hydroxy-N-ethyl-2-methylenetridec-12-enamide (901 mg, 3.37
mmol), was dissolved in CH2Cl2 (20 mL) and cooled to -78 °C.
Et3N (933 µL, 6.75 mmol) was added followed by MsCl (520
µL, 6.75 mmol) dropwise. The solution was allowed to warm to
room temperature over 18 h, then quenched with H2O (20 mL), the
organics were separated, dried (MgSO4), filtered and the solvent
removed under reduced pressure. Column chromatography (40% EtOAc in 40-60 °C
petroleum ether) yielded the title compound as a clear oil (797 mg, 68%). 1H-NMR
(CDCl3, 300 MHz, δ): 6.09 (br s, 1H, NH), 5.84-5.69 (m, 2H, -CHCH2, -CCHH), 5.63
(s, 1H, -CCHH), 5.34 (t, J = 6.6 Hz, -CHOMs), 5.00-4.85 (m, -CHCH2), 3.36-3.27 (m,
2H, -CH3CH2-), 2.97 (s, 3H, -OSOOCH3), 2.02-1.95 (m, 2H, CH2CHCH2-), 1.84-1.78
(m, 2H, -CH2CHOH-), 1.41-1.20 (m, 12H, 6 x -CH2), 1.14 (t, J = 7.4 Hz, CH3CH2N-
); 13C-NMR (CDCl3, 75 MHz, δ): 165.6 (C=O), 142.9 (C), 138.5 (CH), 119.6 (CH2),
113.5 (CH2), 80.8 (CH), 37.8 (CH3), 34.4 (CH2), 34.0 (CH2), 33.2 (CH2), 28.7 (CH2),
28.4 (CH2), 28.2 (CH2), 24.6 (CH2), 14.1 (CH3); MS-ESI: 368 [M + Na]+; HRMS ES+:
[M + Na]+ calcd for C17H31NNaO4S, 368.1866; found, 368.1847; Rf = 0.3 (40% EtOAc
in 40-60 °C petroleum ether).
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4-(Dec-9-enyl)-1-(ethyl)-3-methyleneazetidin-2-one (66)
N
O Et
2-(Ethyl)trideca-1,12-dien-3-yl methanesulfonate (797 mg, 2.31
mmol) was dissolved in THF (10 mL) and cooled to 0 °C. KOtBu
(205 mg, 2.54 mmol) was added in one portion. The reaction was al-
lowed to warm to room temperature over 16 h, then quenched with
sat. NH4Cl (10 mL). The organics were separated, dried (MgSO4),
filtered and the volatiles removed under reduced pressure. Column chromatography
(20% EtOAc in 40-60 °C petroleum ether) yielded the title compound as a clear oil (416
mg, 72%). 1H-NMR (CDCl3, 300 MHz, δ): 5.78 (ddt, J = 16.9 Hz, 10.2 Hz, 6.6 Hz,
1H, -CHCH2), 5.57 (s, 1H, -CCHH), 5.01 (s, 1H, -CCHH), 5.00-4.87 (m, 2H -CHCH2),
4.02 (t, J = 6.0 Hz 1H, -CHCN-), 3.56-3.43 (m, 1H, -NCHHCH3), 3.20-3.08 (m, 1H,
-NCHHCH3), 2.01 (q, J = 6.9 Hz, 2H, CH2CHCH2-), 1.80-1.67 (m, 1H, -CHHCHCN-
), 1.62-1.45 (m, 1H,-CHHCHCN-), 1.40-1.23 (m, 6H, 3 x CH2), 1.16 (t, J = 7.2 Hz,
3H, -NCH2CH3); 13C-NMR (CDCl3, 75 MHz, δ): 162.1 (C=O), 149.2 (C), 138.5 (CH),
113.6 (CH2), 107.1 (CH2), 59.2 (CH), 34.6 (CH2), 33.2 (CH2), 31.3 (CH2), 29.1 (CH2),
28.8 (CH2), 28.7 (CH2), 28.4 (CH2), 28.3 (CH2), 24.6 (CH2), 12.8 (CH3); 2926; 2854 (-
CH2), 1747 (-CONR2), 1393 (-C=C); MS-ESI: 272 [M + Na]+; HRMS ES+: [M + H]+
calcd for C16H28NO, 250.2165; found, 250.2165; Rf = 0.3 (20% EtOAc in 40-60 °C
petroleum ether).
RCM of 4-(Dec-9-enyl)-1-(ethyl)-3-methyleneazetidin-2-one (66)
4-(Dec-9-enyl)-1-(ethyl)-3-methyleneazetidin-2-one (50 mg, 0.20 mmol) was dissolved
in CH2Cl2 (100 mL). Grubbs 2nd generation catalyst (17 mg, 0.020 mmol) was added
and the solution refluxed for 24 h. The solution was allowed to cool, then the solvent
was removed under reduced pressure. Column chromatography (40-50% EtOAc in 40-
60 °C petroleum ether) yielded the linear dimer (15 mg, 32%) and the 22-membered
dimer which was further purified by semi-preparative HPLC (30% H2O in MeCN)
gave the pure dimer (1Z,14Z)-12,25-diethyl-12,25-diazatricyclo[22.2.0.011,14]hexacosa-
1,14-diene-13,26-dione) (<1 mg, approx 2%).
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(1Z,14Z)-12,25-diethyl-12,25-diazatricyclo[22.2.0.011,14]hexacosa-1,14-diene-
13,26-dione)
N
N
O Et
Et O
1H-NMR (CDCl3, 600 MHz, δ): 5.44 (td, J = 11.6, 4.4 Hz, 2H, -
CCHCH2-), 4.05-4.01 (m, 2H, -NCHCH2(C)-), 3.53-3.46 (m, 2H,
-NCHHCH3), 3.13-3.05 (m, 2H, -NCHHCH3), 2.91-2.80 (m, 4H, -
CCHCH2CH2-), 2.17-2.12 (m, 4H, -CCHCH2CH2-), 1.69-1.20 (m,
24H, 12 x CH2), 1.17 (t, J = 7.0 Hz, 3H, -NCH2CH3); 13C-NMR
(CDCl3, 150 MHz, δ): 164.0 (C=O), 163.9 (C=O), 140.7 (C), 140.4
(C), 128.6 (CH), 128.4 (CH), 58.5 (CH), 58.4 (CH), 34.8 (CH2), 30.8
(CH2), 30.6 (CH2), 30.1 (CH2), 29.8 (CH2), 29.7 (CH2), 29.6 (CH2),
29.4 (CH2), 29.2 (CH2), 29.0 (CH2), 28.95 (CH2), 28.88 (CH2), 28.7
(CH2), 28.1 (CH2), 23.8 (CH2), 23.4 (CH2), 13.4 (CH3), 13.3 (CH3); IR (cm-1): 2924;
2852 (-CH2), 1736 (-CONR2), 1392 (-C=C-); MS-ESI: 465 [M + Na]+; HRMS ES+:
[M + Na]+ calcd for C28H46N2NaO2, 465.3451; found, 465.3453.
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4,4’-(octadec-9-ene-1,18-diyl)bis(1-ethyl-3-methyleneazetidin-2-one (86)
N
O
Et
O
Et
1H-NMR (CDCl3, 700 MHz, δ): 5.54 (s, 2H, -CCHH), 5.31 (t, J
= 3.6 Hz, 2H, -CHCH-), 5.02 (s, 2H, -CCHH), 3.10 (t, J = 6.0
Hz, 2H, -NCH(C)-), 3.38-3.43 (m, 2H, -NCHHCH3), 3.13-3.08 (m,
2H, -NCHHCH3), 1.92-1.88 (m, 4H, -CHCHCH2CH2-), 1.72-1.65
(m, 4H, -CHCH2CH2-), 1.55-1.49 (m, 2H, -CHCH2CHH-), 1.34-
1.29 (m, 2H, -CHCH2CHH-), 1.28-1.18 (m, 20H, 10 x CH2), 1.13
(t, J = 7.5 Hz, 6H, -NCH2CH3); 13C-NMR (CDCl3, 175 MHz, δ):
162.1 (C=O), 148.8 (C), 129.3 (CH), 128.8 (CH), 106.7 (CH2), 58.8
(CH), 34.2 (CH2), 31.6 (CH2), 30.9 (CH2), 28.7 (CH2), 28.6 (CH2),
28.39 (CH2), 28.36 (CH2), 28.1 (CH2), 24.2 (CH2), 12.4 (CH3); IR (cm-1): 2924; 2853
(-CH2), 1747 (-CONR2), 1393 (-C=C-); MS-ESI: 493 [M + Na]+; HRMS ES+: [M +
Na]+ calcd for C30H50N2NaO2, 493.3764; found, 493.3771.
10-(Allyloxy)-3-hydroxy-N-ethyl-2-methylenedecanamide (108)
O
N
H
O
OH
Et
10-(Allyloxy)-3-hydroxy-2-methylenedecanoic acid (421 mg,
1.64 mmol) was dissolved in EtOH (16 mL). NMM (0.4 mL,
3.62 mmol), HOBt (88%, 40 mg, 0.25 mmol) and EtNH2 (2 M
in THF, 0.82 mL, 1.64 mmol) were added and the solution cooled
to 5 °C. EDC ·HCl (378 mg, 1.97 mmol) was added and the so-
lution allowed to warm to room temperature over 16 h. The so-
lution was diluted with EtOAc (20 mL) and H2O (10 mL) added. The aqueous was
extracted with EtOAc (3 x 20 mL), the combined organics were dried (MgSO4), filtered
and the solvent removed under reduced pressure. Column chromatography (45% EtOAc
+ 1% Et3N in 40-60 °C petroleum ether) yielded the title compound (339 mg, 72%).
1H-NMR (CDCl3, 400 MHz, δ): 6.92 (s, 1H, NH), 5.91 (ddt, J = 17.2 Hz, 10.6 Hz,
5.6 Hz, 1H, -CHCH2), 5.78 (s, 1H, -CCHH), 5.39 (s, 1H, -CCHH), 5.26 (dq, J = 17.2
Hz, 1.7 Hz, 1H, -CHCHH), 5.16 (dq, J = 10.4 Hz, 1.3 Hz, -CHCHH), 4.31 (t, J = 6.9
Hz, 1H, -CHOH), 3.95 (dt, J = 5.7 Hz, 1.3 Hz, 2H, -CH2CHCH2), 3.41 (t, J = 6.7 Hz,
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2H, -OCH2-), 3.37-3.29 (m, 2H, -NCH2CH3), 1.73-1.25 (m, 12H, 6 x CH2), 1.17 (t,
J = 7.3, 3H, -NCH2CH3); 13C-NMR (CDCl3, 100 MHz, δ): 167.8 (C=O), 145.4 (C),
135.5 (CH), 119.8 (CH2), 116.8 (CH2), 73.9 (CH), 71.8 (CH2), 70.4 (CH2), 35.7 (CH2),
34.2 (CH2), 29.7 (CH2), 29.4 (CH2), 29.3 (CH2), 26.1 (CH2), 25.9 (CH2), 14.7 (CH3);
IR (cm-1): 3321 (-OH), 2928; 2851 (-CH2) 1619 (-CONR2), 1537 (-C=C), 1245 (-CO-
CH3); ESI+-MS: 283 [M + H]+, 306 [M + Na]+; HRMS: ES+ [M + Na]+ calcd for
C16H29NNaO3, 306.2040; found, 306.2042; mp: 55-58 °C; Rf = 0.3 (45% EtOAc + 1%
Et3N in 40-60 °C petroleum ether).
2-(4-Ethylcarbamoyl)-10-(allyloxy)dec-1-en-3-yl methanesulfonate (109)
O
N
H
O
OMs
Et
10-(Allyloxy)-3-hydroxy-N-ethyl-2-methylenedecanamide
(108) (0.339, 2.00 mmol) was dissolved in CH2Cl2 (10 mL)
and cooled to -78 °C. Et3N (0.3 mL, 2.40 mmol) was added
followed by MsCl (0.2 mL, 2.40 mmol) dropwise. The reaction
was stirred at -78 °C for 4 h. The reaction was quenched with
H2O (5 mL). The organics were separated, dried, and the solvent
removed under reduced pressure. Column chromatography (50% EtOAc in 40-60 °C
petroleum ether) yielded the title compound as a clear oil (363 mg, 84%). 1H-NMR
(CDCl3, 400 MHz, δ): 6.02 (br s, 1H, NH), 5.91 (ddt, J = 17.2 Hz, 10.6 Hz, 5.6 Hz,
1H, -CHCH2), 5.80 (s, 1H, -CCHH), 5.66 (s, 1H, -CCHH), 5.37 (t, J = 6.6 Hz, 1H,
-CHOH), 5.26 (dq, J = 17.3 Hz, 1.7 Hz, 1H, -CHCHH), 5.66 (dq, J = 10.4 Hz, 1.5 Hz,
-CHCHH), 3.95 (dt, J = 5.6 Hz, 1.4 Hz, 2H, -CH2CH=CH2), 3.41 (t, J = 6.6 Hz, 2H,
-OCH2-), 3.38-3.32 (m, 2H, -NCH2CH3), 3.01 (s, 3H, -OSOOCH3), 1.86 (q, J = 7.5
Hz, 2H, -CH2CHOMs-), 1.60-1.53 (m, 2H, -OCH2CH2-), 1.48-1.29 (m, 8H, 4 x CH2),
1.19 (t, J = 6.6 Hz, 3H, -NCH2CH3); 13C-NMR (CDCl3, 100 MHz, δ): 166.2 (C=O),
143.6 (C), 135.1 (CH), 120.2 ( CH2), 116.7 (CH2), 81.4 (CH), 71.8 (CH2), 70.4 (CH2),
38.5 (CH3), 35.0 (CH2), 34.6 (CH2), 29.7 (CH2), 29.2 (CH2), 29.0 (CH2), 26.1 (CH2),
25.3 (CH2), 14.7 (CH3); IR (cm-1): 3337 (-NH), 2933; 2858 (-CH2), 1660 (-C=C), 1536
(-CONR2), 1454 (-C=C), 1352 (-S=O), 1173 (-S=O); MS-ESI: 362 [M + H]+, 384 [M
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+ Na]+; HRMS ES+: calcd for C17H31NNaO5S 384.1815; found, 384.1805; Rf = 0.3
(50% EtOAc in 40-60 °C petroleum ether).
4-(7-(Allyloxy)heptyl)-1-ethyl-3-methyleneazetidin-2-one (102)
N
O Et
O
2-(4-Ethylcarbamoyl)-10-(allyloxy)dec-1-en-3-yl methanesulfonate
(130) (109) (363 mg, 1.01 mmol) was dissolved in THF (10 mL)
and cooled to -15 °C. KOtBu (123 mg, 1.12 mmol) was added in one
portion, and stirred for 3.5 h at -15 °C. The solution was quenched
with NH4Cl (10 mL). The organics were separated, dried and the
volatiles removed under reduced pressure. Column chromatography (40% EtOAc in 40-
60 °C petroleum ether) yielded the title compound as a clear oil (85 mg, 32%). 1H-
NMR (CDCl3, 400 MHz, δ): 5.92 (ddt, J = 17.2 Hz, 10.8 Hz, 5.6 Hz, 1H, -CHCH2),
5.61 (s, 1H, -CCHH), 5.27 (dd, J = 17.2 Hz, 1.7 Hz, 1H -CHCHH), 5.16 (d, J = 10.4
Hz, 1H, -CHCHH), 4.05 (t, J = 5.7 Hz 1H, -CHCNAr), 3.95 (dt, J = 5.5 Hz, 1.1 Hz,
2H, -CH2CH=CH2), 3.57-3.48 (m, 1H, -NCHHCH3) 3.42 (t, J = 6.6 Hz, 2H, -OCH2-),
3.22-3.13 (m, 1H, -NCHHCH3), 1.82-1.71 (m, 1H, -CHHCHCN-), 1.64-1.51 (m, 3H, 1
x -OCH2CH2-, 1 x -CHHCHCN-), 1.45-1.26 (m, 8H, 4 x CH2), 1.19 (t, J = 6.6 Hz, 3H,
-NCH2CH3); 13C-NMR (CDCl3, 100 MHz, δ): 163.0 (C=O), 149.8 (C), 135.1 (CH),
116.7 (CH2), 107.8 (CH2), 71.8 (CH2), 70.4 (CH2), 59.8 (CH), 35.7 (CH2), 31.9 (CH2),
29.7 (CH2), 29.6 (CH2), 29.3 (CH2), 26.1 (CH2), 25.2 (CH2), 13.4 (CH3); IR (cm-1):
2929; 2856 (-CH2), 1746 (-CONR2), 1457 (-C=C), 1222 (-CO-CH3); MS-ESI: 288 [M
+ Na]+; HRMS ES+: [M + Na]+ calcd for C16H27NNaO2, 288.1934; found, 288.1938;
Rf = 0.3 (40% EtOAc in 40-60 °C petroleum ether).
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10-(But-2-en-1-yloxy)-N-ethyl-3-hydroxy-2-methylenedecanamide (118)
O
N
H
O
OH
Et
10-(Allyloxy)-3-hydroxy-2-methylenedecanoic acid (421 mg,
1.64 mmol) was dissolved in EtOH (16 mL). NMM (0.4 mL, 3.62
mmol), HOBt (88%, 40 mg, 0.25 mmol) and EtNH2 (2 M in THF,
0.82 mL, 1.64 mmol) were added and the solution cooled to 5 °C.
EDC ·HCl (378 mg, 1.97 mmol) was added and the solution al-
lowed to warm to room temperature over 16 h. The solution was
diluted with EtOAc (20 mL) and H2O (10 mL) added. The aqueous was extracted with
EtOAc (3 x 20 mL), the combined organics were dried (MgSO4), filtered and the solvent
removed under reduced pressure. Column chromatography (45% EtOAc + 1% Et3N in
40-60 °C petroleum ether) yielded the title compound (339 mg, 72%). 1H-NMR (CDCl3,
400 MHz, δ): 7.42 (t, J = 5.6 Hz, 1H, NH), 5.42 (s, 1H, -CCHH), 5.35-5.25 (m, 1H, -
CH3CHCH-), 5.23-5.12 (m, 1H, -CH3CHCH-) 5.00 (s, 1H, -CCHH), 4.67 (d, J = 5.0
Hz, -OH), 3.97 (q, J = 6.0 Hz, 1H, -CHOH), 3.49 (d, J = 6.1 Hz, 2H, -OCH2CH-), 3.00
(t, J = 6.6 Hz, 2H, -CH2OCH2-), 2.94-2.87 (m, 2H, -NCH2CH3), 1.32 (dd, J = 6.3, 1.1
Hz, 3H, CH3CHCH-), 1.27-0.90 (m, 12H, 6 x -CH2-) 0.77 (t, J = 7.2 Hz, -NCH2CH3);
13C-NMR (CDCl3, 100 MHz, δ): 167.5 (C=O), 145.7 (C), 128.3 (CH), 127.6 (CH),
118.9 (CH2), 72.6 (CH), 71.0 (CH2), 69.6 (CH2), 35.6 (CH2), 33.5 (CH2), 29.5 (CH2),
29.4 (CH2), 29.1 (CH2), 29.0 (CH2), 25.8 (CH2), 25.5 (CH2), 20.4 (CH3), 14.2 (CH3);
IR (cm-1): ; MS-ESI: 320 [M + Na]+; Rf = 0.3 (45% EtOAc + 1% Et3N in 40-60 °C
petroleum ether).
10-(But-2-en-1-yloxy)-2-(ethylcarbamoyl)dec-1-en-3-yl methanesulfonate (119)
O
N
H
O
OMs
Et
10-(But-2-en-1-yloxy)-N-ethyl-3-hydroxy-2-
methylenedecanamide (244) (1.08 g, 3.64 mmol) was dissolved
in CH2Cl2 (15 mL) and cooled to -78 °C. Et3N (940 µL, 7.27
mmol) was added followed by MsCl (560 µL, 7.27 mmol)
drop wise. The solution was allowed to warm to room tem-
perature over 16 h. H2O (10 mL) was added and the solution
138
Chapter 5 - Experimental
separated, and the organics dried (MgSO4), filtered and the volatiles removed under
reduced pressure. The crude material was used directly in the next reaction. 1H-NMR
(CDCl3, 400 MHz, δ): 6.11 (br s, 1H, NH), 5.81 (s, 1H, -CCHH), 5.75-5.67 (m, 1H,
-CH3CHCH-), 5.66 (s, 1H, -CCHH), 5.62-5.54 (m, 1H, -CH3CHCH-), 5.38 (t, J =
6.5 Hz, 1H, -CH2CH(C)O-), 3.88 (dt, J = 6.2, 1.9 Hz, 2H, -OCH2CH-), 3.42-3.32
(m, 4H, -CH2OCH2-; -NCH2CH3), 3.01 (s, 3H, -SOOCH3), 1.88-1.81 (m, 2H,
-CH2CHOSOOMe), 1.71 (dd, J = 6.3, 1.2 Hz, 3H, CH3CHCH-), 1.59-1.51 (m, 2H,
-CH2OCH2CH2-), 1.45-1.28 (m, 8H, 4 x -CH2-), 1.19 (t, J = 7.3 Hz, -NCH2CH3);
13C-NMR (CDCl3, 100 MHz, δ): 166.2 (C=O), 143.5 (C), 129.3 (CH), 127.8 (CH),
120.2 (CH2), 81.4 (CH), 71.6 (CH2), 70.2 (CH2), 38.5 (CH3), 35.0 (CH2), 34.6 (CH2),
29.7 (CH2), 29.2 (CH2), 29.0 (CH2), 26.1 (CH2), 25.2 (CH2), 17.8 (CH3), 14.7 (CH3);
MS-ESI: 398 [M + Na]+; HRMS ES+: [M + Na]+ calcd for C18H33NNaO5S 398.1972;
found, 398.1968.
4-(7-(But-2-en-1-yloxy)heptyl)-1-ethyl-3-methyleneazetidin-2-one (114)
N
O Et
O
10-(But-2-en-1-yloxy)-2-(ethylcarbamoyl)dec-1-en-3-yl methane-
sulfonate (119) (1.40 g, 3.73 mmol) was dissolved in THF (12 mL)
and the solution cooled to -15 °C. KOtBu (460 mg, 4.11 mmol)
was added in one portion and stirred at -15 °C for 2 h. The reaction
was quenched with sat. NH4Cl (10 mL), the organics were sepa-
rated, dried (MgSO4), filtered and the solvent removed under reduced pressure. Column
chromatography (20% EtOAc in 40-60 °C petroleum ether) yielded the title compound
as a clear oil 1H-NMR (CDCl3, 400 MHz, δ): 5.76-5.70 (m, 1H, -CH3CHCH-), 5.60-
5.55 (m, 2H, -CCHH; -CH3CHCH-), 5.09 (s, 1H, -CCHH), 4.05 (t, J = 6.5 Hz, 1H,
-CH(N)CH2), 3.88 (d, J = 6.2 Hz, 2H, -OCH2CH-), 3.17 (ddt, J = 14.3, 7.3, 7.3 Hz,
1H, -NHHCH3), 3.39 (t, J = 6.6 Hz, 2H, -CH2OCH2-), 3.52 (ddt, J = 14.3, 7.1, 7.1
Hz, 1H, -NHHCH3), 1.81-1.73 (m, 1H, -CHHCHN-), 1.71 (dd, J = 6.3, 0.8 Hz, 3H,
CH3CHCH-), 1.62-1.52 (m, 3H, -CH2OCH2CH2-; -CHHCHN-), 1.45-1.28 (m, 8H, 4
x -CH2-), 1.19 (t, J = 7.3 Hz, -NCH2CH3); 13C-NMR (CDCl3, 100 MHz, δ): 163.3
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(C=O), 149.5 (C), 129.3 (CH), 127.7 (CH), 108.0 (CH2), 71.6 (CH2), 70.3 (CH2), 59.8
(CH), 35.3 (CH2), 34.8 (CH2), 31.8 (CH2), 29.7 (CH2), 29.2 (CH2), CH2), 26.1 (CH2),
25.7 (CH2), 17.8 (CH3), 13.4 (CH3); MS-ESI: 302 [M + Na]+; HRMS ES+: [M + Na]+
calcd for C17H29NNaO2 302.2091 ; found, 302.2088; Rf = 0.3 (20% EtOAc in 40-60 °C
petroleum ether).
RCM of 4-(7-(But-2-en-1-yloxy)heptyl)-1-ethyl-3-methyleneazetidin-2-one (114)
4-(7-(But-2-en-1-yloxy)heptyl)-1-ethyl-3-methyleneazetidin-2-one (114) (20 mg, 0.07
mmol) was dissolved in CH2Cl2 (36 mL). Grubbs 2nd generation catalyst (6 mg, 0.007
mmol) was added and the solution refluxed for 24 h. The solution was allowed to cool
and the solvent then removed under reduced pressure. Column chromatography (50%
EtOAc in 40-60 °C petroleum ether) yields the monomeric product and dimeric products
impure, which were further purified by preparative HPLC (30% H2O in MeCN, flow rate
1 mL/min) to yield the monomeric product (4 mg, 24%) which was not stable in CDCl3,
and the dimer (5 mg, 29%).
(1Z,15Z)-13,27-diethyl-4,18-dioxa-13,27-diazatricyclo[24.2.0.012,15]octacosa-1,15-
diene-14,28dione (120)
O
O
N
N
O
O
Et
Et
1H-NMR (CDCl3, 700 MHz, δ): 5.69 (t, J = 7.0 Hz, 2H, -
CCHCH2O-), 4.51 (dd, J = 12.2, 7,9 Hz, 2H, -CCHCHHO-
), 4.46 (dd, J = 12.7, 7.5 Hz, 2H -CCHCHHO-), 4.35 (dd, J
= 12.8, 6.1 Hz, 1H, -CCHCHHO-), 4.31 (dd, J = 12.9, 5.7
Hz, 1H, -CCHCHHO-), 4.03-4.00 (m, 2H, -NCH(C)C-), 3.52-
3.46 (m, 6H, -NCHHCH3; -OCH2CH2-), 3.19-3.13 (m, 2H, -
NCHHCH3), 1.81-1.25 (m, 20H, 10 x CH2), 1.19 (t, J = 7.2
Hz, 6H, -NCH2CH3); 13C-NMR (CDCl3, 175 MHz, δ): 162.9
(C=O), 143.2 (C), 124.7 (CH), 124.6 (CH), 122.6 (C), 70.3
(CH2), 70.2 (CH2), 66.4 (CH2), 58.6 (CH), 34.9 (CH2), 31.72 (CH2), 31.65 (CH2), 29.9
(CH2), 29.7 (CH2), 29.2 (CH2), 26.00 (CH2), 25.97 (CH2), 24.6 (CH2), 24.5 (CH2), 13.4
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(CH3); IR (cm-1): 2922; 2851 (-CH2), 1733 (-CONR2), 1457 (-C=C); MS-ESI: 497 [M
+ Na]+; HRMS ES+: [M + Na]+ calcd for C28H46N2NaO2, 497.3350; found, 497.3355.
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3-Ethenyl-1,4-diphenyl-2-azetidinone (203)
N
Ph
Ph
O
The imine of aniline (0.91 mL, 10.0 mmol) and benzylaldehyde (1.0
mL, 10.0 mmol) was preformed (MgSO4 (0.63 g, 5.00 mmol) in
CH2Cl2 (10 mL) overnight) was dissolved in CH2Cl2 (50 mL). Et3N
(1.37 mL, 10.0 mmol) was added and the imine solution heated to 55 °C
at which point crotonyl chloride (0.95 mL, 10.0 mmol) was added dropwise over a period
of 45 min. Once the addition was completed the mixture was heated for a further 2 h. The
solution was allowed to cool and then washed with H2O (2 x 50 mL). The CH2Cl2 layer
was washed with brine (50 mL) dried (MgSO4), filtered and the solvent removed un-
der reduced pressure. Column chromatography (4%-6% EtOAc in 40-60 °C petroleum
ether) yielded the title compound (1.15 g, 46%). Data is consistent with literature val-
ues.105 1H-NMR (CDCl3, 400 MHz, δ): 7.45-7.20 (m, 9H, 9 x ArH), 7.10-7.00 (m, 1H,
ArH), 6.13-5.67 (m, 1H, CH), 5.45-5.29 (m, 2H, CH2), 4.82-4.81 (m, 1H, CH), 3.78-
3.71 (m, 1H, CH); 13C-NMR (CDCl3, 100 MHz, δ): 164.7 (C), 136.7 (C), 129.9 (CH),
128.6 (CH), 128.6 (CH), 128.0 (CH), 125.2 (CH), 123.4 (CH), 119.4 (CH2), 116.4 (CH),
63.4 (CH), 60.6 (CH); IR (cm-1) 2925 (-CH2), 1751 (-CONR2), 1377 (-C=C-); HRMS
ES+ calcd for C17H15NaNO, 272.1046 [M+Na]+, found 272.1044; Rf = 0.3 (5% EtOAc
in 40-60 °C petroleum ether).
3-(2-Oxiranyl)-1,4-diphenyl-2-azetidinone (206)
N
Ph
Ph
O
O
3-Ethenyl-1,4-diphenyl-2-azetidinone (200 mg, 0.80 mmol) was dis-
solved in CH2Cl2 (10 mL). m-CPBA (207 mg, 1.70 mmol) was added
and the reaction stirred for 18 h. The reaction was diluted with CH2Cl2
(10 mL) then quenched with sat. K2CO3 (5 mL). The organics were
separated, dried (MgSO4), filtered and the solvent removed under reduced pressure.
Column chromatography (5%-15% EtOAc in 40-60 °C petroleum ether) yielded the
title compound as an inseparable mixture of diastereomers (0.17 g, 78%). Data is con-
sistent with literature values.105 1H-NMR (CDCl3, 400 MHz, δ): 7.27-7.20 (m, ArH,
9H), 7.07-6.99 (m, ArH, 1H), 4.98 (d, J = 2.8 Hz, 0.4H), 4.86 (d, J = 2.6 Hz, 0.6H),
142
Chapter 5 - Experimental
3.53 (t, J = 2.7 Hz, 0.4H), 3.44-3.39 (m, 0.6H), 3.39-3.36 (m, 0.4H), 3.22 (q, J = 2.4 Hz,
0.6H), 3.18 (q, J = 2.7 Hz, 0.4H), 2.96 (t, J = 4.2 Hz, 0.6H), 2.89 (t, J = 4.3 Hz, 0.4H),
2.72 (t, J = 2.5 Hz, 0.6H); IR (cm-1) 1745 (-CONR2), 1377 (-C-O), 1265 (-C=C); Rf =
0.3 (10% EtOAc in 40-60 °C petroleum ether).
(S)-N-(2-Bromo-2-propenyl)-l-phenylethylamine (213)
Br
N
H
Ph
K2CO3 (5.89 g, 42.7 mmol) was made into a suspension with THF
(100 mL) and (S)-phenylethylamine (10 mL, 77.2 mmol) added. 2,3
dibromopropene (5 mL, 51.4 mmol) was added and the reaction
stirred for 18 h. Et2O (200 mL) was added and the solution washed
with 10% NaOH (200 mL), H2O (200 mL) and brine (200 mL). The organics were sepa-
rated, dried (MgSO4), filtered and the solvent removed under reduced pressure. Column
chromatography (8% EtOAc in 40-60 °C petroleum ether) yielded the title compound
(10.5 g, 92%). Data is consistent with literature values.109 1H-NMR (CDCl3, 400 MHz,
δ): 7.37-7.22 (m, 5H, 5 x ArH), 5.67 (s, 1H), 5.55 (s, 1H), 3.80 (q, J = 6.4 Hz, 1H), 3.36
(d, J = 15.0 Hz, 1H), 3.26 (d, J = 15.3 Hz, 1H), 1.72 (br s, NH), 1.36 (d, J = 7.13, 2H);
13C-NMR (CDCl3, 100 MHz, δ): 144.8 (C), 133.8 (C), 128.5 (CH), 127.1 (CH), 126.9
(CH), 117.8 (CH2), 60.4 (CH2), 55.6 (CH), 55.1 (CH2), 24.3 (CH); Rf = 0.3 (8% EtOAc
in 40-60 °C petroleum ether).
(S)-N-(l-Phenylethyl)-2-methyleneaziridine (212)
N
Ph
Fe(NO3)3 (cat.) was placed under an atmosphere of NH3 until it had turned
red in colour, NH3 (50 mL) was then condensed to which was added fresh
cut Na metal (0.48 g, 20.9 mmol). The solution was allowed to stir un-
til a light grey. (S)-N-(2-bromo-2-propenyl)-l-phenylethylamine (2 g, 8.33
mmol) in Et2O (2 mL) was added slowly and the reaction allowed to stir for 30 min.
The reaction was diluted with Et2O (20 mL) and quenched slowly with H2O (20 mL).
The ammonia was allowed to evaporate overnight. The mixture was washed with NaOH
(100 mL, 10%), AcOH (100 mL, 0.1 M) and brine (100 mL). The organics were dried
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(MgSO4), filtered and the solvent removed under reduced pressure. Bulb to bulb Kughr-
Rhor distillation (65 °C, <0 mbar) yielded the title compound (0.9 g, 73%). Data was
consistent with literature values.109
3-Methylene-1-((S)1-phenylethyl)-2-azetidinone (214)
N
O Ph
(S)-N-(2-Bromo-2-propenyl)-l-phenylethylamine (600 mg, 2.50)
mmol), Pd(PPh3)4 (289 mg, 10 mol%) and nBu3N (0.74 mL, 3.12
mmol) were dissolved in DMAc (10 mL). The mixture was placed
under an atmosphere of CO (balloon), heated to 100 °C and stirred for
18 h. The solution was allowed to cool and diluted with Et2O (20 mL). The organics
were washed with H2O (10 x 10 mL), dried (MgSO4), filtered and the solvent removed
under reduced pressure. Column chromatography (30% EtOAc in 40-60 °C petroleum
ether) yielded the title compound (0.046 g, 10%). 1H-NMR (CDCl3, 400 MHz, δ):
7.41-7.29 (m, 5H, 5 x ArH), 5.73 (q, J = 1.4 Hz, 1H, CH), 5.16 (q, J = 1.5 Hz, 1H,
CH), 5.07 (q, J = 7.1 Hz, 1H, CH), 3.74 (dt, J = 7.6, 1.4 Hz, 1H, CH), 3.55 (dt, J =
7.6, 1.4 Hz, 1H, CH), 1.66 (d, J = 7.1 Hz, 3H, CH3); 13C-NMR (CDCl3, 100 MHz, δ):
163.0 (C), 144.5 (C), 140.3 (C), 128.8 (CH), 127.4 (CH), 126.7 (CH), 109.4 (CH2),
51.6 (CH), 46.0 (CH2), 18.6 (CH3); Rf = 0.35 (30% EtOAc in 40-60 °C petroleum
ether); HRMS ES+ calcd for C12H13NaNO, 210.0889 [M+Na]+, found 210.0888; Rf =
0.3 (30% EtOAc in 40-60 °C petroleum ether).
(S)-3-Methylene-1-(1-phenylethyl)azetidin-2-one (214)
N
O Ph
CO was bubbled through a solution of DMAC (5 mL) contain-
ing Pd(PPh3)4 (0.03 mmol, 10 mol%) and (S)-N-(l-Phenylethyl)-2-
methyleneaziridine (50 mg, 0.314 mmol). The solution was heated to
100 °C and a CO atmosphere kept overnight via a balloon. The solu-
tion was allowed to cool diluted with Et2O (10 mL) and filtered through Celite. The
organics were washed with H2O (10 x 10 mL) dried (MgSO4), filtered and the solvent
removed. Column chromatography (30% EtOAc in 40-60 °C petroleum ether) yielded
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the title compound (0.001 g, 2%). Data is consistent with those reported above.
1-Iodo-9-decene (215)
I
Dec-9en-ol (2.13 mL, 10.9 mmol) and Et3N (2.30 mL,
16.4 mmol) were combined in CH2Cl2 (20 mL), TsCl
(2.12 g, 10.9 mmol) was added in one portion and the
reaction stirred for 18 h. The solution was diluted with H2O (50 mL) and the aqueous
layer extracted with CHCl3 (3 x 20 mL). The combined organics were dried (MgSO4),
filtered and the solvent removed under reduced pressure. Column chromatography (10%
EtOAc in 40-60 °C petroleum ether) yielded dec-9-en-tosylate. Dec-9-en-tosylate (3.45
g, 10.9 mmol) was dissolved in acetone (100 mL) and NaI (16 g, 0.11 mol) was added in
one portion. The mixture was stirred for 18 h. The solvent was removed under reduced
pressure and EtOAc added to dissolve the solid. The organics were washed with H2O
(150 mL), saturated Na2S2O4 (50 mL) and brine (50 mL). The organics were dried
(MgSO4), filtered and the solvent removed under reduced pressure. The resulting oil
was filtered through a pad of SiO2 to give the title compound 2.6 g (89% over 2 steps).
Data is consistent with literature values.133 1H-NMR (CDCl3, 400 MHz, δ): 5.81 (ddt, J
= 17.1, 10.2, 6.6 Hz, 1H), 4.99 (ddt, J = 17.1, 1.8, 1.5 Hz, 1H), 4.93 (ddt, J = 10.2, 1.8,
0.9 Hz, 1H), 3.19 (t, J = 7.2 Hz, 2H), 2.03 (q, J = 7.2 Hz, 2H), 1.82 (quintet, J = 7.2 Hz,
2H), 1.29-1.38 (br m, 10H); 13C-NMR (CDCl3, 100 MHz, δ): 139.2 (CH), 114.2 (CH2),
33.8 (CH2), 33.6 (CH2), 30.5 (CH2), 29.3 (CH2), 29.0 (CH2), 28.9 (CH2), 28.5 (CH2),
7.3 (CH2).
10-1-[(1S)-1-Phenylethyl]-3-methylene-2-aziridinyl-1-decene (218)
N
Ph
(S)-N-(l-Phenylethyl)-2-methyleneaziridine (200
mg, 1.26 mmol) was dissolved in THF (10 mL).
TMEDA (220 µL, 1.51 mmol) was added and the
solution cooled to -78 °C. sec-BuLi (1.4 M, 1.2 mL,
1.64 mmol) was added slowly and the solution kept at -78 °C for 5 h. 1-Iodo-9-decene
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(300 mg, 1.13 mmol) in THF (2 mL) was added and the solution kept at -78 °C for 10
min before being allowed to warm to room temperature over 18 h. The solution was
diluted with Et2O (10 mL) and H2O (10 mL) added slowly. The organics were separated
and the aqueous extracted with Et2O (2 x 10 mL). The combined organics were dried
(MgSO4), filtered and the solvent removed under reduced pressure. The crude product,
a 1:1 mixture of 1-iodo-9-decene and 1-[(1S)-1-Phenylethyl]-3-methylene-2-aziridinyl-
1-decene as a 40:60 ratio of diastereomers, could not be purified by distillation or
chromatography. 1H-NMR (CDCl3, 400 MHz, δ): 5.81 (ddt, J = 16.9, 10.0, 6.8 Hz, 1H,
CH2CH-), 4.99 (d, J = 17.1 Hz, 1H, CH2CHH-), 4.92 (d, J = 10.2 Hz, 1H, CH2CHH-),
4.82 (s, 0.3H, CHHC-), 4.69 (s, 0.3H, CHHC-), 4.50 (s, 0.2H, CHHC-), 4.23 (s, 0.2H,
CHHC-), 2.08-1.96 (m, 1H, CH2CH(N)C-), 1.60-1.02 (m, 20H, -CH2- x 8; CH3–,
CH3CH–); MS-ESI 298 [M + H]+.
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N-Ethylallenimine (219)
N
Fe(NO3)3 (cat.) was placed under an atmosphere of NH3 until it had turned
red in colour, NH3 (100 mL) was then condensed to which was added fresh
cut Na metal (2.24 g, 93.3 mmol) the solution was allowed to stir until a
light grey. ethyll propene (8.00 g, 48.8 mmol) in Et2O (10 mL) was added,
the solution turned black and was stirred for 3 h. The solution was diluted with Et2O
(25 mL) and H2O (25 mL) added slowly. The NH3 was allowed to evaporate overnight.
The solution was separated and the aqueous extracted with Et2O (20 mL). The com-
bined organics were dried (NaOH) and flash distilled at atmospheric pressure to leave a
concentrated solution (460 mg, 58% N-Ethylallenimine, 12% alkyene and 30% Et2O).
Data was consistant with that reported.108 1H-NMR (CDCl3, 400 MHz, δ): 4.74 (s, 1H,
CHHC-), 4.67 (s, 1H, CHHC-), 2.53 (q, J = 7.2 Hz, 2H, CH3CH2N-), 2.02 (s, 2H,
CH2N(C)-), 1.21 (t, J = 7.2 Hz, 3H, CH3CH2N-).
2-(Dec-9-en-1-yl)-1-ethyl-3-methyleneaziridine (225)
N
N-Ethylallenimine (230 mg, 2.77 mmol) and
TMEDA (440 µL, 3.33 mmol) were dissolved in
THF (10 mL) and cooled to -78 °C. sec-BuLi (1.4
M, 2.5 mL, 3.60 mmol) was added and the solution
stirred at -78 °C for 5 h. 1-aˆIodo-9-decene (520 mg, 1.95 mmol) in THF (2 mL) was
added and stirred at -78 °C for 10 min before being allowed to warm to room tempera-
ture overnight. The solution was diluted with Et2O (10 mL) and H2O (10 mL) added. The
layers were separated and the aqueous extracted with Et2O (3 x 10 mL). The combined
organics were dried (MgSO4), filtered and the solvent removed under reduced pressure.
Analysis of the NMR indicated conversion of 73% to the title compound with 10% 1-
iodo-9-aˆdecene remaining. Attempts to purify this by distillation were unsuccessful. 1H-
NMR (CDCl3, 400 MHz, δ): 5.81 (ddt, J = 17.0, 10.2, 6.7 Hz, 1H, CH2CHCH2-), 4.99
(dq, J = 17.1, 1.7 Hz, 1H, CHHCHCH2-), 4.92 (dq, J = 10.2, 1.3 Hz, 1H, CHHCHCH2-
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), 4.67 (s, 1H, CHHC-), 4.62 (s, 1H, CHHC-), 2.66 (dq, J = 11.7, 7.2 Hz, CH2CHHN-),
2.43 (dq, J = 11.7, 7.2 Hz, CH2CHHN-), 2.03 (qt, J = 6.8, 1.3 Hz, 2H, -CH2CH(C)N-),
1.83 (t, J = 6.0 Hz, 1H, -CH2CH(C)N-), 1.62-1.26 (m, 14H, -CH2 x 7), 1.20 (t, J = 7.2
Hz, 3H, CH3CH2N-); MS-ESI 222 [M + H]+.
3-Methylhept-2-en-1-ol (231)
Bu OH
To CuI (0.5 g, 2.63 mmol) was added dry THF (7 mL) and cooled
to -45 °C. n-BuLi (2.5 M in hexane, 2.1 mL, 5.26 mmol) was added
slowly and the solution kept at -45 °C for 30 min. Ethyl butynoate
(0.5 mL, 4.46 mmol) in THF (0.5 mL) was added slowly at -78 °C and the reaction stirred
for 30 min. MeOH (0.5 mL) was added carefully followed by sat. NH4Cl (2.5 mL) and
the solution allowed to warm to room temperature. The organics were separated, dried
(MgSO4), filtered and the solvent removed under reduced pressure. Column chromatog-
raphy (5% EtOAc in 40-60 °C petroleum ether) yields ethyl 3-methylhept-2-enoate (470
mg, 64%). Ethyl 3-methylhept-2-enoate (470 mg, 2.76 mmol) was dissolved in CH2Cl2
(10 mL) and cooled to -78 °C. DIBAL (1 M in hexane, 7.5 mL, 7.46 mmol) was added
and the solution stirred at 0 °C for 1 h. It was then cooled to -78 °C and quenched care-
fully with 1 M HCl (5 mL). 1 M HCl and CH2Cl2 were added to dissolved the solid. The
organic layer was separated, dried (MgSO4), filtered, and the solvent removed under re-
duced pressure to yield the title compound without purification (352 mg, 99%). Data is
consistent with literature values.100 1H-NMR (CDCl3, 400 MHz, δ): 5.66 (t, J = 1.2 Hz,
1H, -CCH-), 4.10 (d, J = 5.4, 2H, CH2OH), 1.98 (t, J = 7.2, 2H, -CH2CH2CH2CH3),
1.63 (s, 3H, C=CCH3), 1.39-1.27 (m, 4H, -CH2-), 0.89 (t, J = 6.9, 3H, -CH2CH3).
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1-(1-Butyl-1-methyl-2-propenylamino)-2,2,2-trichloro-1-ethanone (233)
HN
O
CCl3
3-Methylhept-2-en-1-ol (231) (100 mg, 0.78 mmol) was dis-
solved in CH2Cl2 (5 mL) and cooled to 0 °C. DBU (30 µL, 0.20
mmol) was added followed by CCl3CN (0.1 mL, 1.17 mmol)
and the reaction stirred at room temperature for 2 h. The solution
was then filtered through SiO2, which was washed with Et2O (25
mL), the combined organics were concentrated to an oil and used with purification. The
crude product was dissolved in CH2Cl2 (5 mL) and Pd[(Cl2)(MeCN)2] (27 mg, 0.078
mmol) added. The solution was stirred for 16 h at room temperature. The solution was
then filtered through celite, which was washed with Et2O (25 mL). The combined or-
ganics were concentrated under reduced pressure and the crude oil purified by column
chromatography (2% EtOAc in hexane) to give the title compound (39 mg, 18%). 1H-
NMR (CDCl3, 400 MHz, δ): 6.58 (s, 1H, -NHCOCCl3), 5.92 (dd, J = 17.5, 10.8 Hz,
-CHCH2), 5.19 (d, J = 9.0 Hz, 1H, -CHCHH), 5.15 (d, J = 15.7 Hz, 1H, -CHCHH),
1.81 (appr dt, J = 11.0, 8.2 Hz, 2H, -CH2CH2C-), 1.50 (s, 3H, CH3), 1.38-1.21 (m, 4H,
-CH2- x 2), 0.91 (t, J = , 7.1 Hz, 3H, CH3CH2-); 13C-NMR (CDCl3, 100 MHz, δ): 160.1
(C=O), 141.4 (CH), 113.4 (CH2), 93.3 (CCl3), 58.7 (C), 38.7 (CH2), 25.8 (CH2), 23.8
(CH3), 22.8 (CH2), 14.0 (CH3); IR (cm-1): 3429,3358 (-NH), 2958, 2866 (-CH2), 1717
(-COCCl3), 1503 (-C=C); MS-ESI 272, 274 [M + H]+ 294, 296 [M + Na]+; HRMS ES+
[M + Na]+ calcd for C1OH16Cl3NaO, 294.0190, 296.0160; found, 294.0188, 296.0160;
Rf = 0.3 (2% EtOAc in hexane).
1-(2-Bromo-1-butyl-1-methyl-2-propenylamino)-2,2,2-trichloro-1-ethanone (234)
HN
O
CCl3
Br
1-(1-Butyl-1-methyl-2-propenylamino)-2,2,2-trichloro-1-
ethanone (233) (50 mg, 0.17 mmol) was dissolved in MeCN
(1 mL) and cooled to 0 °C. PhSeBr (40 mg, 0.17 mmol) was
added and the reaction stirred for 3 days. The solution was
concentrated under reduced pressure then dissolved in CH2Cl2
(15 mL) and cooled to -78 °C. O3 was bubbled through the solution until a fading
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of the yellow colour was seen (3 h). The solution was purged with N2 for 1 h and
allowed to warm to room temperature. It was then was added dropwise to a refluxing
toluene (40 mL) solution. The solution was then refluxed for 30 min. The solution was
cooled to room temperature and the solvent removed under reduced pressure. Column
chromatography (2% EtOAc in hexane) yielded the title product as a clear oil (13 mg,
20%). 1H-NMR (CDCl3, 400 MHz, δ): 6.62 (s, 1H, -NH-), 5.88 (d, J = 2.8 Hz, -CHH),
5.74 (d, J = 2.8 Hz, -CHH), 2.01-1.91 (m, 1H, -CHH-), 1.89-1.78 (m, 1H, -CHH-),
1.67 (s, 3H, CH3), 1.43-1.22 (m, 4H, -CH2- x 2), 0.94 (t, J = 7.3 Hz, 3H, CH3CH2-);
13C-NMR (CDCl3, 100 MHz, δ): 159.9 (C=O), 136.7 (C), 119.1 (CH2), 91.5 (CCl3),
62.0 (C), 38.2 (CH2), 25.8 (CH2), 22.7 (CH2), 22.2 (CH3), 14.0 (CH3); IR (cm-1):
3429,3358 (-NH), 2933, 2871 (-CH2), 1665 (-COCCl3), 1466 (-C=C); MS-ESI 371,
373 [M + Na]+; Rf = 0.3 (2% EtOAc in hexane).
2-Bromo-N-(4-methoxybenzyl)prop-2-en-1-amine (80)
Br
NH
PMB
Paramethoxybenzylamine (5 mL, 19.4 mmol) was dissolved in THF
and K2CO3 (2.7 g, 19.4 mmol) added. 2,3-dibromopropene (2.5 mL,
38.7 mmol) was added drop wise and the solution stirred for 16 h.
The mixture was diluted with Et2O and the excess K2CO3 filtered off.
The organics were washed with NaOH (10%, 2 x 20 mL), dried (MgSO4), filtered and
the volatiles removed. Column chromatography (20% EtOAc in 40-60 °C petroleum
ether) yielded the title product as a clear oil (3.3 mg, 99%). Data is consistent with that
reported.134 1H-NMR (CDCl3, 400 MHz, δ): 7.26-7.24 (m, 2H, ArH), 6.88-6.86 (m,
2H, ArH), 5.79 (d, J = 1.4 Hz, 1H, -CHH), 5.60 (d, J = 1.7 Hz, 1H, -CHH), 3.80 (s, 3H,
-OCH3), 3.67 (s, 2H, -CH2), 3.45 (s, 2H, -CH2) 1.70 (br s, 1H, NH); 13C-NMR (CDCl3,
100 MHz, δ): 158.8 (C), 133.6 (C), 131.8 (C), 129.5 (CH2), 117.9 (CH2), 113.8 (CH),
55.3 (CH3); ESI+-MS: 256 [M + H]+; Rf = 0.3 (20% EtOAc in 40-60 °C petroleum
ether).
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3-Methylene-1-(4-methoxybenzyl)-2-azetidinone (74)
N
O PMB
2-Bromo-N-(4-methoxybenzyl)prop-2-en-1-amine (80 (500 mg, 1.95
mmol), Pd(PPh3)4 (226 mg, 10 mol%) and nBu3N (0.58 mL, 2.44
mmol) were dissolved in DMAc (10 mL). The mixture was placed un-
der an atmosphere of CO (balloon), heated to 100 °C and stirred for 18
h. The solution was allowed to cool and diluted with Et2O (20 mL). The organics were
washed with H2O (10 x 10 mL), dried (MgSO4), filtered and the solvent removed under
reduced pressure. Column chromatography (30% EtOAc in 40-60 °C petroleum ether)
yielded the title compound (0.118 g, 30%). 1H-NMR (CDCl3, 400 MHz, δ): 7.19-7.17
(m, 2H, ArH), 6.89-6.88 (m, 2H, ArH), 5.72 (s, 1H, -CHH), 5.14 (s, 1H, -CHH), 4.45
(s, 2H, -NCH2, 3.80 (s, 3H, -OCH3), 3.62 (s, 2H, -NCH2Ar); 13C-NMR (CDCl3, 100
MHz, δ): 159.3 (C=O), 145.1 (C), 129.5 (CH), 114.2 (CH), 109.5 (CH2), 55.3 (CH3),
47.7 (CH2), 45.5 (CH2); IR (cm-1): 2952, 2866 (-CH2), 1736 (-CONR2), 1512 (-C=C);
MS-ESI 226 [M + Na]+; HRMS ES+ [M + Na]+ calcd for C12H13NNaO2, 226.0838;
found, 226.0836; Rf = 0.3 (30% EtOAc in 40-60 °C petroleum ether).
Methyl 2-(hydroxymethyl)acrylate (76)
O
OMe
HO
Paraformaldehyde (1.1 g, 37.1 mmol) was dissolved in methyl acry-
late (5 mL, 55.6 mmol) and DABCO (410 mg, 3.71 mmol) added. The
solution was stirred for 3 days. The solution was diluted with Et2O,
washed with H2O. The aqueous was extracted with EtOAc (3 x 10
mL) and the combined organics dried (MgSO4), filtered and the solvent removed under
reduced pressure. Column chromatography (30% EtOAc in 40-60 °C petroleum ether)
yielded the title compound as a clear oil (1.78 g, 41%). Data is consistent with that re-
ported.135 1H-NMR (CDCl3, 400 MHz, δ): 6.26 (s, 1H, -CHH), 5.86 (s, 1H, -CHH),
4.33 (d, J = 5.64 Hz, 2H, -CH2), 3.79 (s, 3H, -COOCH3), 2.59 (br s, 1H, -OH); 13C-
NMR (CDCl3, 100 MHz, δ): 166.8 (C=O), 139.3 (C), 125.8 (CH2), 62.4 (CH2), 51.9
(CH3); ESI+-MS: 139 [M + Na]+; Rf = 0.3 (30% EtOAc in 40-60 °C petroleum ether).
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2-(Hydroxymethyl)acrylic acid (77)
O
OH
HO
Methyl 2-(hydroxymethyl)acrylate (76) (1.78 mg, 15.3 mmol) was dis-
solved in THF (20 mL). LiOH ·H2O (3 g, 76.7 mmol) in H2O (20 mL)
was added and the solution stirred for 18 h. The solution was allowed
to separate, and the aqueous acidified to pH 1 with 2 M HCl, then ex-
tracted with EtOAc (3 x 20 mL). The combined organics were dried (MgSO4), filtered
and the solvent removed under reduced pressure to yield the title compound as a viscous
oil (1.5 g, 99%). Data is consistent with that reported.135 1H-NMR (CDCl3, 400 MHz,
δ): 6.42 (s, 1H, -CHH), 5.98 (s, 1H, -CHH), 4.37 (s, 2H, -CH2); 13C-NMR (CDCl3, 100
MHz, δ): 171.0 (C=O), 138.6 (C), 128.4 (CH2), 62.2 (CH2); ESI+-MS: 125 [M + Na]+.
2-(Hydroxymethyl)-N-(4-methoxyphenyl)acrylamide (78)
O
NH
HO PMP
2-(Hydroxymethyl)acrylic acid (77) (1 g, 9.80 mmol) and p-anisidine
(2 g, 9.80 mmol) were dissolved in CH2Cl2 (30 mL). The solution
was cooled to −0 °C and DCC (1.2 g, 9.80 mmol) in CH2Cl2 (100
mL) was added slowly. After 2 h at −0 °C the suspension was fil-
tered through Celite and washed with a small amount of CH2Cl2, the solvent removed
under reduced pressure. Column chromatography (1:2 Et2O:CH2Cl2) yielded the title
compound as an off white solid (1.1 g, 50%). Data is consistent with that reported.53
1H-NMR (CDCl3, 400 MHz, δ): 8.62 (br s, 1H, NH), 7.48-7.45 (m, 2H, ArH), 6.87-
6.85 (m, 2H, ArH), 6.08 (s, 1H, -CHH), 5.57 (s, 1H, -CHH), 4.42 (s, 2H, -CCH2, 3.79
(s, 3H, -OCH3); 13C-NMR (CDCl3, 100 MHz, δ): 165.1 (C=O), 156.6 (C), 142.1 (C),
130.8 (C), 123.1 (CH2), 122.0 (CH), 114.2 (CH), 63.9 (CH2), 55.5 (CH3); ESI+-MS:
230 [M + Na]+; Rf = 0.3 (1:2 Et2O:CH2Cl2).
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1-(4-Methoxyphenyl)-3-methyleneazetidin-2-one (73)
N
O PMP
2-((4-Methoxyphenyl)carbamoyl)allyl methanesulfonate (79) (156 mg,
0.547 mmol) was dissolved in THF (10 mL). The solution was cooled
to −15 °C and KOtBu (67 mg, 0.602 mmol) was added in one portion.
After 4 h at −15 °C sat. NH4Cl (10 mL) was added and the organ-
ics separated, dried (MgSO4), filtered and the solvent removed under reduced pressure.
Column chromatography (30% EtOAc in 40-60 °C petroleum ether) yielded the title
compound as a white solid (46 mg, 45%). Data is consistent with that reported.53 1H-
NMR (CDCl3, 400 MHz, δ): 7.33-7.30 (m, 2H, ArH), 6.89-6.86 (m, 2H, ArH), 5.80 (s,
1H, -CHH), 5.29 (s, 1H, -CHH), 4.06 (s, 2H, -NCH2, 3.78 (s, 3H, -OCH3); 13C-NMR
(CDCl3, 100 MHz, δ): 159.7 (C=O), 156.2 (C), 143.6 (C), 132.0 (C), 117.5 (CH), 114.4
(CH), 110.5 (CH2), 55.5 (CH3), 47.8 (CH2); ESI+-MS: 190 [M + H]+, 212 [M + Na]+;
Rf = 0.3 (30% EtOAc in 40-60 °C petroleum ether).
1-(4-Methoxyphenyl)-3-methyleneazetidin-2-one (241)
N
O PMP
1-(4-Methoxyphenyl)-3-methyleneazetidin-2-one (73) (44 mg, 0.232
mmol) was dissolved in MeOH (2 mL). Pd/C (5 mg) was added and
the atmosphere replaced with hydrogen via a balloon. The suspension
was stirred vigorously for 24 h. The resulting suspension was filtered
through Celite, which was washed with CH2Cl2. The volatiles were removed under re-
duced pressure, to yield the title compound as a clear oil (4 mg, 9%). 1H-NMR (CDCl3,
400 MHz, δ): 7.31-7.29 (m, 2H, ArH), 6.88-6.86 (m, 2H, ArH), 3.79 (s, 3H, -OCH3),
3.75 (t, J = 5.5 Hz, 1H, -NCHH), 3.34 (ddq, J = 7.4, 2.5, 5.4 Hz, 1H, -CHCH3), 3.22 (dd,
J = 5.5, 2.6 Hz, 1H, -NCHH), 1.41 (d, J = 7.4 Hz, 3H, -CHCH3); 13C-NMR (CDCl3,
100 MHz, δ): 168.4 (C=O), 156.0 (C=O), 132.3 (C), 117.5 (CH), 114.4 (CH), 55.5
(CH3), 46.2 (CH2), 43.6 (CH), 13.8 (CH3); ESI+-MS: 192 [M + H]+, 214 [M + Na]+;
IR (cm-1): 1730 (-COOMe), 1519 (-C=C), 825 (para disub -ArH).
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2-(1-(4-Methoxyphenyl)-2-oxoazetidin-3-ylidene)ethyl acetate (242)
N
O PMP
AcO
1-(4-Methoxyphenyl)-3-methyleneazetidin-2-one (73) (43 mg, 0.23
mmol) was dissolved in CH2Cl2 (1.1 mL). Allyl acetate (50 µL,
0.46 mmol) was added followed by Grubbs 2nd generation catalyst
(4 mg, 0.005 mmol). The solution was refluxed for 2 h, at which
time an additional 4 mg of Grubbs 2nd generation catalyst was
added, and refluxed for 1 h. A final 4 mg of Grubbs 2nd generation catalyst was added
and the solution refluxed for 1 h. The solution was allowed to cool and the solvent
removed under reduced pressure. Column chromatography (30% EtOAc in 40-60 °C
petroleum ether) yielded the starting material (27 mg, 63%), E isomer (4 mg, 7%) and
the impure Z isomer (1 mg, 3%).
E isomer: 1H-NMR (CDCl3, 400 MHz, δ): 7.35-7.33 (m, 2H, ArH), 6.91-6.89
(m, 2H, ArH), 6.29 (tt, J = 5.4, 1.6 Hz, 1H, -CH=COCH2-), 4.75 (d, J = 5.4 Hz, 2H,
-C=CHCH2-), 4.20 (s, 2H, -CCH2NAr), 3.80 (s, 3H, -OCH3), 2.13 (s, 3H, -OCOMe);
13C-NMR (CDCl3, 100 MHz, δ): 159.3 (C=O), 156.3 (C=O), 138.5 (C), 131.9 (C),
120.0 (CH), 117.7 (CH), 114.5 (CH), 61.2 (CH2), 55.5 (CH3), 47.3 (CH2), 20.8
(CH3); ESI+-MS: 262 [M + H]+, 284 [M + Na]+; HRMS: ES+ [M + Na]+ calcd
for C14H15NNaO4, 284.0893; found, 284.0888; IR (cm-1): 1733 (-CONR2), 1719
(-COOMe), 1509 (-C=C), 1298 (-CO-CH3), 829 (para disub -ArH); mp 115-117 °C
(from CH2Cl2); Rf = 0.2 (30% EtOAc in 40-60 °C petroleum ether).
3-Heptylidene-1-(4-methoyphenyl)azetidin-2-one
N
O PMP
1-(4-Methoxyphenyl)-3-methyleneazetidin-2-one (73) (48 mg,
0.27 mmol) and 1-octene (83 µL, 0.53 mmol) were combined in
CH2Cl2 (1 mL) and Grubbs 2nd generation catalyst (4 mg, 0.005
mmol) added. The solution was heated to reflux for 1 h, then
cooled and the solvent removed under reduced pressure. Column
chromatography (5% EtOAc in 40-60 °C petroleum ether) yielded the E isomer (43
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mg, 62%) and the Z isomer (19 mg, 28%). E (trans): 1H-NMR (CDCl3, 400 MHz, δ):
m, 2H, ArH), 6.89-6.86 (m, 2H, ArH), 6.26 (dt, J = 7.5, 1.3 Hz, 1H, -CH=COCH2-),
4.07 (s, 2H, -CCH2NAr), 3.78 (s, 3H, -OCH3), 2.15 (q, J = 7.4 Hz, 2H, -C=CHCH2-),
1.51-1.44 (m, 2H, -CHCH2CH2-), 1.37-1.24 (m, 6H, 3 x CH2), 0.92-0.86 (m, 3H,
-CH3); 13C-NMR (CDCl3, 100 MHz, δ): 160.4 (C=O), 156.0 (C), 135.6 (C), 132.4 (C),
128.0 (CH), 117.4 (CH), 114.5 (CH), 55.5 (CH3), 46.8 (CH2), 29.2 (CH2), 28.9 (CH2),
28.5 (CH2), 22.6 (CH2), 14.1 (CH3); IR (cm-1): 2928; 2856 (-CH2), 1734 (-CONR2),
1509 (-C=C), 1241 (-CO-CH3), 825 (para disub -ArH); ESI+-MS: 274 [M + H]+,
296 [M + Na]+; HRMS: ES+ [M + H]+ calcd for C17H23NNaO2, 296.1621; found,
296.1624; mp 44-46 °C (from CH2Cl2); Rf = 0.3 (5% EtOAc in 40-60 °C petroleum
ether).
Z (cis): 1H-NMR (CDCl3, 400 MHz, δ): m, 2H, ArH), 6.89-6.86 (m, 2H, ArH),
5.73 (t, J = 7.8, 1H, -CH=COCH2-), 3.99 (s, 2H, -CCH2NAr), 3.79 (s, 3H, -OCH3),
2.57 (q, J = 7.5 Hz, 2H, -C=CHCH2-), 1.51-1.41 (m, 2H, -CHCH2CH2-), 1.40-1.24 (m,
8H, 4 x CH2), 0.93-0.85 (m, 3H, -CH3); 13C-NMR (CDCl3, 100 MHz, δ): 160.6 (C=O),
156.0 (C), 134.5 (C), 132.6 (C), 132.0 (CH), 117.3 (CH), 114.6 (CH), 55.5 (CH3), 47.0
(CH2), 31.7 (CH2), 29.4 (CH2), 28.84 (CH2), 28.81 (CH2), 22.6 (CH2), 14.1 (CH3); IR
(cm-1): 2925; 2855 (-CH2), 1726 (-CONR2), 1509 (-C=C), 1241 (-CO-CH3), 826 (para
disub -ArH); ESI+-MS: 274 [M + H]+, 296 [M + Na]+; HRMS: ES+ [M + H]+ calcd
for C17H23NNaO2, 296.1621; found, 296.1622; mp 41-43 °C (from CHCl3); Rf = 0.2
(5% EtOAc in 40-60 °C petroleum ether).
3-Heptylidene-1-(4-methoybenzyl)azetidin-2-one
N
O PMP
1-(4-Methoxybenzyl)-3-methyleneazetidin-2-one (74) (20 mg,
0.099 mmol) and 1-octene (30 µL, 0.20 mmol) were combined
in CH2Cl2 (400 µL). Grubbs 2nd generation catalyst (2 mg, 0.002
mmol) was added and the solution reluxed for 1 h. The solution was
allowed to cool and the solvent removed under reduced pressure.
155
Chapter 5 - Experimental
Column chromatography (20% EtOAc in 40-60 °C petroleum ether) yielded the E
isomer (15 mg, 54%) and the Z isomer (6 mg, 21%). E (trans) 1H-NMR (CDCl3, 400
MHz, δ): 7.13-7.08 (m, 2H, ArH), 6.83-6.78 (m, 2H, ArH), 6.06 (t, J = 7.4 Hz, 1H,
-CH2CHC-), 4.36 (s, 2H, ArCH2N-), 3.73 (s, 3H, -OMe), 3.53 (s, 2H, CH2(C)N-),
1.95 (q, J = 7.3 Hz, 2H, -CH2CH2CH-), 1.37-1.14 (m, 8H, -CH2- x 4), 0.79 (t, J =
6.8 Hz, 3H, CH3-); 13C-NMR (CDCl3, 100 MHz, δ): 163.9 (C=O), 159.2 (C), 137.0
(C), 129.5 (CH), 127.8 (C), 126.6 (CH), 114.2 (CH), 55.3 (CH3), 46.6 (CH2), 45.4
(CH2), 31.6 (CH2), 29.0 (CH2), 28.8 (CH2), 28.5 (CH2), 22.6 (CH2), 14.1 (CH3); IR
(cm-1): ;ESI+-MS: 288 [M + H]+, 326 [M + K]+ ; HRMS: ES+ [M + Na]+ calcd
for C18H25NNaO2, 310.1778; found, 310.1778; Rf = 0.3 (20% EtOAc in 40-60 °C
petroleum ether).
Z (cis) 1H-NMR (CDCl3, 400 MHz, δ): 7.23-7.08 (m, 2H, ArH), 6.82-6.78 (m,
2H, ArH), 5.47 (t, J = 7.8 Hz, 1H, -CH2CHC-), 4.34 (s, 2H, ArCH2N-), 3.73 (s, 3H,
-OMe), 3.44 (s, 2H, CH2(C)N-), 2.44 (q, J = 7.4 Hz, 2H, -CH2CH2CH-), 1.39-1.17 (m,
8H, -CH2- x 4), 0.81 (t, J = 6.7 Hz, 3H, CH3-); 13C-NMR (CDCl3, 150 MHz, δ): 164.3
(C=O), 159.1 (C), 136.0 (C), 130.4 (CH), 129.5 (CH), 127.9 (C), 114.1 (CH), 55.3
(CH3), 46.9 (CH2), 45.3 (CH2), 31.6 (CH2), 29.7 (CH2), 29.3 (CH2), 28.8 (CH2), 28.7
(CH2), 22.6 (CH2), 14.1 (CH3); IR (cm-1): ; ESI+-MS: 310 [M + Na]+; HRMS: ES+
[M + Na]+ calcd for C18H25NNaO2, 310.1778; found, 310.1774; Rf = 0.2 (20% EtOAc
in 40-60 °C petroleum ether).
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2-(1-(4-Methoxyphenyl)-2-oxoazetidin-3-ylidine)ethyl acetate
N
O PMB
AcO
1-(4-Methoxybenzyl)-3-methyleneazetidin-2-one (74) (114 mg,
0.56 mmol) and allyl acetate (120 µL, 1.12 mmol) were dissolved
in CH2Cl2 (2.3 mL). Grubbs 2nd generation catalyst (9 mg, 0.011
mmol) was added and the solution refluxed for 16 h. The solution
was cooled and the solvent removed under reduced pressure. Col-
umn chromatography (20% then 50% EtOAc in 40-60 °C petroleum ether) yielded the
E isomer exclusively (38 mg, 25%). 1H-NMR (CDCl3, 400 MHz, δ): 7.19-7.16 (m, 2H,
ArH), 6.90-6.89 (m, 2H, ArH), 6.16 (tt, J = 5.3, 1.4 Hz, 1H, -CH2CHC-), 4.63 (d, J =
5.4 Hz, 2H, -CHCH2COAc), 4.44 (s, 2H, ArCH2N-), 3.80 (s, 3H, -OMe), 3.71 (s, 2H,
CH2(C)N-), 2.04 (s, 3H, CH3); 13C-NMR (CDCl3, 100 MHz, δ): 170.3 (C=O), 163.0
(C=O), 159.3 (C), 140.0 (C), 129.5 (CH), 127.3 (C), 118.9 (CH), 114.3 (CH), 61.1
(CH2), 55.3 (CH3), 47.0 (CH2), 45.5 (CH2), 20.8 (CH3); IR (cm-1): 1736 (-CONR2),
1610 (-C=O), 1221 (-C=C-); ESI+-MS: 298 [M + Na]+; HRMS: ES+ [M + Na]+
calcd for C15H17NNaO4, 298.1050; found, 298.1045; Rf = 0.1 (20% EtOAc in 40-60 °C
petroleum ether).
3-(2-Hydroxyethylidene)-1-(4-methoybenzyl)azetidin-2-one
N
O PMB
HO
1-(4-Methoxybenzyl)-3-methyleneazetidin-2-one (74) (50 mg, 0.25
mmol) and allyl alcohol were dissolved in CH2Cl2 (1 mL). Grubbs
2nd generation catalyst (4 mg, 0.005 mmol) was added and the so-
lution refluxed for 48 h. The solution was cooled and the solvent
removed under reduced pressure. Column chromatography (50%
EtOAc in 40-60 °C petroleum ether) yielded the title compound in a 1:1.2 E:Z ratio
(<1 mg). 1H-NMR (CDCl3, 400 MHz, δ): 7.19-7.14 (m, 2H, ArH), 6.89-6.85 (m, 2h,
ArH), 6.19 (tt, J = 4.6, 1.5 Hz, 0.9H, -CH2CHC-), 5.88-5.87 (m, 1H, -CH2CHC-), 4.42
(s, 2H, ArCH2N-), 4.27 (d, J = 4.7 Hz, 1.8H, -CHCH2COH), 4.15 (d, J = 3.8 Hz, 2H,
-CHCH2COH), 3.80 (s, 3H, -OMe), 3.75 (s, 2H, CH2(C)N-); 13C-NMR (CDCl3, 100
MHz, δ): 164.0 (C=O), 159.2 (C), 137.3 (C), 131.0 (CH), 130.5 (CH), 129.5 (CH),
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127.5 (C), 124.4 (CH), 114.2 (CH), 62.9 (CH2), 60.6 (CH2), 55.3 (CH3), 47.6 (CH2),
45.5 (CH2); ESI+-MS: 256 [M + Na]+; Rf = 0.3 (50% EtOAc in 40-60 °C petroleum
ether).
3-(2-Ethoxyethylidene)-1-(4-methoybenzyl)azetidin-2-one
N
O PMB
O
1-(4-Methoxybenzyl)-3-methyleneazetidin-2-one (74) (40 mg, 0.20
mmol) and allyl ethyl ether (44 µL, 0.39 mmol) were dissolved in
CH2Cl2 (1 mL). Grubbs 2nd generation catalyst (3 mg, 0.004 mmol)
was added and the solution refluxed for 16 h. The solvent was re-
moved under reduced pressure. Column chromatography (20% +
1% Et3N in 40-60 °C petroleum ether) yielded the title compound as the E isomer exclu-
sively (6 mg, 12%). 1H-NMR (CDCl3, 400 MHz, δ): 7.19-7.17 (m, 2H, ArH), 6.89-6.87
(m, 2h, ArH), 6.17 (tt, J = 4.5, 1.4 Hz, 1H, -CH2CHC-), 4.43 (s, 2H, ArCH2N-), 4.06
(d, J = 4.7 Hz, 2H, -CHCH2CO-), 3.80 (s, 3H, -OMe), 3.70 (s, 2H, CH2(C)N-), 3.46
(q, J = 7.0 Hz, 2H, CH3CH2O-), 1.16 (t, J = 7.0 Hz, CH3CH2O-); 13C-NMR (CDCl3,
100 MHz, δ): 163.7 (C=O), 159.2 (C), 138.7 (C), 129.5 (CH), 127.7 (C), 121.2 (CH),
114.2 (CH), 67.9 (CH2), 66.4 (CH2), 55.3 (CH3), 47.6 (CH2), 45.5 (CH2), 15.1 (CH3);
IR (cm-1): 2928; 2851 (-CH2), 1745 (-CONR2), 1513 (-C=C), 1246 (-CO-CH3); ESI+-
MS: 261 [M + H]+, 284 [M + Na]+; Rf = 0.3 (20% + 1% Et3N in 40-60 °C petroleum
ether).
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Appendix I: NMR Spectra of
Phyllostictine A
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Figure I – 1H-NMR
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Figure II – 13C-NMR
161
Figure III – COSY NMR
162
Figure IV – HSQC NMR
163
Figure V – HMBC NMR
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Appendix II: α-Methylene-β-Lactam
E/Z Shifts
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α-Methylene-β-Lactam E-Shift (ppm) Z-Shift (ppm)
N
O PMP
H
- 5.71
N
N
O
O
PMP
PMP
- 5.52
O
N
H
O PMP
6.25 5.88
O
O
N
N
O
O
PMP
PMP
H
H
- 5.86-5.8
NH
O
O
- 5.89
N
O
O
Et
- 5.78
N
N
O
OPMP
PMP
- 5.70-5.57
N
N
O Et
Et O
- 5.44
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O
Et
Et
- 5.69
α-Methylene-β-Lactam E-Shift (ppm) Z-Shift (ppm)
N
O PMB
O
6.29 -
N
O PMB
HO
6.26 5.73
N
O PMB
AcO
6.06 5.47
N
O PMP
6.16 -
N
O PMP
6.19 5.88-5.87
N
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Appendix III: HPLC Traces
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Figure I
Figure II
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Figure III
Figure IV
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